ampicillin has been researched along with ciprofloxacin in 468 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 24 (5.13) | 18.7374 |
1990's | 78 (16.67) | 18.2507 |
2000's | 130 (27.78) | 29.6817 |
2010's | 168 (35.90) | 24.3611 |
2020's | 68 (14.53) | 2.80 |
Authors | Studies |
---|---|
Malan, SF; Swart, H; Van Dyk, S | 1 |
Chen, S; Cui, S; McDermott, PF; Meng, J; Paulsen, I; White, DG; Zhao, S | 1 |
Elkins, CA; Mullis, LB | 1 |
Barth, AL; Castanheira, M; Gales, AC; Nicoletti, AG; Pereira, AS; Pignatari, AC | 1 |
Ko, WC; Tsai, SH; Wu, JJ; Yan, JJ | 1 |
Bradbury, BJ; Buechter, DD; Cheng, J; Deshpande, M; Mushtaq, G; Podos, SD; Pucci, MJ; Thanassi, JA; Thoma, CL; Vigliotti, GA | 1 |
Erdoğan, T; Göker, H; Güven, OO; Yildiz, S | 1 |
Altanlar, N; Tekiner-Gulbas, B; Temiz-Arpaci, O; Yildiz, I | 1 |
Caniça, M; Ferreira, E; Leitão, J; Manageiro, V; Mendonça, N | 1 |
Kwon, DH; Lu, CD | 1 |
Avlami, A; Daikos, GL; Katsilambros, N; Kosmidis, C; Petrikkos, G; Psychogiou, M; Stefanou, I; Tassios, PT; Vasilakopoulou, A | 1 |
Courvalin, P; Galimand, M; Périchon, B | 1 |
Castanheira, M; Jones, RN; Mendes, RE; Sader, HS; Toleman, MA; Walsh, TR | 1 |
Brouillette, CG; Brouillette, WJ; DeLucas, LJ; Luan, CH; Mou, L; Velu, SE; Yang, ZW | 1 |
Arakawa, Y; Kato, H; Kimura, K; Konda, T; Shibata, N; Shibayama, K; Suzuki, S; Wachino, J; Yamane, K | 1 |
Hovde, LB; Kroeger, LA; Mitropoulos, IF; Rotschafer, JC; Schafer, J | 1 |
Jansen, WT; Milatovic, D; Verel, A; Verhoef, J | 1 |
Altanlar, N; Atli, O; Bozdağ-Dündar, O; Ertan, R; Kendi, E; Menteşe, A; Ozgen, O | 1 |
Beceiro, A; Bou, G; Canle, D; Fernández, A; Lasa, I; Latasa, C; Mallo, S; Molina, F; Pérez, A; Pérez, S; Poza, M; Tomás, Mdel M; Villanueva, R | 1 |
Liu, Y; Shi, W; Wang, M; Wu, S; Xu, X; Ye, X; Zhang, Y | 1 |
Iredell, JR; Partridge, SR; Zong, Z | 1 |
Campbell, BJ; Edwards, SW; Hart, CA; Martin, HM; Rhodes, JM; Roberts, CL; Subramanian, S | 1 |
Jones, GL; Stickler, DJ | 1 |
Chen, T; Khalil, H; Riffon, R; Wang, R; Wang, Z | 1 |
Baudry, PJ; DeCorby, M; Hoban, DJ; Mataseje, L; Mulvey, MR; Nichol, K; Zhanel, GG | 1 |
Cai, JC; Chen, GX; Zhang, R; Zhou, HW | 1 |
Beckius, ML; Fraser, SL; Galloway, RL; Griffith, ME; Hospenthal, DR; Mende, K; Miller, RS; Murray, CK; Pimentel, G; Ressner, RA | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Benton, BM; Debabov, DV; Difuntorum, S; Krause, KM; Renelli, M; Wu, TX | 1 |
Alba, V; Blasco, MD; Espinal, P; Fernández-Cuenca, F; Marti, S; Pascual, A; Ruiz, M; Sánchez-Céspedes, J; Vila, J | 1 |
Bammert, GF; Banitt, LS; Barbachyn, MR; Boyle, TP; Bundy, GL; Dolak, LA; Ford, CW; Graber, DR; Hamel, JC; Han, F; Harris, DW; Hromockyj, AE; Hurd, AR; Kamilar, GM; Marotti, KR; Martin, GE; Miller, AA; Mott, JE; Munzner, JB; Palmer, JR; Ruble, JC; Seest, EP; Skepner, JE; Sweeney, MT; Zhong, WZ; Zurenko, GE | 1 |
Hansen, S; Lewis, K; Vulić, M | 1 |
Andersson, DI; Negrea, A; Pränting, M; Rhen, M | 1 |
Albertí, S; Beceiro, A; Bou, G; Garau, M; Gutiérrez, O; Juan, C; Oliver, A; Pérez, JL | 1 |
Bhagwat, SS; Diwakar, SD; Gill, CH; Shingare, MS | 1 |
Altanlar, N; Kiper, T; Tunçbilek, M | 1 |
Afif, C; Bagattini, M; Daoud, Z; Di Popolo, A; Khan, AU; Triassi, M; Vitale, D; Zarrilli, R | 1 |
Adams-Haduch, JM; Doi, Y; Harrison, LH; Muto, CA; Pasculle, AW; Paterson, DL; Potoski, BA; Sidjabat, HE | 1 |
Chang, FY; Chen, JH; Fung, CP; Lai, YK; Lin, CJ; Lin, JC; Ma, L; Siu, LK | 1 |
Chen, Z; Deng, Y; Huang, L; Liu, J; Lü, D; Ma, J; Wang, M; Wang, X; Xu, X; Zeng, Z; Zhang, Y | 1 |
Baptista, BC; Correia, JD; da Fonseca, JD; Martínez-Martínez, L; Pomba, C | 1 |
Bell, JM; Castanheira, M; Deshpande, LM; Jones, RN; Mendes, RE; Turnidge, JD | 1 |
Ike, Y; Inoue, T; Tomita, H; Zheng, B | 1 |
Fanning, S; McCusker, M; O'Regan, E; Pagès, JM; Piddock, L; Quinn, T | 1 |
Bell, JM; Castanheira, M; Jones, RN; Mathai, D; Turnidge, JD | 1 |
Biedenbach, DJ; Fritsche, TR; Jones, RN | 1 |
Cui, L; Hiramatsu, K; Neoh, HM; Shoji, M | 1 |
Bell, JM; Biedenbach, DJ; Jones, RN; Sader, HS; Turnidge, JD | 1 |
Altanlar, N; Ateş-Alagöz, Z; Karayel, A; Ozbey, S; Tunçbilek, M | 1 |
Baraniak, A; Bedenic, B; Fiett, J; Gniadkowski, M; Jajic-Bencic, I; Literacka, E; Tonkic, M | 1 |
Caugant, DA; Fredlund, H; Hedberg, ST; Nicolas, P; Olcén, P; Unemo, M | 1 |
Wang, X; Zhao, X | 1 |
Guo, Q; Hooper, DC; Wang, M; Wang, X; Wu, S; Xu, X; Ye, X | 1 |
Fritsche, TR; Jones, RN; Sader, HS | 1 |
Goy, G; Greub, G | 1 |
Bartolomé, R; Coelho, A; González-López, JJ; Larrosa, MN; Lavilla, S; Prats, G | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Accogli, M; Caprioli, A; Carattoli, A; Cerquetti, M; Fortini, D; García-Fernández, A; Giufrè, M; Graziani, C; Luzzi, I | 1 |
Ansari, KF; Lal, C | 1 |
Capone, A; D'Andrea, MM; D'Arezzo, S; Giani, T; Luzzaro, F; Petrosillo, N; Rossolini, GM; Visca, P | 1 |
Badal, RE; Bouchillon, SK; Hawser, SP; Hoban, DJ; Hsueh, PR; Paterson, DL | 1 |
Gaillard, JL; Jackson, M; McDonnell, G; Niederweis, M; Skovierová, H; Svetlíková, Z | 1 |
Ahmed, NA; Petersen, FC; Scheie, AA | 1 |
Baraniak, A; Fiett, J; Filczak, K; Gniadkowski, M; Herda, M; Hryniewicz, W; Izdebski, R; Kern-Zdanowicz, I; Łopaciuk, U | 1 |
Arai, K; Hasegawa, M; Hatta, M; Hirakata, Y; Jones, RN; Kaku, M; Kawakami, K; Kitagawa, M; Kobayashi, I; Kohno, S; Kunishima, H; Matsuzaki, K; Mikuriya, M; Ohmori, K; Saika, T; Yamaguchi, K; Yamamoto, N; Yano, H | 1 |
Carattoli, A; Ellington, MJ; Karisik, E; Livermore, DM; Underwood, A; Woodford, N | 1 |
Arhin, FF; Draghi, DC; Moeck, G; Parr, TR; Pillar, CM; Sahm, DF | 1 |
Chung, DR; Ko, KS; Peck, KR; Son, JS; Song, JH; Suh, JY | 1 |
Cho, HS; Giske, CG; Lee, K; Sundman, K; Toleman, MA; Walsh, TR; Yong, D | 1 |
Ichiishi, S; Mikamo, H; Nakao, K; Shibata, T; Tanaka, K; Watanabe, K | 1 |
Fanning, S; Fedorka-Cray, PJ; Frye, JG; McClelland, M; O'Regan, E; Pagès, JM; Porwollik, S; Quinn, T | 1 |
Ahmed, S; Calderwood, SB; Faruque, AS; Hooper, DC; Jacoby, GA; Khan, WA; Kim, HB; LaRocque, RC; Park, CH; Qadri, F; Salam, MA; Wang, M | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Hakanen, AJ; Huovinen, P; Kotilainen, P; Lehtopolku, M; Nakari, UM; Siitonen, A | 1 |
Elkins, CA; Jung, CM; Lacher, DW; Mullis, LB | 1 |
Bunders, C; Huigens, RW; Melander, C; Reed, CS; Reyes, S; Rogers, SA; Steinhauer, AT | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Hsueh, PR; Jiang, SS; Liaw, SJ; Liu, MC; Teng, LJ; Wang, WB | 1 |
Bavari, S; Bowlin, TL; Houseweart, C; Moir, DT; Opperman, TJ; Panchal, RG; Peet, NP; Williams, JD | 1 |
Chang, SC; Chen, YC; Hsia, KC; Li, SY; Liao, MH; Lin, YC; Sheng, WH | 1 |
Choi, JY; Ko, KS; Lee, MY; Park, YK; Peck, KR; Rhee, JY; Shin, JY; Song, JH | 1 |
Ardanuy, C; Brito-Avô, A; Gonçalo-Marques, J; Liñares, J; Morais, A; Pires, R; Rolo, D; Santos-Sanches, I | 1 |
Barber, M; Eberly, LE; Feeney, LA; Miller, GH; Summers, A; Wortmann, G; Zapor, MJ | 1 |
Badal, RE; Baquero, F; Bouchillon, SK; Cantón, R; Hawser, SP; Hoban, DJ | 1 |
Dal-Ré, R; García-de-Lomas, J; García-Delafuente, C; Iriarte, V; Martín-Herrero, JE; Mazón, A; Pérez-Trallero, E; Robles, P | 1 |
Badal, RE; Bouchillon, SK; DiPersio, J; Hawser, SP; Hoban, DJ; Labombardi, VJ | 1 |
Goswami, M; Jawali, N | 1 |
Fuller, CA; McGannon, CM; Weiss, AA | 1 |
Bai, N; Cai, Y; Li, R; Liang, B; Liu, Y; Wang, R | 1 |
Bohnert, JA; Karamian, B; Nikaido, H | 1 |
Chen, S; Chen, Z; Deng, Y; Huang, X; Liu, JH; Liu, Y; Sun, Y; Tian, W; Wu, C; Zeng, Z; Zhao, J | 1 |
Gadakh, AV; Karale, BK; Pandit, C; Rindhe, SS | 1 |
Bogaerts, P; Buvens, G; Glupczynski, Y; Lauwers, S; Piérard, D | 1 |
Haveliwala, DD; Kamdar, NR; Mistry, PT; Patel, SK | 1 |
Mali, MD; Patel, MM; Patel, SK | 1 |
Hamprecht, A; Higgins, PG; Schneiders, T; Seifert, H | 1 |
Kalle, AM; Rizvi, A | 1 |
Chiba, T; Hasegawa, T; Horita, Y; Kremer, L; Kuroishi, R; Lee, Y; Ogawa, K; Onozaki, K; Sato, Y; Takii, T | 1 |
Black, T; Daubaras, DL; Mansoor, UF; McNicholas, P; Orth, P; Reddy, PA; Siddiqui, MA; Vitharana, D | 1 |
Makawana, JA; Mungra, DC; Patel, MP; Patel, RG | 1 |
Akhaja, TN; Raval, JP | 1 |
Anderson, KC; Kellogg, GE; Sarkar, A | 1 |
Barad, HA; Gupta, VK; Kant, R; Pansuriya, BR; Parmar, NJ; Teraiya, SB | 1 |
Barad, HA; Gupta, VK; Kant, R; Pansuriya, BR; Parmar, NJ | 1 |
Patel, MP; Patel, RG; Shah, NM | 1 |
Bonifácio, VD; Gawande, MB; Mhaske, GR; Shelke, SN | 1 |
Parmar, BD; Parmar, NJ; Patel, RA; Talpada, NP | 1 |
Chouthe, RS; Darandale, SN; Dharmadhikari, PP; Fatema, B; Karande, V; Lad, V; Sangshetti, JN; Shinde, DB | 1 |
Darandale, SN; Mulla, NA; Pansare, DN; Shinde, DB | 1 |
Kathrotiya, HG; Patel, MP | 1 |
Kanawade, SB; Rajani, DP; Toche, RB | 1 |
Jardosh, HH; Patel, MP | 1 |
Cížek, A; Imramovský, A; Jampílek, J; Masaříková, M; Pauk, K; Pokorná, M; Vinšová, J; Zadražilová, I | 1 |
Cai, G; Cho, S; Franzblau, SG; Jaki, BU; Lee, IA; McAlpine, JB; Napolitano, JG; Pauli, GF; Suh, JW; Wang, Y; Yang, SH | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Bouillon, A; Cresteil, T; Fontaine, F; Hequet, A; Jolivalt, C; Lesnard, A; Rault, S; Voisin-Chiret, AS | 2 |
Gade, WN; Khan, FA; Marathe, SD; Patil, RH; Sangshetti, JN; Shaikh, RI; Shinde, DB | 1 |
Kalaria, PN; Raval, DK; Satasia, SP | 1 |
Mulla, NA; Pansare, DN; Pawar, CD; Shende, VR; Shinde, DB | 1 |
Mishra, NN; Prabhakar, YS; Saquib, M; Sharma, S; Shaw, AK; Shukla, PK; Srivastava, R; Verma, S | 1 |
Karad, SC; Purohit, VB; Raval, DK | 1 |
Alam, MZ; Bruhn, DF; Feng, L; Hurdle, JG; Lee, RB; Lee, RE; Maddox, MM; Narula, G; Sandhaus, S; Simmons, CJ; Sun, D; Tse-Dinh, YC; Tsutsumi, LS; Wu, X | 1 |
Al-Balas, Q; Al-Gharaibeh, M; Alali, F; Albataineh, H; Chen, WL; El-Elimat, T; Falkinham, JO; Oberlies, NH; Swanson, SM | 1 |
Amaral, L; Bojarski, AJ; Handzlik, J; Kieć-Kononowicz, K; Latacz, G; Matys, A; Molnar, J; Otrębska-Machaj, E; Podlewska, S; Schabikowski, J; Szymańska, E; Witek, J; Witek, K | 1 |
Karad, SC; Purohit, VB; Raval, DK; Thakkar, VR; Thakor, P | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Blair, PM; Mitchell, DA; Molloy, EM; Tietz, JI | 1 |
Günal, S; Kaloğlu, M; Kaloğlu, N; Özdemir, İ | 1 |
Kamani, RD; Karad, SC; Purohit, VB; Raval, DK; Ray, A; Thakkar, SS; Thakkar, VR; Thakor, P; Thummar, RP; Vaghasiya, BK | 1 |
Farooqui, M; Khan, FA; Patil, RH; Sangshetti, JN; Zaheer, Z | 1 |
Brozovic, A; Dowson, CG; Gazvoda, M; Košmrlj, J; Lloyd, A; Osmak, M; Proud, C; Roper, DI; Vajs, J | 1 |
Sankar, C; Umamatheswari, S | 1 |
Doshi, H; Ray, A; Thakkar, SS; Thakor, P | 1 |
Bartůněk, P; Benada, O; Bogdanová, K; Ehn, M; Fišer, R; Kolář, M; Krásný, L; Křížek, T; Panova, N; Pohl, R; Pospíšil, J; Rejman, D; Šanderová, H; Sedlák, D; Seydlová, G; Šimák, O; Sudzinová, P; Večeřová, R; Vítovská, D; Zborníková, E | 1 |
Abdel-Aziz, MM; Abdelrahman, MA; Elaasser, MM; Gomaa, MS; Salama, I; Soliman, DH | 1 |
Doshi, H; Ray, A; Thakkar, SS; Thakkar, VR; Thakor, P | 1 |
Bernardino, AMR; Boechat, N; Dos Santos, MS; Faria, JV; Miguita, AGC; Vegi, PF | 1 |
Liu, ML; Liu, X; Pan, B; Zhang, GF; Zhang, S | 1 |
Cizek, A; Imramovsky, A; Jampilek, J; Kauerova, T; Kollar, P; Michnova, H; Pauk, K; Pospisilova, S; Vinsova, J | 1 |
Bai, L; Deng, J; Feng, L; Lv, Z; Wang, Y; Xu, Z; Zhang, F; Zhao, S | 1 |
Bukhari, SNA; Mallesha, N; Manukumar, HM; Qin, HL; Rakesh, KP; Vivek, HK; Wang, SM; Zha, GF | 1 |
Guo, H | 1 |
Björkling, F; Bonke, G; Franzyk, H; Hansen, AM; Hogendorf, WFJ; Kongstad, KT; Nielsen, J; Nielsen, PE; Tomczak, M; Urbas, M; Zabicka, D | 1 |
Zhang, B | 1 |
Gao, F; Huang, G; Wang, T; Xiao, J | 1 |
Ba, Y; Wang, S; Xu, Z; Zhang, J | 1 |
Cheng, W; Kong, H; Wei, H; Yang, Z; Yuan, Y; Zhang, X | 1 |
Gao, F; Huang, G; Xiao, J | 1 |
Liu, H; Long, S; Rakesh, KP; Zha, GF | 1 |
Clark, BR; Li, J | 1 |
Alajlani, M; Bauer, R; Belaj, F; Brantner, A; Dolensky, J; Hochegger, P; Kaiser, M; Kretschmer, N; Mäser, P; Mohsin, NU; Petritsch, M; Saf, R; Schühly, W; Seebacher, W; Weis, R | 1 |
Daraji, DG; Jayanthi, S; Patel, HD; Pithawala, EA; Rajani, DP; Rajani, SD | 1 |
Agostinho, ÍRC; Araújo, AR; Campos, MAS; de Alcântara Oliveira, FA; de Carvalho Sousa, B; de Oliveira Castelo Branco, RR; Dos Santos Soares, MJ; Gonzalez, AGM; Lopes, AP; Pinheiro, REE; Rocha, JA | 1 |
Chen, WM; Hou, W; Huang, MY; Lin, J; Meng, Y; Xu, XF; Yu, JH | 1 |
Bora, A; Deka, B; Devi, MV; Dihingia, A; Pahari, P; Sarma, S; Sen, T; Singh, AK; Suri, M | 1 |
Guo, Y; Jia, G; Li, L; Wang, J; Wei, L; Xu, X; Yang, Y; Yu, Q; Zhou, Y | 1 |
Guo, XC; Huang, XH; Lu, YJ; Ser, HL; She, MT; Sun, N; Wong, WL; Zhang, YH; Zheng, BX; Zhong, DX | 1 |
Benada, O; Bogdanová, K; Dávidová, E; Do Pham, DD; Fišer, R; Galandáková, A; Helusová, M; Kolář, M; Krásný, L; Křížek, T; Mikušová, G; Mojr, V; Pohl, R; Pospíšil, J; Rejman, D; Šanderová, H; Sedláková, MH; Sudzinová, P; Večeřová, R; Vítovská, D | 1 |
Angeles-Solano, M; Brock, JW; Grosser, MR; Murphy, KE; Pugh, BA; Rao, AB; Wolfe, AL | 1 |
Avanessian, AB; Lomeli, SL; Nachnani, S; Newman, MG; Scuteri, A | 1 |
Altay, G; Cokça, F | 1 |
Mattie, H; Sekh, BR; van Furth, R; van Ogtrop, ML; van Strijen, E | 1 |
Hananel, JI; Hulbert, TV; Larsen, RA | 1 |
Dev, R; Goyal, RS; Sen, S | 1 |
Mehta, S; Misra, S; Panigrahi, D; Thapa, BR | 1 |
Balestrieri, GP; Baratto, G; di Stefano, O; Giustina, G; Rossi, M; Salvi, A | 1 |
Kronvall, G; Ringertz, S; Rylander, M | 1 |
Kaatz, GW; Ruble, CA; Seo, SM | 1 |
Dietrich, KA; Dixon, WA; Landau, SW; Miller, WC; Sacher, HL; Sacher, ML | 1 |
Hayran, M; Kocagöz, T; Sener, B; Ustaçelebi, S | 1 |
Fu, KP; Hilliard, J; Isaacson, D; McGuire, JL; Rosenthale, ME; Tobia, AJ | 1 |
Barza, M; Bennish, ML; Haider, R; Salam, MA | 1 |
Campos, LC; dos Reis, EM; Ribeiro Dias, JC | 1 |
Faegri, A; Melby, K | 1 |
Crokaert, F; Van der Linden, MP; Yourassowsky, E | 1 |
Allerberger, F; Dierich, MP | 1 |
Amaral, L; Ernst, J; Lorian, V | 1 |
Chodosh, S; Pizzuto, D; Stottmeier, KD; Tuck, J | 1 |
Ferro, S; Low, DE; Simor, AE | 1 |
Powell, M; Seetulsingh, P; Williams, JD | 1 |
Liu, C; Ratner, HB; Stratton, CW; Weeks, LS | 1 |
Grohe, K; Metzger, KG; Schacht, P; Zeiler, HJ | 1 |
Brunner, H; Zeiler, HJ | 1 |
Handsfield, HH; Hook, EW; Roddy, RE | 1 |
Gottschall, S; Kim, MJ; Randall, EL; Weiser, M | 1 |
Berrocal, CI; Berrocal, L; Pérez, JL; Riera, L; Valls, F | 1 |
Fuursted, K | 1 |
Eng, RH; Smith, SM | 1 |
Dubois, J; Fontaine, V | 1 |
Baars, B; Cullmann, W; Opferkuch, W; Stieglitz, M | 1 |
Hussar, DA | 1 |
Ehlers, S; Hahn, H | 1 |
Holden, P; Nix, DE; Rescott, DL; Schentag, JJ | 1 |
Barry, AL | 1 |
Borner, K; Kemmerich, B; Pennington, JE | 1 |
Afzal, Q; Guarneri, JJ; Khan, FA; LaBombardi, V; Raoof, S; Wollschlager, CM | 1 |
McMillan, A; Scott, GR; Young, H | 1 |
Brkić, S; Celanović, M; Jovanović, J; Knezević, K; Madle-Samardzija, N | 1 |
Das, SS; Lee, PY | 1 |
Bogomolski, V; Kaminski, N; Stalnikowicz, R | 1 |
Bodey, G; Gikas, A; Maraki, S; Samonis, G; Toloudis, P; Tsaparas, N; Tselentis, Y; Vrentzos, G | 1 |
Arman, D; Tural, D; Willke, A | 1 |
Cherubin, CE; Stratton, CW | 1 |
Asikainen, S; Forsblom, B; Jousimies-Somer, H; Pajukanta, R; Piekkola, M | 1 |
Akay, MA; Kiliç, E; Köseoğlu, F | 1 |
Landman, D; Mobarakai, N; Quale, JM | 1 |
Singh, AK | 1 |
Alaluusua, S; Asikainen, S; Jousimies-Somer, H; Pajukanta, R; Saarela, M | 1 |
Delahooke, TE; Nelson, D; Poxton, IR | 1 |
Gant, VA; Phillips, I; Savidge, GF; Warnes, G | 1 |
Bortoletto, ML; Brasil Filho, R; Carvalho, MC; Levi, GC; Lobo, IM; Mendonça, JS; Silva, ML; Trevisanello, C; Yamaguti, A | 1 |
Lloyd, AL; Lloyd, D; Mason, DJ | 1 |
Bennish, ML; Salam, MA; Wahed, MA | 1 |
Eng, RH; Ng, K; Smith, SM | 1 |
Alamo, I; González, A | 1 |
Landman, D; Mobarakai, N; Quale, JM; Zaman, MM | 1 |
Hayden, MK; Matushek, MG; Trenholme, GM | 1 |
Florio, A; Locatelli, A; Rambaldi, A; Rosario, P; Ruggiero, G; Tripodi, MF; Utili, R | 1 |
Veis, JH; Vijayvargiya, R | 1 |
Melonakos, TK | 1 |
Drobot, GR; Hoban, DJ; Karlowsky, JA; Zhanel, GG | 1 |
Akalin, E; Arikan, S; Auckenthaler, R; Bergan, T; Dornbusch, K; Howard, AJ; Hryniewicz, W; Jones, RN; Koupari, G; Legakis, NJ; McLaughlin, J; Ozkuyumcu, C; Percival, A; Phillips, I; Reeves, D; Spencer, R; Warren, RE; Williams, JD; Yeo, SF | 1 |
Chen, YS; Cheng, DL; Liu, YC; Wang, JH; Wann, SR; Yen, MY | 1 |
Miller, LA; Poupard, JA; Rittenhouse, SF; Utrup, LJ | 1 |
Hof, H; Nichterlein, T; Walz, A | 1 |
Blackwell, AL; Singh, G; Thomas, PD | 1 |
Hanif, M; Islam, M; Ruhulamin, M; Saha, S; Saha, SK | 1 |
Deobaldia, J; Evans, PA; Norden, CW; Rhoads, S; Silber, JL | 1 |
Gaudreau, C; Gilbert, H | 1 |
Andriole, VT; Dembry, LM; Farrel, PA; Gerrity, LA; Orcutt, DR | 1 |
Gaudreau, C; Turgeon, P | 1 |
Badrinath, S; Rao, RS; Vijayalakshmi, N | 1 |
Falagas, ME; McDermott, L; Snydman, DR | 1 |
Dotters, DJ; James, AH; Katz, VL; Rogers, RG | 1 |
Nettles, RE; Sexton, DJ | 1 |
Bornitz, F; Hof, H; Kretschmar, M; Nichterlein, T | 1 |
Ercal, N; Matthews, RH | 1 |
Canawati, HN; Montgomerie, JZ; Schick, DG | 1 |
Locatelli, A; Rambaldi, A; Rosario, P; Tripodi, MF; Utili, R | 1 |
Chankova, D; Guirguitzova, B; Minkov, N; Zozikov, B | 1 |
Felmingham, D; Grüneberg, RN; Harding, I; Robbins, MJ; Shrimpton, S; Tesfaslasie, Y | 1 |
Ananthakrishna, NC; Bhat, KG; Paul, C | 1 |
Hoppe, JE; Paulus, T | 1 |
Bouchillon, S; Johnson, J; Pontani, D; Washton, H | 1 |
Gizatullina, ED; Guryleva, ME; Ozol, SM; Vizel', AA | 1 |
Grudinina, SA; Krotova, LA; Rezvan, SP; Sidorenko, SV; Sterkhova, GV | 1 |
Cisterna, R; Fresnadillo, MJ; García-Rodríguez, JA; Gobernado, M; Martín, R; Perea, E; Picazo, J | 1 |
Cavallo, JD; Fabre, R; Martet, G; Nicolas, P | 1 |
Samaranayake, LP; Sedgley, CM | 1 |
Kaufhold, A; Klein, R | 1 |
Lacy, MK; Lu, W; Nicolau, DP; Nightingale, CH; Quintiliani, R; Tessier, PR; Xu, X | 1 |
Dabernat, H | 1 |
Borer, A; Buskila, D; Gilad, J; Riesenberg, K; Schlaeffer, F; Sikuler, E | 1 |
Akman, M; Arseven, O; Aydin Tosun, G; Erelel, M; Erk, M; Göylüsün, V; Gür, A; Ilvan, A; Koşar, F; Müsellim, B; Oztürk, S; Soysal, F; Türker, H; Tutluoglu, B; Umut, S; Unutmaz, S; Vahapoglu, H; Yildirim, N; Yilmaz Kuyucu, T; Yilmaz, N | 1 |
Ragone, E; Rambaldi, A; Sarnataro, G; Tripodi, MF; Utili, R | 1 |
Banevicius, MA; Lacy, MK; Nicolau, DP; Nightingale, CH; Quintiliani, R | 1 |
Bullock, P; Price, EH; Workman, MR | 1 |
Desta, TD; Inciardi, JF; Lam, K; Leung, JW; Libby, ED; Liu, YL | 1 |
Carrie, A; Harding, GK; Hoban, DJ; Karlowsky, JA; Low, DE; Mazzulli, T; Zhanel, GG | 1 |
Chiba, A; Harada, S; Hasegawa, M; Kaneko, A; Kobayashi, I; Koyama, H; Matsuzaki, K; Omika, K; Sasaki, J; Sato, Y | 1 |
Allison, DG; Gilbert, P; Maira-Litrán, T | 1 |
Anderl, JN; Franklin, MJ; Stewart, PS | 1 |
Eckert, SJ; McNeeley, DF; Noel, GJ | 1 |
Amrikachi, M; Finch, CJ; Krishnan, B; Shahab, I | 1 |
Butkevich, OM; Vinogradova, TL | 1 |
Hu, DC; Jowell, PS; Killenberg, PG; McGrath, KM | 1 |
Dunstan, FD; Fitzgerald, KA; Howard, AJ; Magee, JT | 1 |
Fernández, F; Martínez-Martínez, L; Perea, EJ | 1 |
Araj, GF; Zouain, MG | 1 |
Cheng, SH; Chu, FY; Lo, SH; Lu, JJ | 1 |
Coban, AY; Durupinar, B; Ekinci, B | 1 |
Calvo, A; García, R; Gómez-Lus, ML; Leturia, A; Sevillano, D; Valero, E | 1 |
Alcalá, B; Arreaza, L; Salcedo, C; Vázquez, JA | 1 |
Henneberg, JP; Neubert, U | 1 |
Jones, ME; Karlowsky, JA; Kelly, LJ; Sahm, DF; Thornsberry, C | 1 |
Stewart, PS; Zahller, J | 1 |
Chan, JK; Ma, J | 1 |
Ahrén, IL; Forsgren, A; Karlsson, E; Riesbeck, K | 1 |
Ain, Q; Barney, N; Iqbal, M; Kiani, Q; Mehdi, B; Patel, IK; Rabbani, KZ; Shah, SH; Zaidi, G | 1 |
Anderl, JN; Roe, F; Stewart, PS; Zahller, J | 1 |
Dudzevicius, V; Sakalauskas, R; Vitkauskiene, A | 1 |
Brennan, RE; Samuel, JE | 1 |
Baerheim, A; Digranes, A; Jureen, R | 1 |
Burman, LG; Haeggman, S; Hoffman, BM; Kühn, I; Lindahl, C; Olsson-Liljequist, B; Torell, E | 1 |
Liu, J; Meng, QG; Wang, Q | 1 |
Honkanen-Buzalski, T; Lehtolainen, T; Pyörälä, S; Shpigel, NY; Shwimmer, A | 1 |
Böhringer, R; Krautmacher, C; Vetter, H; Weisser, B | 1 |
Celikbaş, A; Dokuzoğuz, B; Ergönül, O; Imre, A | 1 |
Badrina, N; Benjamin, R; DeJesus, Y; Escalante, CP; Fernandez, S; Ho, V; Lam, T; Lee, EL; Manzullo, E; Rivera, E; Rolston, K; Valdres, R; Weiser, MA | 1 |
Arnold, DM; Christjanson, L; Smaill, F; Walker, I; Warkentin, TE | 1 |
Agrappi, C; Clerici, P; Melloni, P; Vasconi, E; Viganò, EF | 1 |
Chadha, R; Jain, DV; Kashid, N | 1 |
Fraser, A; Gafter-Gvili, A; Leibovici, L; Paul, M | 2 |
Gerner-Smidt, P; Jensen, C; Mølbak, K; Olsen, K; Petersen, E; Scheutz, F; Schiellerup, P | 1 |
Jakoniuk, P; Leszczyńska, K; Sacha, PT; Wieczorek, P; Zalewska, M | 1 |
Chowta, MN; Chowta, NK | 1 |
Reinscheid, UM | 1 |
Chatsuwan, T; Hiranrattana, A; Mekmullica, J; Pancharoen, C; Thisyakorn, U | 1 |
Empel, J; Hryniewicz, W; Kadłubowski, M; Skoczyńska, A | 1 |
Brenner, H; Hoewner, M; Lietzau, S; Marre, R; von Baum, H | 1 |
de Jong, A; Friederichs, S; Kehrenberg, C; Michael, GB; Schwarz, S | 1 |
Decorby, MR; Hoban, DJ; Karlowsky, JA; Laing, NM; Zhanel, GG | 1 |
Acar, B; Aysev, D; Ekim, M; Güriz, H; Kavaz, A; Ozçakar, ZB; Oztürk, B; Yalçinkaya, F; Yüksel, S | 1 |
Charlett, A; Day, M; de Pinna, E; Goodyear, KL; Threlfall, EJ | 1 |
Abriba, C; Anwan, EE; Arikpo, GE; Asikong, BE; Eja, ME; Enyi-Idoh, KH | 1 |
Buxbaum, A; Georgopoulos, A; Graninger, W; Kratzer, C; Macfelda, K | 1 |
Duda, U; Szych, J; Wardak, S | 1 |
Anderson, G; Call, V; Foley, SL; Kaldhone, P; Kerdahi, K; Nayak, R; Phillips, S; Tyler, C | 1 |
Alecsandru, D; Garcia, A; Gestoso, I; Lobo, J; Martinez, A; Romero, A; Yagüe, MR | 1 |
Arias Miranda, IM; Cienfuegos Basanta, MC; Fonseca Aizpuru, EM; Nuño Mateo, FJ | 1 |
Fisher, A; Kahn, JB; Kaul, S; Khashab, M; Peterson, J | 1 |
Akhtar, M; Anderson, JF; Hirt, H; Parrish, TD; Zurek, L | 1 |
Becket, E; Bui, A; Hong, J; Kim, K; Liu, A; Miller, JH; Sitz, D; Solaimani, P; Tamae, C; Tran, KP; Yang, H | 1 |
Kannan, A; Pant, A; Upreti, RK | 1 |
Bavbek, N; Bayrak, O; Catal, F; Karabel, D; Karabel, M; Odemis, E; Uz, E | 1 |
Araj, GF; Kanafani, ZA; Kanj, SS; Naba, MR | 1 |
Blázquez, J; López, E | 1 |
Amábile-Cuevas, CF; Arredondo-García, JL | 1 |
Kothari, A; Sagar, V | 1 |
Klein, M; Pfister, HW | 1 |
Chen, CL; Chia, JH; Chiu, CH; Lee, HY; Liu, SY; Su, LH; Tseng, LY | 1 |
Arslan, O; Kockar, F; Sinan, S; Yildirim, H | 1 |
Cho, YH; Lee, G; Lee, SD; Shim, BS | 1 |
Chakraborty, A; Gloriani, NG; Miyahara, S; Villanueva, SY; Yoshida, S | 1 |
Weill, FX | 1 |
Armero, C; Gobernado, M; González, F; López-Quílez, A; Perpiñán, H; Sahuquillo-Arce, JM; Selva, M; Vanaclocha, H | 1 |
Fusté, E; Veiga-Crespo, P; Villa, TG; Viñas, M; Vinuesa, T | 1 |
Choi, JG; Han, SH; Kang, OH; Keum, JH; Kim, SB; Kim, YG; Kwon, DY; Lee, JH; Mun, SH; Obiang-Obounou, BW; Park, CB; Shin, DW | 1 |
Del Campo, R; López, M; Tenorio, C; Torres, C; Zarazaga, M | 1 |
Chakraborty, A; Takade, A; Villanueva, SY; Yoshida, S | 1 |
Fraser, A; Gafter-Gvili, A; Leibovici, L; Paul, M; Zalmanovici Trestioreanu, A | 2 |
Preet, S; Rishi, P; Singh, AP | 1 |
Eriguchi, Y; Harada, Y; Kadowaki, M; Miyake, N; Nagasaki, Y; Sato, Y; Shimono, N; Uchida, Y | 1 |
Brueseke, TJ; Lane, FL | 1 |
Burrows, E; Mandisodza, O; Nulsen, M | 1 |
Doki, Y; Ikeguchi, N; Mori, M; Nakajima, K; Nishida, T; Nishimura, J; Shinohara, N; Souma, Y; Takahashi, T; Takenaka, R | 1 |
Ahmad, S; Cullen, IM; Fennell, JP; Flynn, R; Grainger, R; Manecksha, RP; McCullagh, E; McDermott, TE; Murphy, P; O'Kelly, F; Thornhill, JA | 1 |
Hänninen, ML; Heiska, H; Juntunen, P | 1 |
Degener, JE; Feik, D; Mortensen, JE; Rams, TE; van Winkelhoff, AJ | 1 |
Abriouel, H; Benomar, N; Gálvez, A; Lavilla Lerma, L; Pérez Pulido, R; Sánchez Valenzuela, A | 1 |
Bearden, DT; Elman, MR; McGregor, JC; Smith, DH | 1 |
Goldfarb, DM; Mokomane, M; Narasimhamurthy, M; Renuart, AJ; Silverman, JA; Steenhoff, AP; Tawanana, EO | 1 |
Joung, DK; Kang, OH; Kim, SB; Kim, YC; Kim, YS; Kweon, KT; Kwon, DY; Lee, DS; Mun, SH; Seo, YS; Shin, DW | 1 |
Ari, S; Dal, T; Dayan, S; Dursun, B; Kaya, S; Kortak, MZ; Tekin, R | 1 |
Arabski, M; Drulis-Kawa, Z; Gubernator, J; Wąsik, S | 1 |
Kadlec, MW; Liao, JC; Wong, PK; You, D | 1 |
Choudhary, A; Ghafur, KA; Gopalakrishnan, R; Nambi, PS; Ramasubramanian, V; Thirunarayan, MA | 1 |
Cormican, M; Cummins, E; Harris, S; Morris, C; Morris, D | 1 |
Collins, JJ; Lee, HH; Modi, SR; Spina, CS | 1 |
Bekeredjian-Ding, I; Gravius, S; Hischebeth, GT; Kohlhof, H; Randau, TM; Wimmer, MD | 1 |
Ahmed, D; Akter, M; Azmi, IJ; Faruque, AS; Faruque, SM; Hasan, TN; Hossain, MA; Latif, HA; Shahnaij, M; Talukder, KA; Ud-Din, AI; Wahid, SU | 1 |
Burton, JP; Cadieux, PA; Goneau, LW; MacDonald, KW; Razvi, H; Reid, G; Yeoh, NS | 1 |
Hsueh, PR; Huang, YT; Liao, CH; Tsai, HY | 1 |
Ball, JL; Cavaliere, R; Turnbull, L; Whitchurch, CB | 1 |
Frimodt-Møller, N; Hertz, FB; Løbner-Olesen, A | 1 |
Dörries, K; Lalk, M; Schlueter, R | 1 |
Molineux, IJ; Schofield, DA; Wray, DJ | 1 |
Albright, AL; Ferson, S; Ochieng', N; Okechi, H | 1 |
Abreu, AC; Borges, A; Mcbain, AJ; Saavedra, MJ; Salgado, AJ; Serra, SC; Simões, M | 1 |
Chowdhury, N; Kwan, BW; Wood, TK | 1 |
Jang, EY; Lee, JY; Moon, JH; Shim, KS | 1 |
Cardines, R; Cerquetti, M; Daprai, L; Garlaschi, ML; Giufrè, M; Torresani, E | 1 |
Nepomnyashchiy, VV; Shakalova, EA; Tamm, TI | 1 |
Dvornik, IA; Nepomnyashchiy, VV; Shakalova, EA; Tamm, TI | 1 |
Amemoto, Y; Aoyama, T; Arakawa, S; Deguchi, T; Egawa, S; Fujimoto, Y; Fujisawa, M; Goto, H; Hamasuna, R; Hanaki, H; Hashimura, T; Hayami, H; Hirose, T; Ichikawa, T; Inatomi, H; Ishihara, S; Ishikawa, K; Ishitoya, S; Ito, N; Ito, T; Iwata, S; Kadota, J; Kagara, I; Kaku, M; Kanamaru, S; Kato, M; Kawanishi, H; Kimura, T; Kiyota, H; Kobayashi, K; Kobuke, M; Koda, S; Komeda, H; Kumon, H; Kunishima, Y; Maeda, H; Matsubara, A; Matsuda, Y; Matsui, T; Matsukawa, M; Matsumoto, M; Matsumoto, T; Minamitani, S; Mita, K; Mitsumori, K; Muranaka, T; Nakamura, I; Nishimura, K; Oka, H; Okumura, K; Onishi, H; Onodera, S; Sato, J; Shigeta, M; Sunakawa, K; Taguchi, K; Takahashi, K; Takahashi, S; Takahashi, Y; Takenaka, T; Tanaka, K; Togo, Y; Tsugawa, M; Tsukamoto, T; Uehara, S; Wakeda, H; Watanabe, A; Yamada, D; Yamamoto, S; Yamashita, M; Yasuda, M | 1 |
Abdelsalam, M; Abu-Elala, N; Marouf, Sh; Setta, A | 1 |
Birošová, L; Faberová, M; Gál, M; Grabic, R; Koba, O; Mackuľak, T; Nagyová, K | 1 |
Badal, RE; Cao, B; Chen, S; Chu, Y; Duan, Q; Feng, X; Gui, B; Hu, B; Hu, Z; Huang, W; Kong, H; Liao, K; Luo, Y; Ni, Y; Shao, H; Su, J; Sun, Z; Wang, Y; Wu, A; Xu, Y; Yang, Q; Yu, Y; Zhang, H; Zhang, S | 1 |
Cataldi, V; Cellini, L; Ciccaglione, AF; Di Bartolomeo, S; Di Campli, E; Di Giulio, M; Grossi, L; Marzio, L; Nostro, A | 1 |
Fan, M; He, L; Pang, S; Wang, P; Zhang, H | 1 |
Aksaray, S; Avcıküçük, H; Başustaoğlu, A; Kaşkatepe, B; Süzük, S | 1 |
Antonello, VS; Dallé, J; Jimenez, MF; Kronbauer, K; Riche, CW; Rocha-Castro, J; Santiago, JA | 1 |
Aboderin, AO; Hofmann, J; Odetoyin, BW; Okeke, IN | 1 |
Kidenya, BR; Mirambo, MM; Moremi, N; Mshana, SE; Okamo, B; Seni, J | 1 |
Chen, A; Eliopoulos, GM; Hirsch, EB; Kirby, JE; McCoy, C; Raux, BR; Zucchi, PC | 1 |
Ahn, J; Ding, T; Jo, A; Kim, J; Lee, HY | 1 |
Lepekhina, E; Muzyka, N; Oktyabrsky, O; Smirnova, G | 1 |
Badía, M; Cassini, E; Córdova, E; Gómez, N; López Moral, L; Morganti, L; Rodríguez, C | 1 |
Ali, A; Arora, P; Nalli, Y; Riyaz-Ul-Hassan, S; Wani, ZA | 1 |
Coan, EB; Miller, KE | 1 |
Lauková, A; Ščerbová, J | 1 |
Araújo, MC; De Resende, EA; Lazo-Chica, JE; Miguel, CB; Nogueira, AP; Oliveira, CJ; Paulino, Tde P; Rodrigues, WF; Soares, Sde C; Ueira-Vieira, C | 1 |
Jandaik, S; Kumar, S; Sharma, N | 1 |
Carvalheira, A; Casquete, R; Silva, J; Teixeira, P | 1 |
Dietler, G; Greub, G; Kasas, S; Longo, G; Opota, O; Prod'hom, G; Stupar, P | 1 |
Carr, AN; Cho, J; Johnson, B; Whitworth, L; Wilson, KS | 1 |
Barbosa, MS; Bataus, LA; Carneiro, LC; da Silva Bitencourt Braga, CA; Gomes Freitas, D; Silva, RD | 1 |
Alpay, H; Altuntaş, Ü; Bıyıklı, N; Çiçek, N; Gökçe, İ; Güven, S; Yıldız, N | 1 |
Daniel, P; Hai Nguyen, N; Sarter, S; Xuan Nguyen, NT | 1 |
Bari, H; Khan, MR; Shariff, AH | 1 |
Dybowski, R; Grant, AJ; Maskell, DJ; Mastroeni, P; Restif, O; Rossi, O | 1 |
Heather, CS; Maley, M | 1 |
Harrer, T; Schliep, S; Schuler, G; Simon, M; Tajmir-Riahi, A; Wörl, P | 1 |
Barry, L; Corcoran, GD; Hooton, C; Lucey, B; O'Grady, MC; O'Halloran, C; Walsh, N | 1 |
Edeghere, O; Gossain, S; Hawkey, PM; Hilton, B; Hopkins, S; Ironmonger, D; Verlander, NQ | 1 |
Abraham, S; Badger, S; Caraguel, CGB; Jordan, D; Mitchell, T; Saputra, S; Trott, DJ; Turnidge, J | 1 |
de Moraes, C; Dias, UJ; Gorla, MC; Lemos, AP; Pinhata, JMW | 1 |
Abdelwahab, SI; Dafalla, OME; Homeida, HE; Taha, MME | 1 |
Mengist, A; Mengistu, G; Reta, A | 1 |
Kariuki, S; Muigai, AWT; Mutai, WC; Waiyaki, P | 1 |
Aiyer, KS; Rai, R; Vijayakumar, BS | 1 |
Gudza-Mugabe, M; Mashe, T; Mbanga, J; Mtapuri-Zinyowera, S; Munemo, E; Smith, AM; Smouse, SL; Sooka, A; Stray-Pedersen, B; Tarupiwa, A | 1 |
Asgedom, SW; Kahsay, AG; Weldetinsaa, HL | 1 |
Arnold, SLM; Barrett, LK; Choi, R; Hulverson, MA; McCloskey, MC; Rabago, L; Shaheen, S | 1 |
Card, KJ; Gomez, JB; LaBar, T; Lenski, RE | 1 |
Paranjape, SS; Shashidhar, R | 1 |
Amiel, GE; Badaan, S; Kastin, A; Kravtsov, A; Mullerad, M; Zisman, A | 1 |
Aijaz, I; Berger, M; Berger, P; Dobrindt, U; Koudelka, G | 1 |
Bekele, A; Gandhi, A; Garimella, N; Hartman, N; Li, X; Sacks, L; Stone, H; Weaver, JL; Zere, T | 1 |
Abualrahi, AH; Butzin, NC; Deter, HS; Jadhav, P; Ogle, CT; Schweer, EK | 1 |
Lam, H; Sulaiman, JE | 1 |
Abade, AM; Joachim, A; Majigo, MV; Mizinduko, MM; Ngogo, FA; Rumisha, SF | 1 |
Mohapatra, PP; Padhi, L; Panda, SK; Sahoo, G | 1 |
Grant, AJ; Mastroeni, P; McLean, C; Price, DJ; Restif, O; Rossi, O; Vlazaki, M | 1 |
Ingmer, H; Larsen, MH; Ovsepian, A; Vegge, CS | 1 |
Neguse, S | 1 |
Adjei, DN; Asmah, HR; Forson, AO; Olu-Taiwo, M; Quarchie, MN | 1 |
Fukuda, A; Hirai, Y; Nakamura, H; Ogasawara, J; Umeda, K; Usui, M; Yamamoto, K | 1 |
Bastiaanssen, TFS; Cryan, JF; Dinan, TG; Fitzgerald, P; Fulling, C; Moloney, GM; O'Connor, R; O'Riordan, KJ; Schellekens, H | 1 |
Carolan, JC; Margalit, A; Walsh, F | 1 |
Barkalita, LM; Borah, P; Choudhury, M; Das, L; Deka, NK; Dutta, R; Hazarika, G; Hussain, MI; Malakar, D | 1 |
Blain, AE; Hu, F; Marjuki, H; McNamara, LA; Potts, CC; Retchless, AC; Rodriguez-Rivera, LD; Wang, X | 1 |
Abram, M; Begić, G; Gobin, I; Pavlić, A; Špalj, S; Tota, M | 1 |
Cheng, X; Guan, M; Jolkkonen, J; Lin, X; Liu, C; Liu, F; Liu, Z; Wang, Y; Xiao, T; Zhao, C; Zhao, Y; Zhong, S | 1 |
Borges-Mateus, LM; Carmona-Cartaya, Y; González-Molina, MK; Hidalgo-Benito, M; Pereda-Novales, N; Quiñones-Pérez, D | 1 |
D'Angeli, M; Frisbie, L; Kapoor, H; Rabinowitz, P; Radcliff, J; Salm, A; Weissman, SJ | 1 |
Kubickova, V; Santavy, P; Sima, M; Urbanek, K | 1 |
Pintarić, S; Štritof, Z; Tumpa, A | 1 |
Bénéjat, L; Bessède, E; Ducournau, A; Jehanne, Q; Lehours, P | 1 |
Al Atbee, MYN; Jalil, MB | 1 |
Chen, M; Gao, H; Jia, C; Li, R; Lin, D; Lin, X; Qiu, Y; Shan, Q; Song, W; Tong, J; Wan, C; Wang, C; Wu, S; Xu, Y; Yang, J; Zeng, M; Zhao, S; Zhu, C; Zhu, Y; Zhuo, Z | 1 |
Bhat, KA; Farooq, S; Gani, I; Jameel, S; Riyaz-Ul-Hassan, S | 1 |
Hu, S; Lou, Z; Shen, Y; Tu, M | 1 |
Chen, H; Dai, L; Hou, D; Li, T; Long, X; Sun, C; Wang, Y; Xiong, Z | 1 |
Dai, J; Hu, Q; Li, X; Liu, X; Luo, Y; Shen, F; Wu, N; Xu, Z; Yu, Z | 1 |
Assenga, EN; Godfrey, E; Majaliwa, E | 1 |
Asai, T; Asakura, H; Sasaki, Y; Uema, M; Yonemitsu, K | 1 |
De Jong, A; Dewulf, J; El Garch, F; Hocquet, D; Janosi, S; Migura-Garcia, L; Moyaert, H; Perrin-Guyomard, A; Prenger-Berninghoff, E; Rose, M; Simjee, S; Skarzynska, M; Veldman, KT | 1 |
Mishra, V; Ojha, AK; Shah, NP | 1 |
Adu-Asiamah, CK; Aglomasa, BC; Amewu, EKA; Amponsah, IK; Asiedu, SO; Boahen, KG; Boakye, YD; Boamah, VE; Kini, P; Kwarteng, A; Wireko, S | 1 |
Ghafar, NA; Hamid, AA; Ismail, R; Sulayyim, HJA | 1 |
Hadiyan, M; Momtaz, H; Shakerian, A | 1 |
Debelo, M; Mohammed, N; Tiruneh, A; Tolosa, T | 1 |
Abidi, SH; Ahmed, K; Ali, SN; Khan, S; Mastoor, S; Nazim, F; Rizwan-Ul-Hasan, S | 1 |
Chen, J; Cruz, A; Faron, ML; Gau, V; Gerstbrein, D; Mesich, B; Navarro, E | 1 |
Abdullah, S; Mohsin, M; Muhammad, F; Rahman, SU | 1 |
Kepiro, I; Pagliara, S; Ryadnov, MG; Zhang, Y | 1 |
Chaleshtori, RS; Emami, MS; Rahimi, E; Shakerian, A | 1 |
Abbas, KH; Al-Sallami, D; Alsultan, A; Clarke, SR | 1 |
Asai, T; Hara-Kudo, Y; Ikeda, T; Kuroda, M; Momose, Y; Ogawa, M; Ohya, K; Okamura, M; Sakata, R; Sasaki, Y; Uema, M; Watanabe, M; Yonemitsu, K | 1 |
Akool, MA; Al-Nafak, RT; Al-Turaihi, TSA; Hadi, ZJ; Mubark, HA | 1 |
Goggins, WB; Woh, PY; Yeung, MPS | 1 |
Bignoumba, M; Bisseye, C; Longo-Pendy, NM; Mouanga-Ndzime, Y; Onanga, R | 1 |
Bellizzi, D; D'Aquila, P; De Rango, F; Paparazzo, E; Passarino, G | 1 |
Fang, Y; Qin, B; Wu, X; Xie, Y; Yang, G; Zhuang, L | 1 |
Miriti, DM; Muthini, JM; Nyamache, AK | 1 |
Cheng, WH; Ho, CH; Su, PY | 1 |
Abdollahi, N; Alebouyeh, M; Armin, S; Attaran, B; Azimi, L; Behzad, A; Fahimzad, SA; Fallah, F; Ghanaiee, RM; Ghandchi, G; Gholinejad, Z; Hassanzadeh, R; Karimi, A; Mahdavi, A; Safarkhani, A; Sheikhi, Z; Shirvani, F; Tabatabaei, SR | 1 |
Cruz Spano, L; Dos Santos, KV; Ferreira da Silva, A; Gastaldi Guerrieri, C; Souza Dos Santos, AL; Teixeira Gonçalves, M | 1 |
Choi, HJ; Choi, JY; Choi, YH; Kim, C; Park, RW; Rhie, SJ | 1 |
Barros, TF; de Barros, BC; de Jesus, GS; de Oliveira Figueiredo, P; Dos Santos, ÉL; Ferreira, AMT; Garcez, FR; Micheletti, AC; Silva Trentin, D; Yoshida, NC | 1 |
Bensman, T; Florian, J; Han, X; Igo, M; Krishna, A; Li, Z; Rouse, R; Sacks, L; Stewart, S; Stone, H; Weaver, JL; Xu, L | 1 |
Garza-Cervantes, JA; León-Buitimea, A; Mendiola-Garza, G; Morones-Ramírez, JR | 1 |
19 review(s) available for ampicillin and ciprofloxacin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Recently reported biological activities of pyrazole compounds.
Topics: Analgesics; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antifungal Agents; Antineoplastic Agents; Antiviral Agents; Humans; Pyrazoles | 2017 |
Ciprofloxacin derivatives and their antibacterial activities.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Dose-Response Relationship, Drug; Gram-Negative Bacteria; Gram-Positive Bacteria; Molecular Structure; Structure-Activity Relationship | 2018 |
Benzofuran derivatives and their anti-tubercular, anti-bacterial activities.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Benzofurans; Humans; Structure-Activity Relationship | 2019 |
Isatin derivatives and their anti-bacterial activities.
Topics: Anti-Bacterial Agents; Bacteria; Humans; Isatin; Structure-Activity Relationship | 2019 |
Comprehensive review on the anti-bacterial activity of 1,2,3-triazole hybrids.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Triazoles | 2019 |
Antibacterial activity study of 1,2,4-triazole derivatives.
Topics: Anti-Bacterial Agents; Bacteria; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Triazoles | 2019 |
1,2,4-Triazole-quinoline/quinolone hybrids as potential anti-bacterial agents.
Topics: Anti-Bacterial Agents; Bacteria; Chelating Agents; Fungi; Microbial Sensitivity Tests; Molecular Structure; Quinolones; Structure-Activity Relationship; Triazoles | 2019 |
Current scenario of tetrazole hybrids for antibacterial activity.
Topics: Anti-Bacterial Agents; Bacteria; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Tetrazoles | 2019 |
Structure-activity relationships (SAR) of triazine derivatives: Promising antimicrobial agents.
Topics: Anti-Bacterial Agents; Antiviral Agents; Bacteria; Humans; Microbial Sensitivity Tests; Molecular Structure; Triazines; Viruses | 2020 |
[Actinomycosis].
Topics: Actinomycosis, Cervicofacial; Adolescent; Adult; Aged; Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Clavulanic Acid; Clindamycin; Gentamicins; Humans; Male; Prognosis; Recurrence; Time Factors; Tomography, X-Ray Computed | 2004 |
Antibiotics for preventing meningococcal infections.
Topics: Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Humans; Meningococcal Infections; Minocycline; Neisseria meningitidis; Randomized Controlled Trials as Topic; Rifampin | 2005 |
Antibiotics for preventing meningococcal infections.
Topics: Ampicillin; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Humans; Meningococcal Infections; Minocycline; Neisseria meningitidis; Randomized Controlled Trials as Topic; Rifampin | 2006 |
[Could it be bacterial meningitis?].
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Ciprofloxacin; Community-Acquired Infections; Critical Care; Enzyme Inhibitors; Hospitalization; Humans; Meningitis, Bacterial; Neisseria meningitidis; Prognosis; Rifampin; Streptococcus pneumoniae; Tomography, X-Ray Computed | 2006 |
[Typhoid fever: facing the challenge of resistant strains].
Topics: Ampicillin; Anti-Bacterial Agents; Chloramphenicol; Ciprofloxacin; Drug Resistance; Drug Resistance, Multiple; Humans; Salmonella typhi; Trimethoprim, Sulfamethoxazole Drug Combination; Typhoid Fever | 2010 |
Antibiotics for preventing meningococcal infections.
Topics: Ampicillin; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Humans; Meningococcal Infections; Minocycline; Neisseria meningitidis; Randomized Controlled Trials as Topic; Rifampin | 2011 |
Antibiotics for preventing meningococcal infections.
Topics: Ampicillin; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Humans; Meningococcal Infections; Minocycline; Neisseria meningitidis; Randomized Controlled Trials as Topic; Rifampin | 2013 |
Bacteriological Studies of Venomous Snakebite Wounds in Hangzhou, Southeast China.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Bacteria; Cefazolin; Cefoxitin; Ciprofloxacin; Clavulanic Acid; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Snake Bites; Sulbactam; Venoms | 2022 |
Antibiotic Resistance during COVID-19: A Systematic Review.
Topics: Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Colistin; COVID-19 Drug Treatment; Drug Resistance, Bacterial; Erythromycin; Escherichia coli; Humans; Microbial Sensitivity Tests; Pandemics; Pseudomonas aeruginosa | 2022 |
10 trial(s) available for ampicillin and ciprofloxacin
Article | Year |
---|---|
Therapy for shigellosis. II. Randomized, double-blind comparison of ciprofloxacin and ampicillin.
Topics: Adult; Ampicillin; Ampicillin Resistance; Ciprofloxacin; Double-Blind Method; Dysentery, Bacillary; Feces; Follow-Up Studies; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic | 1990 |
Comparison of ciprofloxacin with ampicillin in acute infectious exacerbations of chronic bronchitis. A double-blind crossover study.
Topics: Adult; Aged; Ampicillin; Bacteria; Bacterial Infections; Bronchitis; Ciprofloxacin; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged | 1989 |
Comparative trial of single-dose ciprofloxacin and ampicillin plus probenecid for treatment of gonococcal urethritis in men.
Topics: Adolescent; Adult; Ampicillin; Chlamydia Infections; Chlamydia trachomatis; Ciprofloxacin; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Probenecid; Urethritis | 1986 |
Controlled, comparative study of ciprofloxacin versus ampicillin in treatment of bacterial respiratory tract infections.
Topics: Adult; Aged; Aged, 80 and over; Ampicillin; Bacterial Infections; Ciprofloxacin; Clinical Trials as Topic; Digestive System; Double-Blind Method; Female; Humans; Male; Middle Aged; Penicillin Resistance; Prospective Studies; Respiratory Tract Infections; Theophylline | 1987 |
Ciprofloxacin versus ampicillin and probenecid in the treatment of uncomplicated gonorrhoea in men.
Topics: Ampicillin; Ciprofloxacin; Gonorrhea; Humans; Infections; Male; Microbial Sensitivity Tests; Pharyngeal Diseases; Probenecid; Random Allocation; Rectal Diseases | 1987 |
[Therapy of salmonella gastroenterocolitis].
Topics: Adolescent; Adult; Ampicillin; Anti-Infective Agents; Child; Child, Preschool; Ciprofloxacin; Colitis; Female; Gastroenteritis; Humans; Infant; Male; Middle Aged; Penicillins; Prospective Studies; Salmonella Infections; Single-Blind Method; Trimethoprim, Sulfamethoxazole Drug Combination | 1994 |
Prevention of mucositis in irradiated head and neck cancer patients.
Topics: Ampicillin; Anti-Infective Agents; Ciprofloxacin; Clotrimazole; Drug Combinations; Gastrointestinal Agents; Head and Neck Neoplasms; Humans; Mouth Mucosa; Penicillins; Stomatitis; Sucralfate | 1996 |
Determination of the etiological organism during acute exacerbations of COPD and efficacy of azithromycin, ampicillin-sulbactam, ciprofloxacin and cefaclor. Turkish Thoracic Society COPD Working Group.
Topics: Ampicillin; Anti-Infective Agents; Azithromycin; Cefaclor; Ciprofloxacin; Drug Therapy, Combination; Female; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Sulbactam; Treatment Outcome | 1999 |
Outcomes of treatment pathways in outpatient treatment of low risk febrile neutropenic cancer patients.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Ampicillin; Anti-Bacterial Agents; Cancer Care Facilities; Ceftazidime; Ciprofloxacin; Clavulanic Acid; Clindamycin; Critical Pathways; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Risk Factors; Treatment Outcome | 2004 |
Identification and pretherapy susceptibility of pathogens in patients with complicated urinary tract infection or acute pyelonephritis enrolled in a clinical study in the United States from November 2004 through April 2006.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Double-Blind Method; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Pyelonephritis; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; United States; Urinary Tract Infections | 2007 |
439 other study(ies) available for ampicillin and ciprofloxacin
Article | Year |
---|---|
The activity of p-methoxybenzylisothiocyanate against Neisseria gonorrhoeae, Haemophilus ducreyi, and other microorganisms.
Topics: Bacteria; Cell Division; Haemophilus ducreyi; Isothiocyanates; Lepidium; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Plant Preparations | 2002 |
Contribution of target gene mutations and efflux to decreased susceptibility of Salmonella enterica serovar typhimurium to fluoroquinolones and other antimicrobials.
Topics: Animals; Anti-Infective Agents; DNA Topoisomerases; Drug Resistance, Bacterial; Fluoroquinolones; Gene Targeting; Genes, Bacterial; Mutation; Salmonella Infections, Animal; Salmonella typhimurium | 2007 |
Substrate competition studies using whole-cell accumulation assays with the major tripartite multidrug efflux pumps of Escherichia coli.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Binding, Competitive; Carrier Proteins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Indicators and Reagents; Microbial Sensitivity Tests; Progesterone; Steroids | 2007 |
First report of plasmid-mediated qnrA1 in a ciprofloxacin-resistant Escherichia coli strain in Latin America.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Conjugation, Genetic; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Integrons; Latin America; Molecular Sequence Data; Plasmids | 2007 |
Prevalence of plasmid-mediated quinolone resistance determinants QnrA, QnrB, and QnrS among clinical isolates of Enterobacter cloacae in a Taiwanese hospital.
Topics: Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Genes, Bacterial; Hospitals; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Prevalence; Quinolones; Taiwan | 2007 |
In vitro and in vivo antibacterial activities of heteroaryl isothiazolones against resistant gram-positive pathogens.
Topics: Animals; Anti-Infective Agents; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Mice; Microbial Sensitivity Tests; Quinolones; Thiazoles | 2007 |
Synthesis and antimicrobial activity of some novel phenyl and benzimidazole substituted benzyl ethers.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Benzimidazoles; Benzyl Compounds; Drug Resistance, Bacterial; Ethers; Methicillin; Microbial Sensitivity Tests; Phenols; Staphylococcus aureus | 2007 |
Synthesis and in vitro antimicrobial activity of new 2-[p-substituted-benzyl]-5-[substituted-carbonylamino]benzoxazoles.
Topics: Amination; Anti-Bacterial Agents; Antifungal Agents; Benzene; Benzoxazoles; Candida; Gram-Negative Bacteria; Gram-Positive Bacteria; Molecular Structure; Structure-Activity Relationship | 2007 |
Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Middle Aged; Portugal | 2007 |
Polyamine effects on antibiotic susceptibility in bacteria.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Drug Resistance, Bacterial; Drug Synergism; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Polyamines; Spermine; Staphylococcus aureus | 2007 |
Enterobacteriaceae bloodstream infections: presence of integrons, risk factors, and outcome.
Topics: Bacteremia; Community-Acquired Infections; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae Infections; Gene Transfer, Horizontal; Humans; Infectious Disease Transmission, Professional-to-Patient; Integrons; Microbial Sensitivity Tests; Nucleic Acid Amplification Techniques; Polymerase Chain Reaction; Prospective Studies; Risk Factors; Sequence Analysis, DNA; Treatment Outcome | 2007 |
Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli.
Topics: Amino Acid Motifs; Amino Acid Sequence; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Conjugation, Genetic; Conserved Sequence; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Escherichia coli; Escherichia coli Proteins; Fluoroquinolones; Genes, rRNA; Methylation; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Norfloxacin; Plasmids; Sequence Analysis, DNA; Sequence Homology, Amino Acid | 2007 |
Characterization of an integron carrying blaIMP-1 and a new aminoglycoside resistance gene, aac(6')-31, and its dissemination among genetically unrelated clinical isolates in a Brazilian hospital.
Topics: Acinetobacter; Amino Acid Sequence; Aminoglycosides; Anti-Bacterial Agents; Base Sequence; Brazil; Codon, Terminator; Cross Infection; Drug Resistance, Multiple, Bacterial; Gene Transfer, Horizontal; Genes, Bacterial; Hospitals; Humans; Integrons; Microbial Sensitivity Tests; Molecular Sequence Data; Open Reading Frames; Plasmids; Pseudomonas putida; Transcription, Genetic | 2007 |
Antibacterial nicotinamide adenine dinucleotide synthetase inhibitors: amide- and ether-linked tethered dimers with alpha-amino acid end groups.
Topics: Amide Synthases; Amides; Amino Acids; Anti-Bacterial Agents; Bacillus subtilis; Detergents; Dimerization; Ethers; Gram-Positive Bacteria; Microbial Sensitivity Tests; NAD; Octoxynol; Structure-Activity Relationship | 2007 |
New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Chitosan; Conjugation, Genetic; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Humans; Malates; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; Transformation, Bacterial; Uncoupling Agents | 2007 |
Colistin methanesulfonate against multidrug-resistant Acinetobacter baumannii in an in vitro pharmacodynamic model.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Ceftazidime; Colistin; Colony Count, Microbial; Drug Combinations; Drug Resistance, Multiple, Bacterial; Microbial Sensitivity Tests | 2007 |
In vitro activity of telavancin against gram-positive clinical isolates recently obtained in Europe.
Topics: Aminoglycosides; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Europe; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus; Streptococcus agalactiae; Streptococcus pyogenes; Vancomycin Resistance; Viridans Streptococci | 2007 |
Synthesis and antimicrobial activity of some new thiazolyl thiazolidine-2,4-dione derivatives.
Topics: Anti-Bacterial Agents; Antifungal Agents; Candida albicans; Escherichia coli; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Models, Chemical; Molecular Structure; Staphylococcus aureus; Thiazolidines | 2007 |
Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate.
Topics: Bacterial Proteins; Base Sequence; beta-Lactamases; Carrier Proteins; Cloning, Molecular; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Genes, MDR; Genetic Vectors; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Porins | 2007 |
Prevalence and expression of the plasmid-mediated quinolone resistance determinant qnrA1.
Topics: Anti-Infective Agents; Base Sequence; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae; Gene Expression Regulation, Bacterial; Genes, Bacterial; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Polymerase Chain Reaction; Promoter Regions, Genetic; Quinolones; Reverse Transcriptase Polymerase Chain Reaction; Sequence Analysis, DNA; Sequence Homology, Nucleic Acid | 2007 |
RmtC 16S rRNA methyltransferase in Australia.
Topics: Aminoglycosides; Anti-Bacterial Agents; Australia; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Drug Resistance, Bacterial; Genes, rRNA; Humans; Methyltransferases; Microbial Sensitivity Tests; Proteus Infections; Proteus mirabilis; RNA, Ribosomal, 16S | 2008 |
Replication of Colonic Crohn's Disease Mucosal Escherichia coli Isolates within Macrophages and Their Susceptibility to Antibiotics.
Topics: Animals; Anti-Bacterial Agents; Cell Line; Cells, Cultured; Colon; Crohn Disease; Culture Media; Escherichia coli; Humans; Macrophages; Mice; Microbial Sensitivity Tests; Monocytes; Mucous Membrane | 2008 |
Reduced Susceptibility of Proteus mirabilis to triclosan.
Topics: Anti-Infective Agents, Local; Biofilms; Colony Count, Microbial; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Models, Anatomic; Mutation; Proteus mirabilis; Triclosan; Urinary Bladder; Urinary Catheterization | 2008 |
Synergy between polyethylenimine and different families of antibiotics against a resistant clinical isolate of Pseudomonas aeruginosa.
Topics: Aminoglycosides; Anti-Bacterial Agents; Carbenicillin; Ceftazidime; Ciprofloxacin; Drug Resistance, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests; Novobiocin; Ofloxacin; Piperacillin; Polyethyleneimine; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin; Ticarcillin; Tobramycin | 2008 |
Comparison of antimicrobial resistance profiles among extended-spectrum-beta-lactamase-producing and acquired AmpC beta-lactamase-producing Escherichia coli isolates from Canadian intensive care units.
Topics: Bacterial Proteins; beta-Lactamases; Canada; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Gentamicins; Humans; Intensive Care Units; Microbial Sensitivity Tests | 2008 |
Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli Isolates possessing the plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in intensive care units of a Chinese hospital.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; China; Conjugation, Genetic; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Hospitals, University; Humans; Hydrolysis; Intensive Care Units; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction; Serratia marcescens | 2008 |
Antimicrobial susceptibilities of geographically diverse clinical human isolates of Leptospira.
Topics: Ampicillin; Anti-Bacterial Agents; Azithromycin; Cefepime; Cefotaxime; Ceftriaxone; Cephalosporins; Ciprofloxacin; Egypt; Hawaii; Humans; Leptospira; Leptospirosis; Levofloxacin; Microbial Sensitivity Tests; Nicaragua; Ofloxacin; Tetracycline; Thailand | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
In vitro activity of telavancin against resistant gram-positive bacteria.
Topics: Aminoglycosides; Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; In Vitro Techniques; Lipoglycopeptides; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus; Streptococcus | 2008 |
Characterization of the carbapenem-hydrolyzing oxacillinase oxa-58 in an Acinetobacter genospecies 3 clinical isolate.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactamases; Carbapenems; Humans; Imipenem; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Sequence Analysis, DNA | 2008 |
Discovery and characterization of QPT-1, the progenitor of a new class of bacterial topoisomerase inhibitors.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Bacteria; Bacterial Infections; Bacterial Proteins; Cell Line; Cell Proliferation; Metabolic Clearance Rate; Mice; Microbial Sensitivity Tests; Molecular Structure; Staphylococcus aureus; Stereoisomerism; Topoisomerase II Inhibitors | 2008 |
Role of global regulators and nucleotide metabolism in antibiotic tolerance in Escherichia coli.
Topics: Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Proteins; Gene Expression Regulation, Bacterial; Microbial Sensitivity Tests; Mutation; Nucleotides; Ofloxacin | 2008 |
Mechanism and fitness costs of PR-39 resistance in Salmonella enterica serovar Typhimurium LT2.
Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Bacterial Proteins; Cathelicidins; Drug Resistance, Multiple, Bacterial; Female; Genetic Complementation Test; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Models, Genetic; Mutagenesis, Insertional; Mutation; Salmonella Infections, Animal; Salmonella typhimurium; Sequence Deletion | 2008 |
Characterization of the new metallo-beta-lactamase VIM-13 and its integron-borne gene from a Pseudomonas aeruginosa clinical isolate in Spain.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Cloning, Molecular; DNA Primers; DNA, Bacterial; Genes, Bacterial; Genetic Variation; Humans; Imipenem; Integrons; Kinetics; Meropenem; Molecular Sequence Data; Phylogeny; Pseudomonas aeruginosa; Pseudomonas Infections; Recombinant Proteins; Sequence Homology, Amino Acid; Spain; Thienamycins | 2008 |
Substituted 3-((Z)-2-(4-nitrophenyl)-2-(1H-tetrazol-5-yl) vinyl)-4H-chromen-4-ones as novel anti-MRSA agents: synthesis, SAR, and in-vitro assessment.
Topics: Anti-Bacterial Agents; Carboxylic Acids; Chemistry, Pharmaceutical; Chromones; Drug Design; Escherichia coli; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Models, Chemical; Molecular Structure; Staphylococcus aureus; Structure-Activity Relationship; Tetrazoles | 2008 |
Synthesis and in vitro antimicrobial activity of some novel substituted benzimidazole derivatives having potent activity against MRSA.
Topics: Anti-Infective Agents; Bacillus subtilis; Benzimidazoles; Candida albicans; Drug Evaluation, Preclinical; Escherichia coli; Magnetic Resonance Spectroscopy; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Spectrometry, Mass, Electrospray Ionization | 2009 |
A plasmid-borne blaOXA-58 gene confers imipenem resistance to Acinetobacter baumannii isolates from a Lebanese hospital.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Conjugation, Genetic; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Hospitals, University; Humans; Imipenem; Lebanon; Molecular Epidemiology; Molecular Sequence Data; Plasmids | 2008 |
Genetic basis of multidrug resistance in Acinetobacter baumannii clinical isolates at a tertiary medical center in Pennsylvania.
Topics: Academic Medical Centers; Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Base Sequence; beta-Lactamases; Cross Infection; DNA Primers; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Pennsylvania; Polymerase Chain Reaction | 2008 |
Widespread dissemination of aminoglycoside resistance genes armA and rmtB in Klebsiella pneumoniae isolates in Taiwan producing CTX-M-type extended-spectrum beta-lactamases.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Blotting, Southern; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Klebsiella pneumoniae; Taiwan | 2009 |
High prevalence of plasmid-mediated quinolone resistance determinants qnr, aac(6')-Ib-cr, and qepA among ceftiofur-resistant Enterobacteriaceae isolates from companion and food-producing animals.
Topics: Acetyltransferases; Adolescent; Adult; Aged; Animals; Animals, Domestic; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cambodia; Cephalosporins; China; Conjugation, Genetic; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli Proteins; Female; Humans; Male; Mali; Microbial Sensitivity Tests; Middle Aged; Nasal Cavity; Plasmids; Quinolones; Young Adult | 2009 |
Detection of the pandemic O25-ST131 human virulent Escherichia coli CTX-M-15-producing clone harboring the qnrB2 and aac(6')-Ib-cr genes in a dog.
Topics: Animals; Anti-Bacterial Agents; Dogs; Drug Resistance, Bacterial; Escherichia coli; Genes, Bacterial; Humans; Plasmids; Virulence | 2009 |
Codetection of blaOXA-23-like gene (blaOXA-133) and blaOXA-58 in Acinetobacter radioresistens: report from the SENTRY antimicrobial surveillance program.
Topics: Acinetobacter; Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Bacterial; Molecular Sequence Data; Plasmids; Population Surveillance; Reverse Transcriptase Polymerase Chain Reaction; Transcription, Genetic | 2009 |
Isolation of VanB-type Enterococcus faecalis strains from nosocomial infections: first report of the isolation and identification of the pheromone-responsive plasmids pMG2200, Encoding VanB-type vancomycin resistance and a Bac41-type bacteriocin, and pMG2
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Bacteriocins; Blotting, Southern; Conjugation, Genetic; Cross Infection; Culture Media; DNA Nucleotidyltransferases; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecalis; Erythromycin; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Perforin; Pheromones; Plasmids; Vancomycin Resistance | 2009 |
Multiple regulatory pathways associated with high-level ciprofloxacin and multidrug resistance in Salmonella enterica serovar enteritidis: involvement of RamA and other global regulators.
Topics: Animals; Anti-Infective Agents; Bacterial Proteins; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Multidrug Resistance-Associated Proteins; Salmonella enteritidis; Trans-Activators | 2009 |
Carbapenem resistance among Pseudomonas aeruginosa strains from India: evidence for nationwide endemicity of multiple metallo-beta-lactamase clones (VIM-2, -5, -6, and -11 and the newly characterized VIM-18).
Topics: Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Humans; India; Microbial Sensitivity Tests; Molecular Sequence Data; Prevalence; Pseudomonas aeruginosa; Ribotyping | 2009 |
Antimicrobial activity of prulifloxacin tested against a worldwide collection of gastroenteritis-producing pathogens, including those causing traveler's diarrhea.
Topics: Anti-Bacterial Agents; Diarrhea; Dioxolanes; Fluoroquinolones; Gastroenteritis; Gram-Negative Bacteria; Humans; Piperazines; Population Surveillance; Prodrugs | 2009 |
Contribution of vraSR and graSR point mutations to vancomycin resistance in vancomycin-intermediate Staphylococcus aureus.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; Chromosome Walking; DNA-Binding Proteins; Genetic Engineering; Genome, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Point Mutation; Sequence Analysis, DNA; Sequence Homology, Amino Acid; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2009 |
Activities of dalbavancin against a worldwide collection of 81,673 gram-positive bacterial isolates.
Topics: Anti-Bacterial Agents; Asia; Drug Resistance, Bacterial; Europe; Gram-Positive Bacteria; Humans; Latin America; Microbial Sensitivity Tests; North America; Pacific Ocean; Quality Control; Teicoplanin; Vancomycin | 2009 |
Synthesis and antimicrobial evaluation of some new substituted purine derivatives.
Topics: Anti-Infective Agents; Methicillin Resistance; Microbial Sensitivity Tests; Purines; Staphylococcus aureus; Structure-Activity Relationship | 2009 |
blaCTX-M genes in escherichia coli strains from Croatian Hospitals are located in new (blaCTX-M-3a) and widely spread (blaCTX-M-3a and blaCTX-M-15) genetic structures.
Topics: Base Sequence; beta-Lactamases; DNA Transposable Elements; Escherichia coli; Molecular Sequence Data; Plasmids; Polymerase Chain Reaction | 2009 |
Antibiotic susceptibility and characteristics of Neisseria meningitidis isolates from the African meningitis belt, 2000 to 2006: phenotypic and genotypic perspectives.
Topics: Africa; Genotype; Humans; Meningitis, Meningococcal; Microbial Sensitivity Tests; Neisseria meningitidis; Phenotype; Sequence Analysis, DNA; Time Factors | 2009 |
Contribution of oxidative damage to antimicrobial lethality.
Topics: 2,2'-Dipyridyl; Anti-Bacterial Agents; Bacterial Proteins; Catalase; Escherichia coli; Escherichia coli Proteins; Hydroxyl Radical; Microbial Sensitivity Tests; Norfloxacin; Oxidative Stress; Superoxide Dismutase; Thiourea | 2009 |
New plasmid-mediated quinolone resistance gene, qnrC, found in a clinical isolate of Proteus mirabilis.
Topics: Amino Acid Sequence; Anti-Infective Agents; Bacterial Proteins; Base Sequence; Conjugation, Genetic; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Polymerase Chain Reaction; Proteus Infections; Proteus mirabilis; Quinolones; Sequence Analysis, DNA | 2009 |
Potency and bactericidal activity of iclaprim against recent clinical gram-positive isolates.
Topics: Anti-Bacterial Agents; Enterococcus faecalis; Europe; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Hospitalization; Humans; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pyrimidines; Staphylococcus aureus; Streptococcus; United States | 2009 |
Antibiotic susceptibility of Waddlia chondrophila in Acanthamoeba castellanii amoebae.
Topics: Acanthamoeba castellanii; Animals; Anti-Bacterial Agents; Chlamydiales; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Quinolones | 2009 |
First detection of plasmid-encoded blaOXY beta-lactamase.
Topics: beta-Lactamases; Blotting, Southern; Child, Preschool; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Klebsiella; Klebsiella oxytoca; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
First report of plasmid-mediated quinolone resistance determinant qnrS1 in an Escherichia coli strain of animal origin in Italy.
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Genes, Bacterial; Microbial Sensitivity Tests; Plasmids; Poultry; Poultry Diseases; Quinolones; Salmonella enterica | 2009 |
Synthesis, physicochemical properties and antimicrobial activity of some new benzimidazole derivatives.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Benzimidazoles; Fungi; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship | 2009 |
Characterization of pABVA01, a plasmid encoding the OXA-24 carbapenemase from Italian isolates of Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Genotype; Microbial Sensitivity Tests; Molecular Sequence Data; Open Reading Frames; Plasmids; Sequence Analysis, DNA | 2009 |
Emergence of high levels of extended-spectrum-beta-lactamase-producing gram-negative bacilli in the Asia-Pacific region: data from the Study for Monitoring Antimicrobial Resistance Trends (SMART) program, 2007.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; China; Drug Resistance, Bacterial; Ertapenem; Escherichia coli; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Imipenem; India; Klebsiella; Quinolones; Thailand | 2009 |
Role of porins in the susceptibility of Mycobacterium smegmatis and Mycobacterium chelonae to aldehyde-based disinfectants and drugs.
Topics: Antitubercular Agents; Disinfectants; Drug Resistance, Bacterial; Glutaral; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Mycobacterium chelonae; Mycobacterium smegmatis; o-Phthalaldehyde; Porins | 2009 |
AI-2/LuxS is involved in increased biofilm formation by Streptococcus intermedius in the presence of antibiotics.
Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Proteins; Biofilms; Carbon-Sulfur Lyases; Ciprofloxacin; Homoserine; Lactones; Microscopy, Electron, Scanning; Polymerase Chain Reaction; Streptococcus intermedius; Tetracycline | 2009 |
Emergence of Klebsiella pneumoniae ST258 with KPC-2 in Poland.
Topics: Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Multiple, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Molecular Sequence Data; Poland | 2009 |
Antimicrobial activities of piperacillin-tazobactam against Haemophilus influenzae isolates, including beta-lactamase-negative ampicillin-resistant and beta-lactamase-positive amoxicillin-clavulanate-resistant isolates, and mutations in their quinolone re
Topics: Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; beta-Lactamases; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Haemophilus influenzae; Microbial Sensitivity Tests; Mutation | 2009 |
Complete nucleotide sequences of plasmids pEK204, pEK499, and pEK516, encoding CTX-M enzymes in three major Escherichia coli lineages from the United Kingdom, all belonging to the international O25:H4-ST131 clone.
Topics: beta-Lactamases; Computational Biology; Escherichia coli; Models, Genetic; Molecular Sequence Data; Open Reading Frames; Plasmids; United Kingdom | 2009 |
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus faecium; Glycopeptides; Gram-Positive Bacteria; Humans; Lipoglycopeptides; Microbial Sensitivity Tests; Staphylococcus aureus; Streptococcus | 2009 |
Nonclonal emergence of colistin-resistant Klebsiella pneumoniae isolates from blood samples in South Korea.
Topics: Anti-Bacterial Agents; Bacteremia; Colistin; Cross Infection; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Population Surveillance; Republic of Korea | 2010 |
Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; Carboxylic Ester Hydrolases; Cefotaxime; Cefuroxime; Cephalosporins; Cephalothin; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; India; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillins; Sequence Analysis, DNA; Sequence Homology, Amino Acid | 2009 |
Susceptibilities of 23 Desulfovibrio isolates from humans.
Topics: Ampicillin; Anti-Bacterial Agents; Chloramphenicol; Clindamycin; Desulfovibrio; Fluoroquinolones; Humans; Metronidazole; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam | 2009 |
Fitness costs and stability of a high-level ciprofloxacin resistance phenotype in Salmonella enterica serotype enteritidis: reduced infectivity associated with decreased expression of Salmonella pathogenicity island 1 genes.
Topics: Anti-Bacterial Agents; Bacterial Adhesion; Caco-2 Cells; Ciprofloxacin; Conjugation, Genetic; DNA Gyrase; Drug Resistance, Bacterial; Gene Expression Regulation, Bacterial; Humans; Lipopolysaccharides; Microbial Sensitivity Tests; Microscopy, Electron; Nucleic Acid Hybridization; Oligonucleotide Array Sequence Analysis; Phenotype; Porins; Reverse Transcriptase Polymerase Chain Reaction; Salmonella enteritidis; Salmonella Infections | 2010 |
Transferable quinolone resistance in Vibrio cholerae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Chromosomes, Bacterial; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; DNA Transposable Elements; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Mutation; Polymerase Chain Reaction; Quinolones; Vibrio cholerae | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Antimicrobial susceptibilities of multidrug-resistant Campylobacter jejuni and C. coli strains: in vitro activities of 20 antimicrobial agents.
Topics: Anti-Bacterial Agents; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Carbapenems; Drug Resistance, Multiple, Bacterial; Erythromycin; Feces; Finland; Humans; Macrolides; Microbial Sensitivity Tests; Minocycline; Tigecycline | 2010 |
Single nucleotide polymorphism analysis of the major tripartite multidrug efflux pump of Escherichia coli: functional conservation in disparate animal reservoirs despite exposure to antimicrobial chemotherapy.
Topics: Animals; Anti-Bacterial Agents; Catfishes; Cattle; Disease Reservoirs; Escherichia coli; Escherichia coli Proteins; Feces; Gene Expression Regulation, Bacterial; Intestines; Mice; Microbial Sensitivity Tests; Multidrug Resistance-Associated Proteins; Mutation; Phylogeny; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Rats; Recombination, Genetic; Sequence Analysis, DNA; Structure-Activity Relationship | 2010 |
The chemical synthesis and antibiotic activity of a diverse library of 2-aminobenzimidazole small molecules against MRSA and multidrug-resistant A. baumannii.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Benzimidazoles; Drug Resistance, Multiple, Bacterial; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Conformation; Small Molecule Libraries; Stereoisomerism; Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Proteus mirabilis pmrI, an RppA-regulated gene necessary for polymyxin B resistance, biofilm formation, and urothelial cell invasion.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; Biofilms; Carboxy-Lyases; Cell Line; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Epithelial Cells; Gene Expression Regulation, Bacterial; Genes, Bacterial; Genetic Complementation Test; Humans; Lipopolysaccharides; Molecular Sequence Data; Mutagenesis, Insertional; Operon; Phenotype; Polymyxin B; Promoter Regions, Genetic; Proteus mirabilis; Urothelium | 2010 |
Efflux-mediated bis-indole resistance in Staphylococcus aureus reveals differential substrate specificities for MepA and MepR.
Topics: Bacterial Proteins; Drug Resistance, Bacterial; Indoles; Microbial Sensitivity Tests; Mutation; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; Staphylococcus aureus; Structure-Activity Relationship; Substrate Specificity | 2010 |
Genetic basis of multidrug resistance in Acinetobacter clinical isolates in Taiwan.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aminoglycosides; beta-Lactamases; Carbapenems; Cephalosporins; DNA Gyrase; Drug Resistance, Bacterial; Drug Resistance, Multiple; Fluoroquinolones; Humans; Taiwan | 2010 |
KPC-producing extreme drug-resistant Klebsiella pneumoniae isolate from a patient with diabetes mellitus and chronic renal failure on hemodialysis in South Korea.
Topics: Aged; beta-Lactamases; Diabetic Nephropathies; Humans; Kidney Failure, Chronic; Klebsiella Infections; Klebsiella pneumoniae; Male; Renal Dialysis; Republic of Korea | 2010 |
Emergence of ciprofloxacin-nonsusceptible Streptococcus pyogenes isolates from healthy children and pediatric patients in Portugal.
Topics: Amino Acid Substitution; Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Outer Membrane Proteins; Bacterial Typing Techniques; Carrier Proteins; Child; Ciprofloxacin; Drug Resistance, Bacterial; Humans; Molecular Epidemiology; Norfloxacin; Point Mutation; Portugal; Streptococcal Infections; Streptococcus pyogenes | 2010 |
In vitro activity of the aminoglycoside antibiotic arbekacin against Acinetobacter baumannii-calcoaceticus isolated from war-wounded patients at Walter Reed Army Medical Center.
Topics: Acinetobacter baumannii; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Dibekacin; Hospitals, Military; Humans; Microbial Sensitivity Tests; Warfare | 2010 |
Incidence and antimicrobial susceptibility of Escherichia coli and Klebsiella pneumoniae with extended-spectrum beta-lactamases in community- and hospital-associated intra-abdominal infections in Europe: results of the 2008 Study for Monitoring Antimicrob
Topics: Abdomen; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae | 2010 |
Antimicrobial resistance among respiratory pathogens in Spain: latest data and changes over 11 years (1996-1997 to 2006-2007).
Topics: Ampicillin; Anti-Bacterial Agents; Cefotaxime; Erythromycin; Haemophilus influenzae; Lincosamides; Macrolides; Microbial Sensitivity Tests; Penicillins; Respiratory Tract Infections; Spain; Streptococcus pneumoniae; Streptococcus pyogenes; Streptogramin B | 2010 |
Susceptibility of gram-negative pathogens isolated from patients with complicated intra-abdominal infections in the United States, 2007-2008: results of the Study for Monitoring Antimicrobial Resistance Trends (SMART).
Topics: Abdomen; Amikacin; beta-Lactams; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Ertapenem; Escherichia coli; Gram-Negative Bacteria; Humans; Imipenem; Microbial Sensitivity Tests | 2010 |
N-acetylcysteine-mediated modulation of bacterial antibiotic susceptibility.
Topics: Acetylcysteine; Anti-Bacterial Agents; Culture Media; Drug Resistance, Bacterial; Expectorants; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests | 2010 |
Different classes of antibiotics differentially influence shiga toxin production.
Topics: Anti-Bacterial Agents; Azithromycin; Bacteriophages; Ciprofloxacin; Escherichia coli; Escherichia coli O157; Shiga Toxin; Sulfamethoxazole; Trimethoprim | 2010 |
In vitro antimicrobial activity and mutant prevention concentration of colistin against Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Colistin; Drug Resistance, Multiple, Bacterial; Microbial Sensitivity Tests; Mutation | 2010 |
Optimized Nile Red efflux assay of AcrAB-TolC multidrug efflux system shows competition between substrates.
Topics: Anti-Bacterial Agents; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Chlortetracycline; Dipeptides; Doxorubicin; Doxycycline; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Proteins; Minocycline; Onium Compounds; Organophosphorus Compounds; Tetracycline | 2010 |
Prevalence and dissemination of oqxAB in Escherichia coli isolates from animals, farmworkers, and the environment.
Topics: Animals; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Quinolones | 2010 |
Synthesis and antimicrobial activity of novel fluorine containing 4-(substituted-2-hydroxybenzoyl)-1H-pyrazoles and pyrazolyl benzo[d]oxazoles.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Bacillus subtilis; Bacteria; Bacterial Infections; Candida albicans; Candidiasis; Escherichia coli; Fluorine; Humans; Microbial Sensitivity Tests; Oxazoles; Pseudomonas aeruginosa; Pyrazoles; Staphylococcus aureus; Structure-Activity Relationship | 2010 |
Antimicrobial resistance testing of verocytotoxin-producing Escherichia coli and first description of TEM-52 extended-spectrum β-lactamase in serogroup O26.
Topics: Adhesins, Bacterial; Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Proteins; Humans; Plasmids; Shiga Toxins | 2010 |
Design, synthesis and in vitro evaluation of antitubercular and antimicrobial activity of some novel pyranopyrimidines.
Topics: Anti-Infective Agents; Aspergillus niger; Bacteria; Drug Design; Drug Evaluation, Preclinical; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Pyrimidines | 2010 |
Bernthsen synthesis, antimicrobial activities and cytotoxicity of acridine derivatives.
Topics: Acridines; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Antineoplastic Agents; Aspergillus niger; Bacteria; Gram-Negative Bacteria; Gram-Positive Bacteria; Indicators and Reagents; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Spectrophotometry, Infrared | 2010 |
In vivo selection of a missense mutation in adeR and conversion of the novel blaOXA-164 gene into blaOXA-58 in carbapenem-resistant Acinetobacter baumannii isolates from a hospitalized patient.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacterial Proteins; Carbapenems; Drug Resistance, Bacterial; Fatal Outcome; Humans; Male; Middle Aged; Molecular Sequence Data; Mutation, Missense; Reverse Transcriptase Polymerase Chain Reaction | 2010 |
Inhibition of bacterial multidrug resistance by celecoxib, a cyclooxygenase-2 inhibitor.
Topics: Ampicillin; Celecoxib; Chloramphenicol; Ciprofloxacin; Cyclooxygenase 2 Inhibitors; Drug Resistance, Multiple, Bacterial; Kanamycin; Microbial Sensitivity Tests; Mycobacterium smegmatis; Pyrazoles; Staphylococcus aureus; Sulfonamides | 2011 |
Synthesis and evaluation of anti-tubercular activity of new dithiocarbamate sugar derivatives.
Topics: Antitubercular Agents; Carbohydrates; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxidoreductases; Thiocarbamates; Thioglucosides | 2011 |
Design and synthesis of potent Gram-negative specific LpxC inhibitors.
Topics: Amidohydrolases; Anti-Bacterial Agents; Benzodiazepinones; Binding Sites; Catalysis; Catalytic Domain; Crystallography, X-Ray; Drug Design; Gram-Negative Bacteria; Hydroxamic Acids; Microbial Sensitivity Tests; Structure-Activity Relationship; Zinc | 2011 |
Microwave assisted synthesis and antimicrobial evaluation of new fused pyran derivatives bearing 2-morpholinoquinoline nucleus.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Candida albicans; Fungi; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Microwaves; Mycoses; Pyrans; Quinolines | 2011 |
1,3-Dihydro-2H-indol-2-ones derivatives: design, synthesis, in vitro antibacterial, antifungal and antitubercular study.
Topics: Antifungal Agents; Antitubercular Agents; Chemistry Techniques, Synthetic; Drug Design; Fungi; Indoles; Microbial Sensitivity Tests; Mycobacterium tuberculosis | 2011 |
Computational analysis of structure-based interactions and ligand properties can predict efflux effects on antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Computational Biology; Drug Resistance, Bacterial; Hydrophobic and Hydrophilic Interactions; Ligands; Membrane Transport Proteins; Microbial Sensitivity Tests; Models, Molecular; Protein Binding; Protein Conformation; Quantitative Structure-Activity Relationship; Regression Analysis; Thermodynamics | 2012 |
An efficient one-pot synthesis, structure, antimicrobial and antioxidant investigations of some novel quinolyldibenzo[b,e][1,4]diazepinones.
Topics: Anti-Infective Agents; Antioxidants; Azepines; Crystallography, X-Ray; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Molecular Conformation; Quinolines | 2012 |
An improved microwave assisted one-pot synthesis, and biological investigations of some novel aryldiazenyl chromeno fused pyrrolidines.
Topics: Antifungal Agents; Antitubercular Agents; Aspergillus fumigatus; Azo Compounds; Benzopyrans; Candida albicans; Crystallography, X-Ray; Gram-Negative Bacteria; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Microwaves; Molecular Structure; Mycobacterium tuberculosis; Pyrrolidines; Stereoisomerism; Thiosemicarbazones | 2012 |
New N-arylamino biquinoline derivatives: synthesis, antimicrobial, antituberculosis, and antimalarial evaluation.
Topics: Antimalarials; Antitubercular Agents; Chemistry Techniques, Synthetic; Electrons; Fungi; Hydrophobic and Hydrophilic Interactions; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Plasmodium falciparum; Quinolines | 2012 |
Green synthesis and anti-infective activities of fluorinated pyrazoline derivatives.
Topics: Anti-Infective Agents; Antitubercular Agents; Bacteria; Bacterial Infections; Fungi; Green Chemistry Technology; Halogenation; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Mycoses; Pyrazoles; Tuberculosis | 2012 |
An efficient domino reaction in ionic liquid: synthesis and biological evaluation of some pyrano- and thiopyrano-fused heterocycles.
Topics: Aldehydes; Anti-Bacterial Agents; Coumarins; Gram-Negative Bacteria; Gram-Positive Bacteria; Heterocyclic Compounds; Ionic Liquids; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrans; Pyrazolones; Quinolines; Structure-Activity Relationship | 2013 |
Microwave assisted nano (ZnO-TiO2) catalyzed synthesis of some new 4,5,6,7-tetrahydro-6-((5-substituted-1,3,4-oxadiazol-2-yl)methyl)thieno[2,3-c]pyridine as antimicrobial agents.
Topics: Anti-Bacterial Agents; Antifungal Agents; Aspergillus niger; Bacillus subtilis; Candida albicans; Catalysis; Dose-Response Relationship, Drug; Escherichia coli; Microbial Sensitivity Tests; Microwaves; Molecular Structure; Nanostructures; Oxadiazoles; Pseudomonas aeruginosa; Pyridines; Staphylococcus aureus; Structure-Activity Relationship; Titanium; Zinc Oxide | 2013 |
Green synthesis of tetrahydropyrimidine analogues and evaluation of their antimicrobial activity.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Aspergillus; Bacillus subtilis; Candida albicans; Catalysis; Escherichia coli; Green Chemistry Technology; Microbial Sensitivity Tests; Pyrimidines; Staphylococcus aureus; Zirconium | 2013 |
Synthesis and identification of β-aryloxyquinoline based diversely fluorine substituted N-aryl quinolone derivatives as a new class of antimicrobial, antituberculosis and antioxidant agents.
Topics: Animals; Anti-Infective Agents; Antioxidants; Antitubercular Agents; Artemia; Aspergillus fumigatus; Candida albicans; Dose-Response Relationship, Drug; Fluorine; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Models, Chemical; Molecular Structure; Mycobacterium tuberculosis; Ovum; Quinolines; Structure-Activity Relationship | 2013 |
Synthetic tactics of new class of 4-aminothieno[2,3-d]pyrimidine-6-carbonitrile derivatives acting as antimicrobial agents.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Benzoxazines; Dose-Response Relationship, Drug; Fungi; Microbial Sensitivity Tests; Molecular Structure; Piperidines; Structure-Activity Relationship | 2013 |
Design and synthesis of biquinolone-isoniazid hybrids as a new class of antitubercular and antimicrobial agents.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Antitubercular Agents; Artemia; Bacteria; Dose-Response Relationship, Drug; Drug Design; Fungi; Isoniazid; Microbial Sensitivity Tests; Molecular Structure; Motor Activity; Quinolones; Structure-Activity Relationship; Tuberculosis | 2013 |
New derivatives of salicylamides: Preparation and antimicrobial activity against various bacterial species.
Topics: Ampicillin; Anti-Infective Agents; Ciprofloxacin; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Salicylamides; Structure-Activity Relationship | 2013 |
Hytramycins V and I, anti-Mycobacterium tuberculosis hexapeptides from a Streptomyces hygroscopicus strain.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Chromatography, High Pressure Liquid; Inhibitory Concentration 50; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nuclear Magnetic Resonance, Biomolecular; Peptides, Cyclic; Streptomyces; Vero Cells | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
First identification of boronic species as novel potential inhibitors of the Staphylococcus aureus NorA efflux pump.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Bacterial Proteins; Boronic Acids; Cell Survival; Ciprofloxacin; Culture Media; Drug Resistance, Bacterial; Drug Screening Assays, Antitumor; Humans; Indicators and Reagents; KB Cells; Microbial Sensitivity Tests; Multidrug Resistance-Associated Proteins; Staphylococcus aureus; Structure-Activity Relationship | 2014 |
Synthesis, antileishmanial activity and docking study of N'-substitutedbenzylidene-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetohydrazides.
Topics: Administration, Oral; Anti-Infective Agents; Antiprotozoal Agents; Benzylidene Compounds; Binding Sites; Drug Design; Half-Life; Hydrazines; Leishmania donovani; Microbial Sensitivity Tests; Molecular Docking Simulation; Oxidoreductases; Protein Structure, Tertiary; Protozoan Proteins; Pyridines | 2014 |
Synthesis, characterization and pharmacological screening of some novel 5-imidazopyrazole incorporated polyhydroquinoline derivatives.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antimalarials; Bacteria; Dose-Response Relationship, Drug; Fungi; Microbial Sensitivity Tests; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymers; Pyrazoles; Quinolines; Structure-Activity Relationship | 2014 |
One pot three components microwave assisted and conventional synthesis of new 3-(4-chloro-2-hydroxyphenyl)-2-(substituted) thiazolidin-4-one as antimicrobial agents.
Topics: Anti-Bacterial Agents; Antifungal Agents; Aspergillus flavus; Aspergillus niger; Candida albicans; Dose-Response Relationship, Drug; HeLa Cells; Humans; MCF-7 Cells; Microbial Sensitivity Tests; Microwaves; Molecular Structure; Staphylococcus aureus; Structure-Activity Relationship; Thiazolidines | 2014 |
Synthesis of 2,3,6-trideoxy sugar triazole hybrids as potential new broad spectrum antimicrobial agents.
Topics: Anti-Infective Agents; Bacteria; Carbohydrates; Catalytic Domain; Cell Line; Chemistry Techniques, Synthetic; Click Chemistry; Drug Design; Fungi; Microbial Sensitivity Tests; Models, Molecular; Penicillin-Binding Proteins; Triazoles | 2014 |
Design, synthesis and characterization of fluoro substituted novel pyrazolylpyrazolines scaffold and their pharmacological screening.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antimalarials; Bacteria; Dose-Response Relationship, Drug; Drug Design; Fungi; Microbial Sensitivity Tests; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyrazoles; Structure-Activity Relationship | 2014 |
Synthesis, structure-activity relationship studies, and antibacterial evaluation of 4-chromanones and chalcones, as well as olympicin A and derivatives.
Topics: Animals; Anti-Bacterial Agents; Chalcones; Chemistry Techniques, Synthetic; Chlorocebus aethiops; Chromones; DNA Gyrase; DNA Topoisomerase IV; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Phloroglucinol; Structure-Activity Relationship; Topoisomerase II Inhibitors; Vero Cells | 2014 |
Boronic species as promising inhibitors of the Staphylococcus aureus NorA efflux pump: study of 6-substituted pyridine-3-boronic acid derivatives.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Boronic Acids; Ciprofloxacin; Humans; KB Cells; Multidrug Resistance-Associated Proteins; Pyridines; Staphylococcal Infections; Staphylococcus aureus | 2015 |
Cytotoxic Homoisoflavones from the Bulbs of Bellevalia eigii.
Topics: HT29 Cells; Humans; Inhibitory Concentration 50; Isoflavones; Jordan; Liliaceae; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium; Mycobacterium smegmatis; Nuclear Magnetic Resonance, Biomolecular; Plant Roots; Structure-Activity Relationship; Vinblastine | 2015 |
Imidazolidine-4-one derivatives in the search for novel chemosensitizers of Staphylococcus aureus MRSA: synthesis, biological evaluation and molecular modeling studies.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Imidazolidines; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Models, Molecular; Molecular Dynamics Simulation; Molecular Structure; Structure-Activity Relationship | 2015 |
Novel morpholinoquinoline nucleus clubbed with pyrazoline scaffolds: Synthesis, antibacterial, antitubercular and antimalarial activities.
Topics: Anti-Infective Agents; Antimalarials; Antitubercular Agents; Bacteria; Bacterial Infections; Fungi; Humans; Malaria, Falciparum; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Mycoses; Plasmodium falciparum; Pyrazoles; Quinolines; Structure-Activity Relationship; Tuberculosis | 2016 |
Biological characterization of the hygrobafilomycin antibiotic JBIR-100 and bioinformatic insights into the hygrolide family of natural products.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Biological Products; Computational Biology; Dose-Response Relationship, Drug; Fungi; Macrolides; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship | 2016 |
Novel benzimidazol-2-ylidene carbene precursors and their silver(I) complexes: Potential antimicrobial agents.
Topics: Anti-Infective Agents; Benzimidazoles; Candida; Enterococcus faecalis; Escherichia coli; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Silver; Spectrum Analysis; Staphylococcus aureus | 2016 |
Synthesis and biological screening of novel 2-morpholinoquinoline nucleus clubbed with 1,2,4-oxadiazole motifs.
Topics: Anti-Infective Agents; Bacteria; Bacterial Proteins; Catalytic Domain; Chemistry Techniques, Synthetic; Drug Evaluation, Preclinical; Fungi; Microbial Sensitivity Tests; Molecular Docking Simulation; Oxadiazoles; Quinolines; Structure-Activity Relationship | 2017 |
Antileishmanial evaluation of clubbed bis(indolyl)-pyridine derivatives: One-pot synthesis, in vitro biological evaluations and in silico ADME prediction.
Topics: Anti-Bacterial Agents; Antiprotozoal Agents; Bacteria; Dose-Response Relationship, Drug; Leishmania donovani; Microbial Sensitivity Tests; Molecular Structure; Parasitic Sensitivity Tests; Pyridines; Structure-Activity Relationship | 2017 |
Diaryltriazenes as antibacterial agents against methicillin resistant Staphylococcus aureus (MRSA) and Mycobacterium smegmatis.
Topics: Anti-Bacterial Agents; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mycobacterium smegmatis; Triazenes | 2017 |
Synthesis, identification and in vitro biological evaluation of some novel quinoline incorporated 1,3-thiazinan-4-one derivatives.
Topics: Anti-Bacterial Agents; Antimalarials; Antitubercular Agents; Clostridium tetani; Gram-Negative Bacteria; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Plasmodium falciparum; Quinolines; Spectroscopy, Fourier Transform Infrared; Structure-Activity Relationship; Thiazines | 2017 |
1,2,4-Triazole and 1,3,4-oxadiazole analogues: Synthesis, MO studies, in silico molecular docking studies, antimalarial as DHFR inhibitor and antimicrobial activities.
Topics: Anti-Infective Agents; Antimalarials; Folic Acid Antagonists; Molecular Docking Simulation; Oxadiazoles; Spectrum Analysis; Triazoles | 2017 |
Lipophosphonoxins II: Design, Synthesis, and Properties of Novel Broad Spectrum Antibacterial Agents.
Topics: Animals; Anti-Bacterial Agents; Apoptosis; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Survival; Drug Design; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Lipid Bilayers; Male; Mice, Inbred ICR; Microbial Sensitivity Tests; Phospholipids; Pyrazoles; Rabbits; Skin Irritancy Tests; Stereoisomerism; Structure-Activity Relationship; Uridine Monophosphate | 2017 |
Design, synthesis and 2D QSAR study of novel pyridine and quinolone hydrazone derivatives as potential antimicrobial and antitubercular agents.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Cell Line; Dose-Response Relationship, Drug; Drug Design; Fibroblasts; Fungi; Humans; Hydrazones; Microbial Sensitivity Tests; Molecular Structure; Pyridines; Quantitative Structure-Activity Relationship; Quinolones | 2017 |
Benzothiazole analogues: Synthesis, characterization, MO calculations with PM6 and DFT, in silico studies and in vitro antimalarial as DHFR inhibitors and antimicrobial activities.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antimalarials; Benzothiazoles; Cell Survival; Computer Simulation; Dose-Response Relationship, Drug; Folic Acid Antagonists; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Molecular Structure; Plasmodium falciparum; Quantum Theory; Schizosaccharomyces; Structure-Activity Relationship; Tetrahydrofolate Dehydrogenase | 2017 |
In vitro activity of salicylamide derivatives against vancomycin-resistant enterococci.
Topics: Anti-Bacterial Agents; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Enterococcus faecalis; Humans; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Vancomycin; Vancomycin-Resistant Enterococci | 2018 |
Discovery of novel arylethenesulfonyl fluorides as potential candidates against methicillin-resistant of Staphylococcus aureus (MRSA) for overcoming multidrug resistance of bacterial infections.
Topics: Bacterial Infections; Biofilms; Drug Resistance, Multiple; Electron Transport Chain Complex Proteins; Fluorides; Methicillin-Resistant Staphylococcus aureus; Molecular Docking Simulation; Oxidation-Reduction; Staphylococcal Infections; Sulfinic Acids; Sulfones | 2019 |
Microwave-assisted solid-phase synthesis of antisense acpP peptide nucleic acid-peptide conjugates active against colistin- and tigecycline-resistant E. coli and K. pneumoniae.
Topics: Anti-Bacterial Agents; Colistin; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Escherichia coli; Klebsiella pneumoniae; Microbial Sensitivity Tests; Microwaves; Molecular Structure; Peptide Nucleic Acids; Peptides; Solid-Phase Synthesis Techniques; Structure-Activity Relationship; Tigecycline | 2019 |
An overview of recent progress in siderophore-antibiotic conjugates.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Molecular Structure; Siderophores; Structure-Activity Relationship | 2019 |
Synthesis of Natural and Unnatural Quinolones Inhibiting the Growth and Motility of Bacteria.
Topics: Anti-Bacterial Agents; Bacillus subtilis; Bacteria; Cyclization; Microbial Sensitivity Tests; Molecular Structure; Pseudomonas aeruginosa; Quinolones | 2020 |
Preparation of new 1,3-dibenzyl tetrahydropyridinylidene ammonium salts and their antimicrobial and anticellular activities.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Antimalarials; Antineoplastic Agents; Candida albicans; Cell Line; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Epidermis; Escherichia coli; Female; Humans; Mice; Microbial Sensitivity Tests; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Pseudomonas aeruginosa; Quaternary Ammonium Compounds; Rats; Salts; Staphylococcus aureus; Structure-Activity Relationship | 2021 |
Structure based design, synthesis, and biological evaluation of imidazole derivatives targeting dihydropteroate synthase enzyme.
Topics: Anti-Bacterial Agents; Dihydropteroate Synthase; Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors; Imidazoles; Ligands; Microbial Sensitivity Tests; Molecular Structure; Staphylococcus aureus; Structure-Activity Relationship; Vancomycin-Resistant Enterococci | 2021 |
Antimicrobial, modulatory, and antibiofilm activity of tt-farnesol on bacterial and fungal strains of importance to human health.
Topics: Anti-Bacterial Agents; Biofilms; Dose-Response Relationship, Drug; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Molecular Docking Simulation; Molecular Structure; Structure-Activity Relationship | 2021 |
Synthetic cajaninstilbene acid derivatives eradicate methicillin-resistant Staphylococcus aureus persisters and biofilms.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Cell Survival; Cell Wall; Disease Models, Animal; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; RAW 264.7 Cells; Salicylates; Skin Diseases; Staphylococcal Infections; Staphylococcus aureus; Stilbenes; Structure-Activity Relationship | 2021 |
Potentiating the intracellular killing of Staphylococcus aureus by dihydroquinazoline analogues as NorA efflux pump inhibitor.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cell Survival; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Molecular Structure; Multidrug Resistance-Associated Proteins; Quinazolines; Staphylococcus aureus; Structure-Activity Relationship; THP-1 Cells | 2022 |
Metallo-β-lactamases inhibitor fisetin attenuates meropenem resistance in NDM-1-producing Escherichia coli.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Escherichia coli; Flavonols; Meropenem; Microbial Sensitivity Tests | 2022 |
Design and synthesis of quinolinium-based derivatives targeting FtsZ for antibacterial evaluation and mechanistic study.
Topics: Amines; Anti-Bacterial Agents; Bacterial Proteins; Cytoskeletal Proteins; Microbial Sensitivity Tests; Molecular Docking Simulation; Staphylococcus aureus; Staphylococcus epidermidis; Structure-Activity Relationship | 2022 |
LEGO-Lipophosphonoxins: A Novel Approach in Designing Membrane Targeting Antimicrobials.
Topics: Albumins; Anti-Bacterial Agents; Cell Membrane; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Structure-Activity Relationship | 2022 |
Design and evaluation of poly-nitrogenous adjuvants capable of potentiating antibiotics in Gram-negative bacteria.
Topics: | 2022 |
E-test: a new technique for antimicrobial susceptibility testing for periodontal microorganisms.
Topics: Adult; Aged; Aggregatibacter actinomycetemcomitans; Ampicillin; Anti-Bacterial Agents; Bacteria; Bacteroides; Bacteroides fragilis; Campylobacter; Capnocytophaga; Cefoxitin; Ciprofloxacin; Clindamycin; Clostridium perfringens; Dental Plaque; Eikenella corrodens; Female; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Peptostreptococcus; Periodontal Diseases; Periodontitis; Porphyromonas gingivalis; Tetracycline | 1992 |
[Development of resistance in bacteria interacting with subinhibitory antibiotic concentrations].
Topics: Amikacin; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Ampicillin Resistance; Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Clavulanic Acids; Drug Resistance, Microbial; Drug Therapy, Combination; Escherichia coli; Gentamicins; Humans; Microbial Sensitivity Tests; Pseudomonas; Serial Passage; Staphylococcus aureus; Vancomycin | 1992 |
Comparison of the antibacterial efficacies of ampicillin and ciprofloxacin against experimental infections with Listeria monocytogenes in hydrocortisone-treated mice.
Topics: Ampicillin; Animals; Ciprofloxacin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Hydrocortisone; Immunocompromised Host; Injections, Subcutaneous; Listeriosis; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests | 1992 |
Case report: recurrent Salmonella typhi chest wall abscess associated with a pituitary macroadenoma.
Topics: Abscess; Adenoma; Adult; Ampicillin; Ciprofloxacin; Hormones; Humans; Male; Microbial Sensitivity Tests; Pituitary Neoplasms; Salmonella typhi; Thorax; Typhoid Fever | 1992 |
Ciprofloxacin in the management of multiple drug resistant typhoid fever.
Topics: Adolescent; Amoxicillin; Ampicillin; Child; Child, Preschool; Chloramphenicol; Chloramphenicol Resistance; Ciprofloxacin; Drug Resistance, Microbial; Female; Humans; India; Male; R Factors; Salmonella typhi; Trimethoprim Resistance; Trimethoprim, Sulfamethoxazole Drug Combination; Typhoid Fever | 1991 |
Treatment of enteric fever--what next?
Topics: Ampicillin; Cefotaxime; Child; Child, Preschool; Chloramphenicol; Chloramphenicol Resistance; Ciprofloxacin; Drug Resistance, Microbial; Female; Humans; India; Male; Salmonella typhi; Trimethoprim Resistance; Trimethoprim, Sulfamethoxazole Drug Combination; Typhoid Fever | 1991 |
Septic polyarthritis in chronic tophaceous gout.
Topics: Ampicillin; Arthritis, Infectious; Cefotaxime; Ciprofloxacin; Gout; Humans; Male; Middle Aged; Pneumococcal Infections | 1991 |
Disk diffusion method for susceptibility testing of Neisseria gonorrhoeae.
Topics: Ampicillin; Cefuroxime; Ciprofloxacin; Culture Media; Doxycycline; Drug Resistance, Microbial; Erythromycin; Hemoglobins; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillins; Regression Analysis; Reproducibility of Results; Spectinomycin; Tetracycline | 1991 |
Mechanisms of fluoroquinolone resistance in Staphylococcus aureus.
Topics: Ampicillin; Anti-Infective Agents; Bacterial Proteins; Ciprofloxacin; Cloning, Molecular; DNA Topoisomerases, Type II; DNA, Bacterial; Drug Resistance, Microbial; Humans; Membrane Proteins; Mutation; Norfloxacin; Nucleic Acid Hybridization; R Factors; Restriction Mapping; Staphylococcus aureus | 1991 |
Relapsing native-valve enterococcal endocarditis: a unique cure with oral ciprofloxacin combination drug therapy.
Topics: Adult; Ampicillin; beta-Lactamases; Ciprofloxacin; Drug Synergism; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecalis; Female; Gentamicins; Humans; Penicillins; Recurrence; Streptococcal Infections | 1991 |
[The in vitro activity of ciprofloxacin against clinically-isolated strains of Pseudomonas aeruginosa and comparison with some other antibiotics].
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Aztreonam; Ceftriaxone; Ciprofloxacin; Gentamicins; Humans; Ofloxacin; Pseudomonas aeruginosa | 1990 |
In-vivo evaluation of ofloxacin in Salmonella typhimurium infection in mice.
Topics: Ampicillin; Animals; Chloramphenicol; Ciprofloxacin; Female; Liver; Mice; Microbial Sensitivity Tests; Ofloxacin; Salmonella Infections, Animal; Salmonella typhimurium; Spleen | 1990 |
In vitro susceptibility of Salmonella to ciprofloxacin and pefloxacin compared with three other antibiotics.
Topics: Ampicillin; Chloramphenicol; Ciprofloxacin; Drug Resistance, Microbial; Pefloxacin; Salmonella; Salmonella typhimurium; Serotyping; Trimethoprim, Sulfamethoxazole Drug Combination | 1990 |
The in vitro activity of norfloxacin, ofloxacin and ciprofloxacin and other antibiotics in current use against Neisseria gonorrhoeae.
Topics: Ampicillin; Ampicillin Resistance; Ciprofloxacin; Doxycycline; Drug Resistance, Microbial; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Norfloxacin; Ofloxacin; Penicillin Resistance | 1989 |
Correlation between growth curves and killing curves of Escherichia coli in the presence of fleroxacin and ampicillin.
Topics: Ampicillin; Ampicillin Resistance; Anti-Infective Agents; Ciprofloxacin; Colony Count, Microbial; Culture Media; Drug Resistance, Microbial; Escherichia coli; Fleroxacin; Nephelometry and Turbidimetry; Species Specificity; Time Factors | 1989 |
[Mechanisms of action of chemotherapeutic drugs--microcalorimetric studies].
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Calorimetry; Calorimetry, Differential Scanning; Ciprofloxacin; Colistin; Disinfectants; Dose-Response Relationship, Drug; Energy Metabolism; Escherichia coli; Imipenem; Phenol; Phenols; Polymyxin B | 1989 |
The post-antibiotic effect defined by bacterial morphology.
Topics: Ampicillin; Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Colony Count, Microbial; Escherichia coli; Microbial Sensitivity Tests; Time Factors | 1989 |
Comparative in vitro activities of six new fluoroquinolones and other oral antimicrobial agents against Campylobacter pylori.
Topics: Ampicillin; Anti-Infective Agents; Campylobacter; Ciprofloxacin; Colony Count, Microbial; Erythromycin; Microbial Sensitivity Tests; Nitrofurantoin; Sulfamethoxazole; Tetracycline; Trimethoprim | 1989 |
In-vitro susceptibility of Haemophilus influenzae to meropenem compared with imipenem, five other beta-lactams, chloramphenicol and ciprofloxacin.
Topics: Ampicillin; Anti-Bacterial Agents; Carbapenems; Chloramphenicol; Ciprofloxacin; Culture Media; Haemophilus influenzae; Imipenem; Meropenem; Microbial Sensitivity Tests; Penicillin Resistance; Thienamycins | 1989 |
Bactericidal activity of deptomycin (LY146032) compared with those of ciprofloxacin, vancomycin, and ampicillin against enterococci as determined by kill-kinetic studies.
Topics: Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Daptomycin; Enterococcus faecalis; Humans; Microbial Sensitivity Tests; Peptides; Vancomycin | 1987 |
Assessment of the in vitro and in vivo activity of ciprofloxacin measured against current standards of therapy.
Topics: Ampicillin; Animals; Azlocillin; Blood; Ciprofloxacin; Escherichia coli; Humans; In Vitro Techniques; Mice; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Oxazines; Pseudomonas aeruginosa; Quinolines; Sisomicin; Tobramycin | 1985 |
Oral ciprofloxacin treatment for Salmonella typhimurium infection of normal and immunocompromised mice.
Topics: Administration, Oral; Ampicillin; Animals; Chloramphenicol; Ciprofloxacin; Female; Immune Tolerance; Liver; Mice; Mice, Inbred C57BL; Organ Size; Salmonella Infections, Animal; Salmonella typhimurium; Specific Pathogen-Free Organisms; Virulence | 1988 |
Identification of Streptococcus faecalis and Streptococcus faecium and susceptibility studies with newly developed antimicrobial agents.
Topics: Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Enterococcus faecalis; Erythromycin; Fluoroquinolones; Humans; Imipenem; Microbial Sensitivity Tests; Quinolines; Streptococcus; Thienamycins; Vancomycin | 1987 |
A comparison of the in-vitro activity of seventeen antibiotics against Streptococcus faecalis.
Topics: Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Enterococcus faecalis; Mezlocillin; Microbial Sensitivity Tests; Norfloxacin | 1987 |
Comparative killing activity and postantibiotic effect of streptomycin combined with ampicillin, ciprofloxacin, imipenem, piperacillin or vancomycin against strains of Streptococcus faecalis and Streptococcus faecium.
Topics: Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Drug Synergism; Enterococcus faecalis; Imipenem; Piperacillin; Streptococcus; Streptomycin; Thienamycins; Vancomycin | 1988 |
Interaction of ciprofloxacin with ampicillin and vancomycin for Streptococcus faecalis.
Topics: Ampicillin; Ciprofloxacin; Drug Interactions; Drug Synergism; Enterococcus faecalis; Microbial Sensitivity Tests; Vancomycin | 1988 |
In-vitro activity of fleroxacin against urinary tract and genital tract pathogens.
Topics: Ampicillin; Anti-Infective Agents; Bacteria; Ciprofloxacin; Female; Fleroxacin; Genital Diseases, Female; Genital Diseases, Male; Male; Nalidixic Acid; Penicillins; Tetracyclines; Trimethoprim; Urinary Tract Infections | 1988 |
Comparative evaluation of recently developed quinolone compounds--with a note on the frequency of resistant mutants.
Topics: Acinetobacter; Ampicillin; Anti-Bacterial Agents; Bacteria; Cefotaxime; Ciprofloxacin; Enoxacin; Enterobacteriaceae; Enterococcus faecalis; Gentamicins; Haemophilus influenzae; Mezlocillin; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Penicillin Resistance; Pseudomonas aeruginosa; Quinolines; Staphylococcus aureus | 1985 |
New drugs of 1987.
Topics: Ampicillin; Aztreonam; Ciprofloxacin; Humans; Sulbactam; United States; United States Food and Drug Administration | 1988 |
The influence of ciprofloxacin treatment in vivo on cell-mediated immunity to Listeria monocytogenes.
Topics: Ampicillin; Animals; Ciprofloxacin; Female; Hypersensitivity, Delayed; Immunity, Cellular; Immunization, Passive; Injections, Intraperitoneal; Injections, Intravenous; Listeriosis; Lymphocyte Activation; Mice; Recurrence; T-Lymphocytes | 1988 |
Comparison of two methods for determining in vitro postantibiotic effects of three antibiotics on Escherichia coli.
Topics: Ampicillin; Ciprofloxacin; Escherichia coli; Microbial Sensitivity Tests; Spectrophotometry; Time Factors; Tobramycin | 1988 |
In vitro evaluation of DuP 105 and DuP 721, two new oxazolidinone antimicrobial agents.
Topics: Ampicillin; Anti-Bacterial Agents; Cefaclor; Chemical Phenomena; Chemistry; Ciprofloxacin; Erythromycin; Gram-Positive Bacteria; Oxazoles; Oxazolidinones; Vancomycin | 1988 |
Comparative efficacies of ciprofloxacin, ampicillin and chloramphenicol in treatment of experimental Haemophilus influenzae pneumonia.
Topics: Ampicillin; Animals; Chloramphenicol; Ciprofloxacin; Female; Haemophilus Infections; Haemophilus influenzae; Lung; Male; Mice; Pneumonia | 1987 |
Endocarditis due to high-level gentamicin-resistant Enterococcus faecalis.
Topics: Adult; Ampicillin; Ciprofloxacin; Drug Resistance, Microbial; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecalis; Gentamicins; Gram-Positive Bacterial Infections; Humans; Male | 1995 |
Acute bacterial diarrhoea in the emergency room: therapeutic implications of stool culture results.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Ampicillin; Bacterial Infections; Bacteriological Techniques; Child; Child, Preschool; Ciprofloxacin; Diarrhea; Drug Resistance, Microbial; Dysentery, Bacillary; Emergency Service, Hospital; Escherichia coli Infections; Feces; Humans; Infant; Microbial Sensitivity Tests; Middle Aged; Salmonella Infections; Trimethoprim, Sulfamethoxazole Drug Combination | 1994 |
Prospective study of the impact of broad-spectrum antibiotics on the yeast flora of the human gut.
Topics: Adult; Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Candida; Ciprofloxacin; Clavulanic Acids; Feces; Female; Humans; Intestinal Mucosa; Male; Middle Aged; Prospective Studies; Trimethoprim, Sulfamethoxazole Drug Combination | 1994 |
In vitro activity of eight antibiotics against Salmonella and Shigella species.
Topics: Ampicillin; Anti-Bacterial Agents; Chloramphenicol; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Fleroxacin; Microbial Sensitivity Tests; Ofloxacin; Pefloxacin; Salmonella; Shigella; Trimethoprim, Sulfamethoxazole Drug Combination | 1994 |
Assessment of the bactericidal activity of sparfloxacin, ofloxacin, levofloxacin, and other fluoroquinolones compared with selected agents of proven efficacy against Listeria monocytogenes.
Topics: Ampicillin; Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Levofloxacin; Listeria monocytogenes; Listeriosis; Microbial Sensitivity Tests; Ofloxacin; Quinolones; Trimethoprim, Sulfamethoxazole Drug Combination | 1994 |
Evaluation of the E test for antimicrobial susceptibility testing of Porphyromonas gingivalis.
Topics: Ampicillin; Anti-Bacterial Agents; Cefaclor; Cefuroxime; Ciprofloxacin; Clindamycin; Colony Count, Microbial; Doxycycline; Erythromycin; Evaluation Studies as Topic; Metronidazole; Microbial Sensitivity Tests; Penicillin G; Porphyromonas gingivalis; Tetracyclines | 1994 |
The non-aqueous titrimetric assay of selected antibiotics using tetra-N-butylammonium hydroxide as titrant.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Chemistry, Pharmaceutical; Ciprofloxacin; Detergents; Hydrogen-Ion Concentration; Netilmicin; Potentiometry; Quality Control; Quaternary Ammonium Compounds; Reproducibility of Results; Rifampin | 1994 |
Bactericidal activities of peptide antibiotics against multidrug-resistant Enterococcus faecium.
Topics: Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Daptomycin; Depsipeptides; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus faecalis; Humans; Microbial Sensitivity Tests; Peptides, Cyclic; Vancomycin | 1994 |
Changing trends in the treatment of enteric fever.
Topics: Ampicillin; Carrier State; Chloramphenicol Resistance; Ciprofloxacin; Humans; Salmonella typhi; Typhoid Fever | 1993 |
In vitro antimicrobial susceptibility of different serotypes of Actinobacillus actinomycetemcomitans.
Topics: Aggregatibacter actinomycetemcomitans; Ampicillin; Ampicillin Resistance; Anti-Bacterial Agents; Cefaclor; Cefuroxime; Ciprofloxacin; Doxycycline; Drug Resistance, Microbial; Erythromycin; Metronidazole; Penicillin G; Penicillin Resistance; Serotyping; Tetracycline; Tetracycline Resistance; Trimethoprim, Sulfamethoxazole Drug Combination | 1993 |
Influence of subinhibitory levels of antibiotics on expression of Escherichia coli lipopolysaccharide and binding of anti-lipopolysaccharide monoclonal antibodies.
Topics: Ampicillin; Anti-Bacterial Agents; Antibodies, Monoclonal; Chloramphenicol; Ciprofloxacin; Enzyme-Linked Immunosorbent Assay; Escherichia coli; Flow Cytometry; Gentamicins; Humans; Immunoblotting; Lipopolysaccharides; Silver Staining | 1993 |
The application of flow cytometry to the study of bacterial responses to antibiotics.
Topics: Amdinocillin; Ampicillin; Anti-Bacterial Agents; Cefotaxime; Cell Membrane; Cell Membrane Permeability; Ciprofloxacin; Escherichia coli; Flow Cytometry; Gentamicins; Humans; Microspheres | 1993 |
Oral ciprofloxacin for treatment of chronic osteomyelitis.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Ampicillin; Bacterial Infections; Chronic Disease; Ciprofloxacin; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Osteomyelitis; Treatment Outcome | 1993 |
An inexpensive infrared growth sensor array for detection of bacterial antibiotic susceptibility.
Topics: Ampicillin; Bacteria; Ciprofloxacin; Escherichia coli; Evaluation Studies as Topic; Gentamicins; Humans; Infrared Rays; Microbial Sensitivity Tests; Penicillins; Pseudomonas aeruginosa; Staphylococcus aureus | 1993 |
Enteric protein loss during shigellosis.
Topics: Adult; alpha 1-Antitrypsin; Ampicillin; Blood Proteins; Ciprofloxacin; Drug Resistance, Microbial; Dysentery, Bacillary; Erythrocyte Count; Feces; Humans; Male; Middle Aged; Protein-Losing Enteropathies; Shigella boydii; Shigella dysenteriae; Shigella flexneri; Shigella sonnei | 1993 |
Susceptibility of resistant Enterococcus faecium to unusual antibiotics.
Topics: Ampicillin; Ciprofloxacin; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus faecium; Humans; Microbial Sensitivity Tests; Tetracycline; Vancomycin | 1993 |
[Detection of antibiotic resistance in Enterococcus sp. Comparison of GPS-TA (BioMérieux-Vitek), Uniscept MIC-3 (bioMérieux-Vitek) and conventional methods].
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Enterococcus; Microbial Sensitivity Tests; Penicillins; Vancomycin | 1995 |
Ampicillin plus ciprofloxacin therapy of experimental endocarditis caused by multidrug-resistant Enterococcus faecium.
Topics: Ampicillin; Animals; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Multiple; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Kidney; Microbial Sensitivity Tests; Penicillins; Rabbits; Spleen | 1995 |
Comparison of the in vitro activity of levofloxacin and other antimicrobial agents against vancomycin-susceptible and vancomycin-resistant Enterococcus species.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Enterococcus; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Penicillins; Vancomycin | 1995 |
Unorthodox antibiotic combinations including ciprofloxacin against high-level gentamicin resistant enterococci.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Combinations; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus; Gentamicins; Humans; Microbial Sensitivity Tests; Penicillins; Sulfamethoxazole; Trimethoprim | 1996 |
Antibiotic-resistant endocarditis in a hemodialysis patient.
Topics: Ampicillin; Bacteremia; Ciprofloxacin; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecium; Gentamicins; Gram-Positive Bacterial Infections; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Teicoplanin; Vancomycin | 1996 |
Ciprofloxacin-ampicillin sulbactam incompatibility.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Chemistry, Pharmaceutical; Ciprofloxacin; Crystallization; Drug Incompatibility; Penicillins; Sulbactam | 1996 |
Antibiotic activity in microbiological media versus that in human urine: comparison of ampicillin, ciprofloxacin, and trimethoprim-sulfamethoxazole.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Infective Agents, Urinary; Ciprofloxacin; Culture Media; Escherichia coli; Humans; Microbial Sensitivity Tests; Penicillins; Predictive Value of Tests; Trimethoprim, Sulfamethoxazole Drug Combination | 1996 |
Susceptibility testing of Haemophilus influenzae--an international collaborative study in quality assessment.
Topics: Ampicillin; Ampicillin Resistance; beta-Lactamases; Cephalosporins; Chloramphenicol; Ciprofloxacin; Drug Resistance, Microbial; Greece; Haemophilus influenzae; Microbial Sensitivity Tests; Norway; Poland; Sweden; Switzerland; Tetracycline; Trimethoprim; Turkey; United Kingdom; United States | 1996 |
Mycotic aneurysm due to non-typhi salmonella: report of 16 cases.
Topics: Aged; Ampicillin; Aneurysm, Infected; Anti-Bacterial Agents; Arteriosclerosis; Bacteremia; Cefazolin; Ceftriaxone; Cephalosporins; Ciprofloxacin; Female; Gallium Radioisotopes; Humans; Male; Middle Aged; Mortality; Penicillins; Retrospective Studies; Salmonella; Salmonella Infections; Seroepidemiologic Studies; Tomography, X-Ray Computed; Trimethoprim, Sulfamethoxazole Drug Combination | 1996 |
Evaluation of 500 gram negative isolates to determine the number of major susceptibility interpretation discrepancies between the Vitek and MicroScan Walkaway for 9 antimicrobial agents.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Clavulanic Acid; Clavulanic Acids; Enterobacter; Escherichia coli; Imipenem; Klebsiella pneumoniae; Mezlocillin; Microbial Sensitivity Tests; Norfloxacin; Penicillins; Piperacillin; Proteus mirabilis; Pseudomonas aeruginosa; Quality Control; Reproducibility of Results; Sulbactam; Thienamycins; Ticarcillin | 1996 |
Excellent activity of newer quinolones on Legionella pneumophila in J774 macrophages.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bacteriological Techniques; Ciprofloxacin; Colony Count, Microbial; Erythromycin; Fluoroquinolones; Gentamicins; Legionella pneumophila; Legionnaires' Disease; Macrophages; Mice; Penicillins; Quinolones; Tumor Cells, Cultured | 1997 |
An audit of the problems in management of patients with gonorrhoea.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Antitrichomonal Agents; Bacteriological Techniques; Ciprofloxacin; Drug Therapy, Combination; Erythromycin; Female; Gonorrhea; Humans; Male; Metronidazole; Oxytetracycline; Penicillins; Probenecid; Renal Agents; Reproducibility of Results | 1997 |
Decreasing trend of multiresistant Salmonella typhi in Bangladesh.
Topics: Ampicillin; Bangladesh; Ceftriaxone; Chloramphenicol; Ciprofloxacin; Drug Resistance, Multiple; Humans; Longitudinal Studies; Salmonella Infections; Salmonella typhi; Trimethoprim, Sulfamethoxazole Drug Combination | 1997 |
In vitro susceptibilities of clinical isolates of vancomycin-resistant enterococci.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Chloramphenicol; Ciprofloxacin; Doxycycline; Drug Resistance, Microbial; Enterococcus faecalis; Enterococcus faecium; Microbial Sensitivity Tests; Penicillins; Vancomycin; Virginiamycin | 1997 |
Comparison of disc diffusion and agar dilution methods for antibiotic susceptibility testing of Campylobacter jejuni subsp. jejuni and Campylobacter coli.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Campylobacter coli; Campylobacter jejuni; Ciprofloxacin; Colony Count, Microbial; Diffusion; Erythromycin; Microbial Sensitivity Tests; Statistics as Topic; Tetracycline | 1997 |
In-vitro activity of trovafloxacin against sensitive and resistant aerobic bacteria using the standard microdilution broth method and Etest.
Topics: Ampicillin; Anti-Infective Agents; Bacteria, Aerobic; Ciprofloxacin; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Fluoroquinolones; Gentamicins; Gram-Negative Aerobic Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Sulbactam; Vancomycin | 1997 |
Antibiotic resistance of Shigella spp., Salmonella spp., and Yersinia spp. isolated in Quebec.
Topics: Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Multiple; Humans; Microbial Sensitivity Tests; Quebec; Salmonella; Shigella; Trimethoprim, Sulfamethoxazole Drug Combination; Yersinia | 1997 |
Minimum inhibitory concentration (MIC) of some antibiotics against Vibrio cholerae O139 isolates from Pondicherry.
Topics: Ampicillin; Anti-Bacterial Agents; Cefotaxime; Ciprofloxacin; Drug Resistance, Microbial; Drug Resistance, Multiple; Furazolidone; Gentamicins; India; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; O Antigens; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination; Vibrio cholerae | 1997 |
Effect of pH on in vitro antimicrobial susceptibility of the Bacteroides fragilis group.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteroides fragilis; Ciprofloxacin; Clindamycin; Drug Therapy, Combination; Fluoroquinolones; Hydrogen-Ion Concentration; Imipenem; Meropenem; Microbial Sensitivity Tests; Naphthyridines; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam; Thienamycins | 1997 |
Clostridium difficile infection in obstetric and gynecologic patients.
Topics: Abdominal Pain; Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Bacterial Toxins; Cefoxitin; Cephalexin; Cephalosporins; Cephamycins; Ciprofloxacin; Clindamycin; Clostridioides difficile; Colonoscopy; Diarrhea; Enterocolitis, Pseudomembranous; Female; Fever; Gentamicins; Humans; Imipenem; Incidence; Middle Aged; Nausea; Penicillins; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Thienamycins; Trimethoprim, Sulfamethoxazole Drug Combination; Vomiting | 1997 |
Successful treatment of Edwardsiella tarda prosthetic valve endocarditis in a patient with AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Ampicillin; Cefotaxime; Ciprofloxacin; Drug Therapy, Combination; Endocarditis, Bacterial; Gentamicins; Gram-Negative Bacterial Infections; Heart Valve Prosthesis; Humans; Male; Prosthesis-Related Infections | 1997 |
Clinafloxacin (CL 960) is superior to standard therapeutics in the treatment of murine listeriosis and salmonellosis.
Topics: Ampicillin; Animals; Anti-Infective Agents; Cells, Cultured; Ciprofloxacin; Female; Fluoroquinolones; Listeriosis; Mice; Mice, Nude; Microbial Sensitivity Tests; Penicillins; Quinolones; Salmonella enterica; Salmonella Infections, Animal; Salmonella typhimurium | 1997 |
In vitro activity of the combination of trovafloxacin and other antibiotics against enterococci.
Topics: Ampicillin; Ampicillin Resistance; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Enterococcus; Enterococcus faecalis; Fluoroquinolones; Gentamicins; Humans; Microbial Sensitivity Tests; Naphthyridines; Novobiocin; Rifampin; Sulbactam; Teicoplanin; Vancomycin | 1997 |
In-vitro activity of combined ampicillin and ciprofloxacin against high-level gentamicin-resistant strains of Enterococcus faecium: influence of the medium on susceptibility test results.
Topics: Ampicillin; Ciprofloxacin; Culture Media; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus faecium; Gentamicins; Microbial Sensitivity Tests | 1998 |
[Enterococci as uropathogens. Frequency of isolation and sensitivity to antibacterial agents].
Topics: Adult; Amikacin; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteriuria; beta-Lactamases; Child; Ciprofloxacin; Drug Resistance, Microbial; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Gentamicins; Gram-Positive Bacterial Infections; Humans; Penicillin Resistance; Penicillins; Streptomycin; Urinary Tract Infections; Vancomycin | 1998 |
Antimicrobial susceptibility of community-acquired lower respiratory tract bacterial pathogens isolated in the UK during the 1995-1996 cold season.
Topics: Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Ampicillin Resistance; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactam Resistance; beta-Lactamases; Cefaclor; Cephalosporins; Ciprofloxacin; Clarithromycin; Common Cold; Community-Acquired Infections; Dose-Response Relationship, Drug; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Moraxella catarrhalis; Multicenter Studies as Topic; Penicillins; Respiratory System; Respiratory Tract Infections; Streptococcus pneumoniae; United Kingdom | 1998 |
Drug resistant enterococci in a south Indian hospital.
Topics: Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Enterococcus; Gentamicins; Humans; Tetracycline; Vancomycin | 1998 |
Comparison of three media for agar dilution susceptibility testing of Bordetella pertussis using six antibiotics.
Topics: Ampicillin; Anti-Bacterial Agents; Bordetella pertussis; Chloramphenicol; Ciprofloxacin; Culture Media; Doxycycline; Erythromycin; Microbial Sensitivity Tests; Trimethoprim, Sulfamethoxazole Drug Combination | 1998 |
Susceptibility of European respiratory tract isolates to trovafloxacin, ciprofloxacin, clarithromycin, azithromycin and ampicillin.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Drug Resistance, Microbial; Europe; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Cocci; Haemophilus influenzae; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Moraxella catarrhalis; Naphthyridines; Pseudomonas aeruginosa; Respiratory System; Staphylococcus aureus; Streptococcus pneumoniae | 1998 |
[Antibiotic sensitivity of pathogenic microflora: data of the bacteriological laboratory at the antituberculosis clinic].
Topics: Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Antibiotics, Antitubercular; Bacteria; Carbenicillin; Cefuroxime; Cephalexin; Cephalosporins; Chloramphenicol; Ciprofloxacin; Doxycycline; Drug Therapy, Combination; Erythromycin; Female; Gentamicins; Humans; Inpatients; Lincomycin; Male; Microbial Sensitivity Tests; Neomycin; Outpatients; Oxacillin; Penicillins; Rifampin; Spiramycin; Streptomycin; Tetracycline | 1998 |
[Multicenter trial of Enterococcus antibiotic susceptibility].
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Enterococcus; Gentamicins; Microbial Sensitivity Tests; Moscow; Penicillins; Russia; Streptomycin; Sulbactam; Vancomycin | 1998 |
[Ampicillin-sulbactam activity against respiratory isolates of Haemophilus influenzae].
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; Cefuroxime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Drug Therapy, Combination; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Penicillins; Respiratory Tract Infections; Sulbactam | 1998 |
[Standardization of the Neisseria meningitidis antibiogram. Detection of strains relatively resistant to penicillin].
Topics: Amoxicillin; Ampicillin; Ampicillin Resistance; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Cefotaxime; Ceftriaxone; Cephalosporins; Chloramphenicol; Ciprofloxacin; Drug Resistance, Microbial; Microbial Sensitivity Tests; Neisseria meningitidis; Penicillin G; Penicillin Resistance; Penicillins; Rifampin; Spiramycin | 1998 |
Antimicrobial susceptibility of oral isolates of Enterobacter cloacae and Klebsiella pneumoniae from a southern Chinese population.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Ceftazidime; Cefuroxime; Cephalothin; Child; Ciprofloxacin; Diet, Vegetarian; Drug Resistance, Microbial; Enterobacter cloacae; Gentamicins; Hong Kong; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Mouth; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination | 1998 |
Species identification and antibiotic susceptibility of enterococci isolated from clinical specimens of hospitalized patients.
Topics: Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Enterococcus; Erythromycin; Gram-Positive Bacterial Infections; Hospitalization; Humans; Imipenem; Microbial Sensitivity Tests | 1995 |
Pharmacodynamic comparisons of levofloxacin, ciprofloxacin, and ampicillin against Streptococcus pneumoniae in an in vitro model of infection.
Topics: Ampicillin; Ampicillin Resistance; Anti-Infective Agents; Ciprofloxacin; Culture Media; Drug Resistance, Microbial; Levofloxacin; Microbial Sensitivity Tests; Models, Biological; Ofloxacin; Penicillins; Pneumococcal Infections | 1999 |
The bactericidal activity of levofloxacin against ampicillin-resistant and ampicillin-susceptible Haemophilus influenzae in comparison with ofloxacin, ciprofloxacin and sparfloxacin.
Topics: Ampicillin; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Haemophilus influenzae; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin | 1999 |
Fatal Clostridium sordellii ischio-rectal abscess with septicaemia complicating ultrasound-guided transrectal prostate biopsy.
Topics: Abscess; Adenocarcinoma; Aged; Ampicillin; Anti-Infective Agents; Bacteremia; Biopsy; Ciprofloxacin; Clostridium; Clostridium Infections; Diuretics; Fatal Outcome; Furosemide; Humans; Ischium; Male; Metronidazole; Penicillins; Prostate; Prostatic Neoplasms; Rectal Diseases; Rectum; Ultrasonography | 1999 |
The effects of the level of ampicillin resistance and the inoculum size on the in-vitro bactericidal activity of the combination of ampicillin and ciprofloxacin against high-level gentamicin-resistant strains of Enterococcus faecium.
Topics: Ampicillin; Ampicillin Resistance; Anti-Infective Agents; Ciprofloxacin; Drug Combinations; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterococcus faecium; Gentamicins; Humans; Microbial Sensitivity Tests; Penicillins | 1999 |
Protective effect of trovafloxacin, ciprofloxacin and ampicillin against Streptococcus pneumoniae in a murine sepsis model.
Topics: Ampicillin; Animals; Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Mice; Naphthyridines; Penicillin Resistance; Pneumococcal Infections; Streptococcus pneumoniae | 1999 |
Salmonella meningitis and multiple cerebral abscesses in an infant.
Topics: Amoxicillin; Ampicillin; Brain Abscess; Cefotaxime; Chloramphenicol; Ciprofloxacin; Drug Therapy, Combination; Female; Humans; Infant; Meningitis, Bacterial; Metronidazole; Salmonella enteritidis; Salmonella Infections | 1999 |
National guideline for the management of gonorrhoea in adults. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases).
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Contact Tracing; Female; Gonorrhea; Humans; Male; Neisseria gonorrhoeae; Ofloxacin; Penicillins; Urethritis | 1999 |
In vitro evaluation of antibiotic prophylaxis in the prevention of biliary stent blockage.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Adhesion; Biofilms; Ceftazidime; Cephalosporins; Ciprofloxacin; Enterococcus; Escherichia coli; Humans; In Vitro Techniques; Penicillins; Polyethylene; Stents | 2000 |
A Canadian national surveillance study of urinary tract isolates from outpatients: comparison of the activities of trimethoprim-sulfamethoxazole, ampicillin, mecillinam, nitrofurantoin, and ciprofloxacin. The Canadian Urinary Isolate Study Group.
Topics: Amdinocillin; Ampicillin; Anti-Infective Agents; Anti-Infective Agents, Urinary; Canada; Ciprofloxacin; Drug Resistance, Microbial; Escherichia coli; Microbial Sensitivity Tests; Nitrofurantoin; Penicillins; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2000 |
[In vitro activities of levofloxacin and other antibiotics against fresh clinical isolates].
Topics: Ampicillin; Anti-Infective Agents; Bacteria; Bacterial Infections; Cefaclor; Cefpodoxime; Ceftizoxime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Humans; Levofloxacin; Methicillin; Ofloxacin; Penicillin G; Penicillin Resistance; Penicillins | 1999 |
An evaluation of the potential of the multiple antibiotic resistance operon (mar) and the multidrug efflux pump acrAB to moderate resistance towards ciprofloxacin in Escherichia coli biofilms.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Proteins; Biofilms; Carrier Proteins; Cephalosporin Resistance; Ciprofloxacin; Culture Media; Drug Resistance, Multiple; Escherichia coli; Escherichia coli Proteins; Membrane Proteins; Microbial Sensitivity Tests; Multidrug Resistance-Associated Proteins; Operon; Penicillins; Tetracycline | 2000 |
Role of antibiotic penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin.
Topics: Ampicillin; Anti-Infective Agents; Biofilms; Biological Transport; Ciprofloxacin; Drug Resistance, Microbial; Drug Stability; Klebsiella pneumoniae; Microbial Sensitivity Tests; Mutation; Penicillin Resistance; Penicillins; Permeability | 2000 |
Antimicrobial-resistant enterococcal isolates from fluoroquinolone-naive children.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Child, Preschool; Ciprofloxacin; Drug Resistance, Microbial; Enterococcus faecalis; Enterococcus faecium; Fluoroquinolones; Gram-Positive Bacterial Infections; Humans; Infant; Infant, Newborn; Naphthyridines; Penicillins; Vancomycin | 2000 |
Actinomyces and actinobacillus actinomycetemcomitans-Actinomyces-associated lymphadenopathy mimicking lymphoma.
Topics: Actinobacillus; Actinobacillus Infections; Actinomyces; Actinomycosis; Adult; Ampicillin; Anti-Infective Agents; Ciprofloxacin; Diagnosis, Differential; Head and Neck Neoplasms; Humans; Lymph Nodes; Lymphatic Diseases; Lymphoma; Male; Penicillins; Submandibular Gland Neoplasms; Tomography, X-Ray Computed | 2000 |
[Some problems of the current therapy of infective endocarditis].
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Cefotaxime; Cephalosporins; Ciprofloxacin; Cross Infection; Drug Therapy, Combination; Echocardiography; Endocarditis, Bacterial; Follow-Up Studies; Gentamicins; Humans; Male; Oxacillin; Plasmapheresis; Recurrence; Time Factors | 2000 |
Phlegmonous gastritis: successful treatment with antibiotics and resolution documented by EUS.
Topics: Adult; Ampicillin; Biopsy, Needle; Cellulitis; Ciprofloxacin; Drug Therapy, Combination; Endosonography; Female; Follow-Up Studies; Gastritis; Gastroscopy; Humans; Infusions, Intravenous; Sulbactam; Tomography, X-Ray Computed; Treatment Outcome | 2000 |
Factors associated with antibiotic resistance in coliform organisms from community urinary tract infection in Wales.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Cephalexin; Cephradine; Child; Child, Preschool; Ciprofloxacin; Community-Acquired Infections; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Infant, Newborn; Male; Microbial Sensitivity Tests; Middle Aged; Trimethoprim; Urinary Tract Infections | 2001 |
Relationship between haemolysis production and resistance to fluoroquinolones among clinical isolates of Escherichia coli.
Topics: Amoxicillin; Ampicillin; Animals; Anti-Infective Agents; Ciprofloxacin; Clavulanic Acid; Drug Resistance, Microbial; Escherichia coli; Fluoroquinolones; Gentamicins; Hemolysin Proteins; Hemolysis; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Pefloxacin; Tetracycline | 1999 |
Antimicrobial resistance of Enterococci in Lebanon.
Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Chloramphenicol; Ciprofloxacin; Drug Resistance, Microbial; Enterococcus; Erythromycin; Gentamicins; Humans; Lebanon; Microbial Sensitivity Tests; Norfloxacin; Penicillins; Rifampin; Streptomycin; Teicoplanin; Tetracycline; Vancomycin | 2001 |
Antimicrobial susceptibility of Clostridium difficile by E test.
Topics: Ampicillin; Ciprofloxacin; Clostridioides difficile; Drug Resistance, Microbial; Humans; Metronidazole; Microbial Sensitivity Tests | 1999 |
In vitro effects of ampicillin, ciprofloxacin and ofloxacin on Salmonella typhi within human monocyte-derived macrophages.
Topics: Ampicillin; Anti-Infective Agents; Ciprofloxacin; Humans; Macrophages; Microbial Sensitivity Tests; Monocytes; Ofloxacin; Penicillins; Salmonella typhi | 2001 |
[Activity of new fluoroquinolones against clinical isolates of Acinetobacter baumannii].
Topics: Acinetobacter; Acinetobacter Infections; Ampicillin; Anti-Infective Agents; Aza Compounds; Cefepime; Cephalosporins; Ciprofloxacin; Colistin; Fluoroquinolones; Gatifloxacin; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Moxifloxacin; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Opportunistic Infections; Quinolines; Sulbactam; Thienamycins | 2001 |
What about antibiotic resistance in Neisseria lactamica?
Topics: Ampicillin; Anti-Bacterial Agents; Cefotaxime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Microbial Sensitivity Tests; Neisseria; Neisseriaceae Infections; Penicillins; Rifampin | 2002 |
[Borrelia burgdorferi Group: in-vitro antibiotic sensitivity].
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Borrelia burgdorferi Group; Cephalosporins; Ciprofloxacin; Erythromycin; In Vitro Techniques; Microbial Sensitivity Tests; Penicillin G; Penicillins; Tetracycline | 2002 |
Trends in antimicrobial resistance among urinary tract infection isolates of Escherichia coli from female outpatients in the United States.
Topics: Ampicillin; Anti-Infective Agents; Anti-Infective Agents, Urinary; Ciprofloxacin; Databases, Factual; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infections; Female; Geography; Humans; Microbial Sensitivity Tests; Nitrofurantoin; Outpatients; Penicillins; Phenotype; Trimethoprim, Sulfamethoxazole Drug Combination; United States; Urinary Tract Infections | 2002 |
Transmission electron microscopic study of antibiotic action on Klebsiella pneumoniae biofilm.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Biofilms; Ciprofloxacin; Klebsiella pneumoniae; Microscopy, Electron; Penicillins; Ultraviolet Rays | 2002 |
Granulomatous osteomyelitis caused by bacteria other than mycobacteria: a report of two cases.
Topics: Adult; Ampicillin; Anti-Infective Agents; Ciprofloxacin; Female; Granuloma; Humans; Male; Middle Aged; Ofloxacin; Osteomyelitis; Penicillins; Salmonella; Salmonella Infections; Serratia Infections; Serratia marcescens; Treatment Outcome | 2002 |
Comparison of the antibacterial activities of ampicillin, ciprofloxacin, clarithromycin, telithromycin and quinupristin/dalfopristin against intracellular non-typeable Haemophilus influenzae.
Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Typing Techniques; Ciprofloxacin; Clarithromycin; Haemophilus influenzae; Humans; Intracellular Fluid; Ketolides; Macrolides; Microbial Sensitivity Tests; Tumor Cells, Cultured; Virginiamycin | 2002 |
Susceptibility patterns of Escherichia coli: prevalence of multidrug-resistant isolates and extended spectrum beta-lactamase phenotype.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; beta-Lactam Resistance; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Phenotype; Retrospective Studies | 2002 |
Role of nutrient limitation and stationary-phase existence in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin.
Topics: Ampicillin; Biofilms; Ciprofloxacin; Culture Media; Glucose; Klebsiella pneumoniae; Oxygen | 2003 |
[The impact of antibiotic use on hospital-acquired pneumonia: data of etiology tests].
Topics: Acinetobacter; Acinetobacter Infections; Amikacin; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Bronchoalveolar Lavage Fluid; Ceftazidime; Cefuroxime; Ciprofloxacin; Cross Infection; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Fusidic Acid; Gentamicins; Haemophilus Infections; Haemophilus influenzae; Humans; Male; Methicillin; Microbial Sensitivity Tests; Middle Aged; Penicillins; Pneumonia, Bacterial; Pneumonia, Staphylococcal; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin; Staphylococcus aureus; Sulbactam; Vancomycin Resistance | 2003 |
Evaluation of Coxiella burnetii antibiotic susceptibilities by real-time PCR assay.
Topics: Ampicillin; Animals; Base Sequence; Cell Line; Chloramphenicol; Ciprofloxacin; Coxiella burnetii; DNA, Bacterial; Drug Resistance, Bacterial; Fluorescent Antibody Technique; Humans; Mice; Microbial Sensitivity Tests; Polymerase Chain Reaction; Q Fever; Rifampin; Tetracycline | 2003 |
[Urinary tract pathogens in uncomplicated lower urinary tract infections in women in Norway].
Topics: Adult; Aged; Amdinocillin; Ampicillin; Ampicillin Resistance; Anti-Infective Agents, Urinary; Bacteriuria; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gram-Positive Bacterial Infections; Humans; Middle Aged; Nitrofurantoin; Penicillins; Trimethoprim Resistance; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2003 |
Clonality among ampicillin-resistant Enterococcus faecium isolates in Sweden and relationship with ciprofloxacin resistance.
Topics: Ampicillin; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Genetic Variation; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Phylogeny; Point Mutation; Sweden | 2003 |
[Synthesis and in vitro antibacterial activities of new 3,5-disubstituted oxazolidinone compounds].
Topics: Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Microbial Sensitivity Tests; Molecular Structure; Oxazolidinones; Staphylococcus aureus; Streptococcus; Structure-Activity Relationship; Sulbactam; Vancomycin | 2003 |
In vitro antimicrobial susceptibility of Escherichia coli isolates from clinical bovine mastitis in Finland and Israel.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Cattle; Ceftazidime; Cephalexin; Ciprofloxacin; Dihydrostreptomycin Sulfate; Drug Combinations; Drug Resistance, Microbial; Escherichia coli; Female; Finland; Gentamicins; Israel; Mastitis, Bovine; Microbial Sensitivity Tests; Sulfadiazine; Tetracycline; Trimethoprim | 2003 |
Drug resistance of Shigella species: changes over 20 years in Turkey.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Biological Evolution; Ceftriaxone; Chloramphenicol; Ciprofloxacin; Drug Resistance, Bacterial; Dysentery, Bacillary; Gentamicins; Humans; Shigella; Turkey | 2004 |
Cardiobacterium hominis endocarditis associated with very severe thrombocytopenia and platelet autoantibodies.
Topics: Ampicillin; Antigens, Human Platelet; Aortic Valve Stenosis; Autoantibodies; Autoimmune Diseases; Bacteremia; Bone Marrow; Cardiobacterium; Ceftriaxone; Ciprofloxacin; Diagnostic Errors; Drug Therapy, Combination; Endocarditis, Bacterial; Gentamicins; Gram-Negative Bacterial Infections; Heart Valve Prosthesis; Histiocytosis, Non-Langerhans-Cell; Humans; Jehovah's Witnesses; Male; Middle Aged; Platelet Transfusion; Postoperative Complications; Purpura, Thrombocytopenic; Splenic Infarction; Thrombocytopenia; Treatment Refusal | 2004 |
Use of simulated blood cultures for antibiotic effect on time to detection of the two blood culture systems BacT/ALERT and BACTEC 9240.
Topics: Ampicillin; Anti-Bacterial Agents; Bacteremia; Bacteria; Bacteriological Techniques; Blood; Cefotaxime; Ciprofloxacin; Culture Media; Enterococcus faecalis; Escherichia coli; Gentamicins; Staphylococcus aureus; Streptococcus pneumoniae; Time Factors; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2004 |
Microcalorimetric evaluation of the in vitro compatibility of amoxicillin/clavulanic acid and ampicillin/sulbactam with ciprofloxacin.
Topics: Algorithms; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Buffers; Calorimetry; Ciprofloxacin; Drug Incompatibility; Drug Therapy, Combination; Hydrogen-Ion Concentration; Penicillins; Solutions; Sulbactam; Thermodynamics | 2004 |
Antimicrobial treatment of asymptomatic carriers of verocytotoxin-producing Escherichia coli: an empiric study.
Topics: Adult; Ampicillin; Anti-Infective Agents; Carrier State; Child, Preschool; Ciprofloxacin; Denmark; Escherichia coli Infections; Female; Hemolytic-Uremic Syndrome; Humans; Incidence; Male; Middle Aged; Serotyping; Shiga Toxins | 2005 |
[Susceptibility of Branhamella catarrhalis to antibiotics].
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; beta-Lactamases; Cefaclor; Cefotaxime; Cefuroxime; Ciprofloxacin; Clavulanic Acids; Drug Combinations; Erythromycin; Microbial Sensitivity Tests; Moraxella catarrhalis; Tetracycline | 2004 |
Study of clinical profile and antibiotic response in typhoid fever.
Topics: Adult; Amoxicillin; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Chloramphenicol; Ciprofloxacin; Drug Resistance, Bacterial; Female; Hospitals, County; Hospitals, Teaching; Humans; Male; Microbial Sensitivity Tests; Retrospective Studies; Salmonella typhi; Trimethoprim, Sulfamethoxazole Drug Combination; Typhoid Fever | 2005 |
Direct determination of ciprofloxacin in admixtures with metronidazol and ampicillin by NMR.
Topics: Ampicillin; Anti-Infective Agents; Ciprofloxacin; Diffusion; Magnetic Resonance Spectroscopy; Metronidazole; Reproducibility of Results; Solutions | 2006 |
Childhood shigellosis at King Chulalongkorn Memorial Hospital, Bangkok, Thailand: a 5-year review (1996-2000).
Topics: Adolescent; Age Distribution; Ampicillin; Anti-Infective Agents; Cefazolin; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Bacterial; Dysentery, Bacillary; Feces; Female; Hospitalization; Humans; Infant; Infant, Newborn; Male; Retrospective Studies; Shigella; Thailand; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 2005 |
Characteristics of Haemophilus influenzae type b responsible for meningitis in Poland from 1997 to 2004.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; Cefotaxime; Ciprofloxacin; Electrophoresis, Gel, Pulsed-Field; Enzyme Inhibitors; Haemophilus influenzae type b; Humans; Meningitis; Microbial Sensitivity Tests; Poland; Rifampin | 2005 |
Antibiotic resistant fecal isolates of Enterococci among unselected patients outside the clinical sector: an epidemiological study from Southern Germany.
Topics: Adult; Aged; Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Doxycycline; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Enterococcus faecium; Feces; Female; Germany; Gram-Positive Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence | 2006 |
Identification of the plasmid-borne quinolone resistance gene qnrS in Salmonella enterica serovar Infantis.
Topics: Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Evolution, Molecular; Genes, Bacterial; Nalidixic Acid; Plasmids; Quinolones; Salmonella enterica | 2006 |
Fluoroquinolone-resistant urinary isolates of Escherichia coli from outpatients are frequently multidrug resistant: results from the North American Urinary Tract Infection Collaborative Alliance-Quinolone Resistance study.
Topics: Adolescent; Adult; Ampicillin; Anti-Infective Agents, Urinary; Cefdinir; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Humans; In Vitro Techniques; Male; Microbial Sensitivity Tests; Middle Aged; Nitrofurantoin; North America; Outpatients; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2006 |
Antibiotic resistance of urinary tract pathogens and evaluation of empirical treatment in Turkish children with urinary tract infections.
Topics: Adolescent; Age Factors; Amikacin; Ampicillin; Antibiotic Prophylaxis; Bacterial Infections; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Female; Gentamicins; Humans; Infant; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Nitrofurantoin; Trimethoprim, Sulfamethoxazole Drug Combination; Turkey; Urinary Tract Infections | 2006 |
Assessment of factors contributing to changes in the incidence of antimicrobial drug resistance in Salmonella enterica serotypes Enteritidis and Typhimurium from humans in England and Wales in 2000, 2002 and 2004.
Topics: Ampicillin; Animals; Ciprofloxacin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; England; Food Microbiology; Humans; Incidence; Microbial Sensitivity Tests; Nalidixic Acid; Salmonella enteritidis; Salmonella Infections; Salmonella Infections, Animal; Salmonella typhimurium; Serotyping; Tetracyclines; Travel; Veterinary Drugs; Wales; Zoonoses | 2006 |
A comparative assessment of the antimicrobial effects of garlic (Allium sativum) and antibiotics on diarrheagenic organisms.
Topics: Ampicillin; Analysis of Variance; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Diarrhea; Enterobacteriaceae; Feces; Garlic; Humans; Microbial Sensitivity Tests; Plants, Medicinal | 2007 |
Comparative activities of antibiotics against intracellular non-typeable Haemophilus influenzae.
Topics: Adolescent; Adult; Ampicillin; Anti-Bacterial Agents; Aza Compounds; Azithromycin; Bacterial Typing Techniques; Bronchi; Cells, Cultured; Ciprofloxacin; Epithelial Cells; Female; Fluoroquinolones; Haemophilus influenzae; Humans; Ketolides; Male; Moxifloxacin; Quinolines | 2007 |
[Antimicrobial susceptibilities of Campylobacter sp strains isolated from humans in 2005 to 2006 in Bielsko-Biala Region, Poland].
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Ciprofloxacin; Diarrhea; Disk Diffusion Antimicrobial Tests; Drug Resistance, Multiple, Bacterial; Erythromycin; Gentamicins; Humans; Microbial Sensitivity Tests; Poland; Tetracycline | 2007 |
Comparison of Salmonella enterica serovar Heidelberg susceptibility testing results.
Topics: Amikacin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Animals; Anti-Bacterial Agents; Chloramphenicol; Ciprofloxacin; Colony Count, Microbial; Drug Combinations; Drug Resistance, Microbial; Gentamicins; Indicator Dilution Techniques; Microbial Sensitivity Tests; Poultry; Quality Control; Salmonella enterica; Sulfamethizole; Tetracycline; Trimethoprim | 2007 |
E. coli multiresistant meningitis after transrectal prostate biopsy.
Topics: Acute Disease; Aged; Ampicillin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Biopsy; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Humans; Male; Meningitis; Prostate; Tobramycin | 2006 |
[Listeriosis in the adult].
Topics: Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Ciprofloxacin; Female; Gentamicins; Humans; Listeriosis; Male; Middle Aged; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 2007 |
Antibiotic resistance of enterococci in American bison (Bison bison) from a nature preserve compared to that of Enterococci in pastured cattle.
Topics: Ampicillin; Animals; Bacteriocins; Biodiversity; Bison; Cattle; Chloramphenicol; Ciprofloxacin; Drug Resistance, Bacterial; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Erythromycin; Feces; Gelatinases; Hemolysin Proteins; Phenotype; Tetracycline; Vancomycin | 2008 |
Determination of antibiotic hypersensitivity among 4,000 single-gene-knockout mutants of Escherichia coli.
Topics: Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Escherichia coli; Genes, Bacterial; Gentamicins; Metronidazole; Microbial Sensitivity Tests; Mutation; Rifampin; Sulfamethoxazole; Vancomycin | 2008 |
Alterations in rat gut bacteria and intestinal epithelial cells following experimental exposure of antimicrobials.
Topics: Amphotericin B; Ampicillin; Animals; Anti-Bacterial Agents; Cells, Cultured; Ciprofloxacin; Colony Count, Microbial; Digestive System; Epithelial Cells; Gram-Negative Bacteria; Gram-Positive Bacteria; Intestines; Male; Microbial Sensitivity Tests; Rats; Rats, Wistar | 2008 |
Antimicrobial resistance patterns of urinary tract pathogens and rationale for empirical therapy in Turkish children for the years 2000-2006.
Topics: Adolescent; Amikacin; Ampicillin; Analysis of Variance; Antibiotic Prophylaxis; Bacterial Infections; Child; Child, Preschool; Ciprofloxacin; Cohort Studies; Drug Resistance, Bacterial; Female; Follow-Up Studies; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Infant; Male; Microbial Sensitivity Tests; Probability; Retrospective Studies; Risk Assessment; Severity of Illness Index; Treatment Outcome; Turkey; Urinalysis; Urinary Tract Infections; Urine | 2009 |
First case of Pasteurella multocida endocarditis of the tricuspid valve: a favorable outcome following medical treatment.
Topics: Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Blood; Ciprofloxacin; Culture Media; Echocardiography; Endocarditis, Bacterial; Female; Heart Valve Diseases; Humans; Pasteurella Infections; Pasteurella multocida; Tomography, X-Ray Computed; Treatment Outcome; Tricuspid Valve | 2009 |
Effect of subinhibitory concentrations of antibiotics on intrachromosomal homologous recombination in Escherichia coli.
Topics: Ampicillin; Anti-Bacterial Agents; Ceftazidime; Chloramphenicol; Chromosomes, Bacterial; Ciprofloxacin; Colistin; Escherichia coli; Fosfomycin; Gentamicins; Imipenem; Microbial Sensitivity Tests; Recombination, Genetic; Rifampin; Tetracycline; Trimethoprim | 2009 |
High resistance prevalence towards ampicillin, co-trimoxazole and ciprofloxacin, among uropathogenic Escherichia coli isolates in Mexico City.
Topics: Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Escherichia coli Infections; Female; Humans; Mexico; Microbial Sensitivity Tests; Netilmicin; Nitrofurantoin; Pregnancy; Prevalence; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections; Uropathogenic Escherichia coli | 2008 |
Antibiotic resistance in pathogens causing community-acquired urinary tract infections in India: a multicenter study.
Topics: Adolescent; Adult; Aged; Ampicillin; Anti-Infective Agents, Urinary; Ciprofloxacin; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; India; Middle Aged; Nitrofurantoin; Retrospective Studies; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2008 |
Mechanisms of resistance to ciprofloxacin, ampicillin/sulbactam and imipenem in Acinetobacter baumannii clinical isolates in Taiwan.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Cross Infection; DNA, Bacterial; Drug Resistance, Bacterial; Gene Expression; Humans; Imipenem; Integrons; Point Mutation; Polymerase Chain Reaction; Sequence Analysis, DNA; Sulbactam; Taiwan | 2010 |
Differential effects of some antibiotics on paraoxonase enzyme activity on human hepatoma cells (HepG2) in vitro.
Topics: Ampicillin; Anti-Bacterial Agents; Aryldialkylphosphatase; Ciprofloxacin; Clindamycin; Hep G2 Cells; Hepatocytes; Humans; Kinetics; Osmolar Concentration; Rifamycins | 2010 |
Risk factors for antimicrobial resistance among the Escherichia coli strains isolated from Korean patients with acute uncomplicated cystitis: a prospective and nationwide study.
Topics: Acute Disease; Adolescent; Adult; Aged; Ampicillin; Anti-Bacterial Agents; Cefazolin; Ciprofloxacin; Cystitis; Drug Resistance, Bacterial; Escherichia coli; Female; Humans; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Republic of Korea; Risk Factors; Trimethoprim, Sulfamethoxazole Drug Combination | 2010 |
In vitro sensitivity and resistance of 46 Leptospira strains isolated from rats in the Philippines to 14 antimicrobial agents.
Topics: Amphotericin B; Ampicillin; Animals; Anti-Bacterial Agents; Cefotaxime; Ciprofloxacin; Doxycycline; Erythromycin; Fluorouracil; Fosfomycin; Leptospira; Microbial Sensitivity Tests; Neomycin; Philippines; Rats; Sulfamethoxazole; Trimethoprim; Vancomycin | 2010 |
Antimicrobial resistance in more than 100,000 Escherichia coli isolates according to culture site and patient age, gender, and location.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Ampicillin; Anti-Bacterial Agents; Cefotaxime; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Fosfomycin; Humans; Imipenem; Infant; Male; Middle Aged; Nitrofurantoin; Retrospective Studies; Tobramycin; Young Adult | 2011 |
Synergism between outer membrane proteins and antimicrobials.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Cefotaxime; Chlorocebus aethiops; Ciprofloxacin; Clindamycin; Erythromycin; Escherichia coli; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Tetracycline; Vero Cells | 2011 |
In vitro potentiation of ampicillin, oxacillin, norfloxacin, ciprofloxacin, and vancomycin by sanguinarine against methicillin-resistant Staphylococcus aureus.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Load; Benzophenanthridines; Ciprofloxacin; Drug Synergism; Drug Therapy, Combination; Isoquinolines; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Norfloxacin; Oxacillin; Species Specificity; Vancomycin | 2011 |
Characterization of the mechanisms of fluoroquinolone resistance in vancomycin-resistant enterococci of different origins.
Topics: Ampicillin; Anti-Infective Agents; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Multiple, Bacterial; Enterococcus; Fluoroquinolones; Genes, Bacterial; Genotype; Humans; Microbial Sensitivity Tests; Mutation; Vancomycin | 2011 |
Electron microscopic study of the effects of antimicrobial agents on the cellular architecture of Leptospira.
Topics: Ampicillin; Anti-Infective Agents; Cell Membrane Permeability; Cell Shape; Ciprofloxacin; Leptospira; Microscopy, Electron, Transmission; Streptomycin | 2011 |
Augmentation of antimicrobial activity of conventional antibiotics by cell-free extract of L. plantarum.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Drug Synergism; Lactobacillus plantarum; Macrophages, Peritoneal; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Probiotics; Salmonella typhimurium | 2011 |
[Influence of inoculum size on MICs for methicillin-susceptible Staphylococcus aureus and methicillin-resistant Staphylococcus aureus].
Topics: Acetamides; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteriological Techniques; Cefazolin; Ciprofloxacin; Dibekacin; Drug Resistance, Bacterial; Linezolid; Meropenem; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcus aureus; Teicoplanin; Thienamycins; Vancomycin | 2011 |
Ischiorectal fossa abscess after pelvic floor injection of botulinum toxin.
Topics: Abscess; Ampicillin; Anti-Bacterial Agents; Anti-Dyskinesia Agents; Anus Diseases; Botulinum Toxins; Ciprofloxacin; Drug Therapy, Combination; Female; Gentamicins; Humans; Metronidazole; Pelvic Floor; Pelvic Pain; Radiography; Treatment Outcome | 2012 |
Arcobacter species in diarrhoeal faeces from humans in New Zealand.
Topics: Adult; Aged; Ampicillin; Arcobacter; Child, Preschool; Ciprofloxacin; Diarrhea; Erythromycin; Feces; Female; Gram-Negative Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; New Zealand; Prevalence | 2012 |
The possibility of using fibrin-based collagen as an antibiotic delivery system.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Aprotinin; Ciprofloxacin; Dibekacin; Disk Diffusion Antimicrobial Tests; Drug Combinations; Drug Delivery Systems; Escherichia coli; Fibrinogen; Fosfomycin; Gentamicins; Mice; Mice, Inbred C57BL; Polytetrafluoroethylene; Thrombin | 2013 |
An 11-year analysis of the prevalent uropathogens and the changing pattern of Escherichia coli antibiotic resistance in 38,530 community urinary tract infections, Dublin 1999-2009.
Topics: Adolescent; Adult; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Cefuroxime; Child; Ciprofloxacin; Community-Acquired Infections; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Gentamicins; Humans; Incidence; Male; Microbial Sensitivity Tests; Nitrofurantoin; Prevalence; Retrospective Studies; Time Factors; Trimethoprim; Urinary Tract Infections | 2013 |
Campylobacter coli isolates from Finnish farrowing farms using aminopenicillins: high prevalence of bla(OXA-61) and β-lactamase production, but low MIC values.
Topics: Amoxicillin; Ampicillin; Animals; Anti-Bacterial Agents; beta-Lactamases; Campylobacter coli; Campylobacter Infections; Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacterial; Erythromycin; Finland; Microbial Sensitivity Tests; RNA, Ribosomal, 23S; Swine; Swine Diseases | 2012 |
Antibiotic susceptibility of periodontal Enterococcus faecalis.
Topics: Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteriological Techniques; Chronic Periodontitis; Ciprofloxacin; Clindamycin; Dental Plaque; Drug Resistance, Bacterial; Enterococcus faecalis; Erythromycin; Female; Gingiva; Gram-Positive Bacterial Infections; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Periodontal Pocket; Periodontitis; Teicoplanin; Tetracycline Resistance; Vancomycin | 2013 |
Phenotypic and molecular antibiotic resistance profile of Enterococcus faecalis and Enterococcus faecium isolated from different traditional fermented foods.
Topics: Ampicillin; Bacterial Proteins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Enterococcus faecium; Erythromycin; Fermentation; Food Contamination; Food Microbiology; Genes, Bacterial; Gentamicins; Levofloxacin; Microbial Sensitivity Tests; Nitrofurantoin; Ofloxacin; Penicillins; Phenotype; Vancomycin | 2013 |
Sex- and age-specific trends in antibiotic resistance patterns of Escherichia coli urinary isolates from outpatients.
Topics: Adolescent; Adult; Age Factors; Aged; Ambulatory Care; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Cross-Sectional Studies; Drug Resistance, Bacterial; Escherichia coli; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Nitrofurantoin; Sex Factors; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections; Young Adult | 2013 |
Microbiology of urinary tract infections in Gaborone, Botswana.
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Botswana; Ciprofloxacin; Comorbidity; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; HIV Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Nitrofurantoin; Retrospective Studies; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2013 |
Synergistic antibacterial effect of curcumin against methicillin-resistant Staphylococcus aureus.
Topics: Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Curcuma; Curcumin; Drug Synergism; Humans; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Norfloxacin; Oxacillin; Plant Extracts; Rhizome; Time Factors | 2013 |
Evaluation of cutaneous palpebral anthrax.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ampicillin; Anthrax; Anti-Bacterial Agents; Bacillus anthracis; Cefazolin; Child; Child, Preschool; Ciprofloxacin; Eye; Female; Humans; Infant; Male; Middle Aged; Penicillins; Skin Diseases, Bacterial; Sulbactam; Young Adult | 2013 |
Laser interferometry analysis of ciprofloxacin and ampicillin diffusion from liposomal solutions to water phase.
Topics: Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Diffusion; Hydrogen-Ion Concentration; Interferometry; Lasers; Liposomes; Solutions; Water | 2013 |
A Cell Phone-Based Microphotometric System for Rapid Antimicrobial Susceptibility Testing.
Topics: Ampicillin; Anti-Bacterial Agents; Automation, Laboratory; Cell Phone; Chromogenic Compounds; Ciprofloxacin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Lab-On-A-Chip Devices; Microarray Analysis; Microbial Sensitivity Tests; Microbial Viability; Microspectrophotometry; Oxidation-Reduction; Point-of-Care Systems; Sulfamethizole; Tetrazolium Salts; Trimethoprim; Urinary Tract Infections | 2014 |
Antimicrobial susceptibility of Salmonella enterica serovars in a tertiary care hospital in southern India.
Topics: Ampicillin; Chloramphenicol; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Humans; India; Microbial Sensitivity Tests; Nalidixic Acid; Salmonella paratyphi A; Salmonella typhi; Tertiary Healthcare; Trimethoprim, Sulfamethoxazole Drug Combination; Typhoid Fever | 2013 |
The effect of hospital effluent on antimicrobial resistant E. coli within a municipal wastewater system.
Topics: Ampicillin; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Hospitals; Wastewater; Water Purification | 2013 |
Antibiotic treatment expands the resistance reservoir and ecological network of the phage metagenome.
Topics: Aerobiosis; Ampicillin; Animals; Anti-Bacterial Agents; Bacteriophages; Ciprofloxacin; Drug Resistance, Microbial; Feces; Female; Gene Transfer, Horizontal; Genes, Viral; Genome, Viral; Host Specificity; Metagenome; Mice; Symbiosis | 2013 |
Detection of Pantoea agglomerans in hip prosthetic infection by sonication of the removed prosthesis: the first reported case.
Topics: Administration, Intravenous; Administration, Oral; Ampicillin; Anti-Bacterial Agents; Arthroplasty, Replacement, Hip; Ciprofloxacin; Female; Hip Prosthesis; Humans; Middle Aged; Osteoarthritis, Hip; Pantoea; Postoperative Complications; Prosthesis-Related Infections; Sonication; Sulbactam | 2013 |
Changing trends in the prevalence of Shigella species: emergence of multi-drug resistant Shigella sonnei biotype g in Bangladesh.
Topics: Amdinocillin; Ampicillin; Anti-Bacterial Agents; Bangladesh; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Dysentery, Bacillary; Humans; Integrons; Nalidixic Acid; Phylogeny; Prevalence; Shigella sonnei; Trimethoprim, Sulfamethoxazole Drug Combination | 2013 |
Selective target inactivation rather than global metabolic dormancy causes antibiotic tolerance in uropathogens.
Topics: Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Escherichia coli; Gentamicins; Microbial Sensitivity Tests; Staphylococcus | 2014 |
In vitro synergy of ampicillin with gentamicin, ceftriaxone and ciprofloxacin against Enterococcus faecalis.
Topics: Ampicillin; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Colony Count, Microbial; Drug Synergism; Enterococcus faecalis; Gentamicins; Microbial Sensitivity Tests; Time Factors | 2014 |
The biofilm matrix destabilizers, EDTA and DNaseI, enhance the susceptibility of nontypeable Hemophilus influenzae biofilms to treatment with ampicillin and ciprofloxacin.
Topics: Ampicillin; Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Deoxyribonuclease I; Edetic Acid; Haemophilus Infections; Haemophilus influenzae; Humans; Microbial Sensitivity Tests | 2014 |
Antibiotic selection of Escherichia coli sequence type 131 in a mouse intestinal colonization model.
Topics: Amdinocillin; Ampicillin; Animals; Anti-Bacterial Agents; Cefotaxime; Cefuroxime; Ciprofloxacin; Clindamycin; Dicloxacillin; Escherichia coli; Gram-Positive Bacteria; Meropenem; Mice; Penicillins; Thienamycins | 2014 |
Impact of antibiotics with various target sites on the metabolome of Staphylococcus aureus.
Topics: Ampicillin; Anti-Bacterial Agents; Cell Wall; Ciprofloxacin; Erythromycin; Fosfomycin; Metabolic Networks and Pathways; Metabolome; Peptidoglycan; Staphylococcus aureus; Vancomycin | 2014 |
Isolation and development of bioluminescent reporter phages for bacterial dysentery.
Topics: Ampicillin; Anti-Bacterial Agents; Bacteriophages; Ciprofloxacin; DNA, Viral; Dysentery, Bacillary; Feces; Genes, Reporter; Humans; Luciferases; Luminescent Measurements; Sequence Analysis, DNA; Shigella dysenteriae; Shigella flexneri; Wastewater | 2015 |
Bacteria causing ventriculoperitoneal shunt infections in a Kenyan population.
Topics: Adolescent; Ampicillin; Anti-Bacterial Agents; Child; Child, Preschool; Chloramphenicol; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gentamicins; Gram-Negative Bacterial Infections; Humans; Hydrocephalus; Infant; Kenya; Male; Meropenem; Microbial Sensitivity Tests; Retrospective Studies; Thienamycins; Treatment Outcome; Ventriculoperitoneal Shunt | 2015 |
Combinatorial Activity of Flavonoids with Antibiotics Against Drug-Resistant Staphylococcus aureus.
Topics: Ampicillin; Anti-Bacterial Agents; Catechin; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Erythromycin; Flavonoids; Hesperidin; Humans; Microbial Sensitivity Tests; Oxacillin; Quercetin; Rutin; Staphylococcal Infections; Staphylococcus aureus; Tetracycline | 2015 |
Combatting bacterial infections by killing persister cells with mitomycin C.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Biofilms; Caenorhabditis elegans; Ciprofloxacin; Cross-Linking Reagents; Cystic Fibrosis; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Escherichia coli Infections; Escherichia coli K12; Humans; Mitomycin; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus | 2015 |
In vitro effects of N-acetyl cysteine alone and in combination with antibiotics on Prevotella intermedia.
Topics: Acetylcysteine; Ampicillin; Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Metronidazole; Microbial Sensitivity Tests; Prevotella intermedia; Tetracycline | 2015 |
Genital carriage of the genus Haemophilus in pregnancy: species distribution and antibiotic susceptibility.
Topics: Adolescent; Adult; Ampicillin; beta-Lactamases; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Female; Genitalia, Female; Haemophilus; Haemophilus Infections; Humans; Microbial Sensitivity Tests; Pregnancy; Reproductive Tract Infections; Young Adult | 2015 |
[Experimental substantiation of possibility of sanation for purulent enteritis in mechanical acute ileus].
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Bacteria; Ceftriaxone; Ciprofloxacin; Fluoroquinolones; Gentamicins; Ileitis; Ileum; Ileus; Injections, Intramuscular; Microbial Sensitivity Tests; Rats; Rats, Wistar | 2015 |
[Prophylaxis of purulent complications in mechanical ileus].
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Biological Transport; Cephalosporins; Ciprofloxacin; Disease Models, Animal; Fluoroquinolones; Gentamicins; Ileus; Peritonitis; Permeability; Rats; Rats, Wistar | 2015 |
Japanese nationwide surveillance in 2011 of antibacterial susceptibility patterns of clinical isolates from complicated urinary tract infection cases.
Topics: Aged; Aged, 80 and over; Amikacin; Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Escherichia coli; Female; Fluoroquinolones; Gram-Negative Bacteria; Humans; Imipenem; Japan; Klebsiella oxytoca; Klebsiella pneumoniae; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Population Surveillance; Proteus mirabilis; Pseudomonas aeruginosa; Serratia marcescens; Urinary Tract Infections; Vancomycin | 2015 |
Comparative analysis of virulence genes, antibiotic resistance and gyrB-based phylogeny of motile Aeromonas species isolates from Nile tilapia and domestic fowl.
Topics: Aeromonas caviae; Aeromonas hydrophila; Ampicillin; Animals; Anti-Bacterial Agents; Cefotaxime; Chickens; Cichlids; Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacterial; Feces; Fish Diseases; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny; Polymerase Chain Reaction; Poultry Diseases; Sulbactam; Virulence Factors | 2015 |
Utilization of Fenton-like reaction for antibiotics and resistant bacteria elimination in different parts of WWTP.
Topics: Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Gentamicins; Slovakia; Wastewater; Water Microbiology; Water Pollutants, Chemical; Water Purification | 2015 |
Antimicrobial Susceptibilities of Aerobic and Facultative Gram-Negative Bacilli from Intra-abdominal Infections in Patients from Seven Regions in China in 2012 and 2013.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefoxitin; China; Ciprofloxacin; Community-Acquired Infections; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Gene Expression; Humans; Imipenem; Intraabdominal Infections; Levofloxacin; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam | 2016 |
In vitro antimicrobial susceptibility of Helicobacter pylori to nine antibiotics currently used in Central Italy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Ampicillin; Anti-Bacterial Agents; Child; Ciprofloxacin; Clarithromycin; Drug Resistance, Multiple, Bacterial; Dyspepsia; Female; Fluoroquinolones; Gastric Fundus; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Pyloric Antrum; Rifabutin; Tetracycline; Young Adult | 2016 |
Characterization of Lactococcus lactis response to ampicillin and ciprofloxacin using surface-enhanced Raman spectroscopy.
Topics: Ampicillin; Anti-Bacterial Agents; Cell Wall; Ciprofloxacin; Lactococcus lactis; Spectrum Analysis, Raman | 2016 |
[The comparison of antibiotic susceptibilities of uropathogenic Escherichia coli isolates in transition from CLSI to EUCAST].
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Bacteriuria; Cefuroxime; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Escherichia coli Infections; European Union; Gentamicins; Humans; Imipenem; Levofloxacin; Microbial Sensitivity Tests; Reference Standards; Sulbactam; Trimethoprim, Sulfamethoxazole Drug Combination; Turkey; Urinary Tract Infections; Uropathogenic Escherichia coli | 2015 |
Characteristics of bacterial acute diarrhea among women.
Topics: Adolescent; Adult; Ampicillin; Anti-Bacterial Agents; Brazil; Ceftriaxone; Ciprofloxacin; Cross-Sectional Studies; Diarrhea; Dysentery, Bacillary; Female; Humans; Microbial Sensitivity Tests; Pregnancy; Retrospective Studies; Salmonella; Salmonella Infections; Shigella; Sulfamethoxazole; Trimethoprim; Young Adult | 2016 |
Diarrhoeagenic Escherichia coli in mother-child Pairs in Ile-Ife, South Western Nigeria.
Topics: Adolescent; Adult; Ampicillin; Anti-Bacterial Agents; Child, Preschool; Ciprofloxacin; Diarrhea; Diarrhea, Infantile; Disk Diffusion Antimicrobial Tests; DNA Transposable Elements; Escherichia coli; Escherichia coli Infections; Female; Humans; Infant; Infant, Newborn; Middle Aged; Mothers; Multiplex Polymerase Chain Reaction; Nigeria; Tetracycline; Young Adult | 2016 |
Prevalence and antimicrobial susceptibility profiles of Staphylococcus aureus nasal carriage among pre-clinical and clinical medical students in a Tanzanian University.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Carrier State; Ciprofloxacin; Cross-Sectional Studies; Drug Resistance, Bacterial; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Nasal Cavity; Prevalence; Staphylococcal Infections; Students, Medical; Tanzania; Universities; Vancomycin | 2016 |
Susceptibility of Multidrug-Resistant Gram-Negative Urine Isolates to Oral Antibiotics.
Topics: Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Fosfomycin; Microbial Sensitivity Tests; Nitrofurantoin; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2016 |
Assessment of altered binding specificity of bacteriophage for ciprofloxacin-induced antibiotic-resistant Salmonella Typhimurium.
Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Proteins; Bacteriophages; beta-Lactamases; Binding Sites; Chloramphenicol; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Membrane Transport Proteins; Microbial Sensitivity Tests; Norfloxacin; Salmonella typhimurium; Tetracycline; Trans-Activators | 2016 |
Roles of the glutathione- and thioredoxin-dependent systems in the Escherichia coli responses to ciprofloxacin and ampicillin.
Topics: Ampicillin; Anti-Bacterial Agents; Antioxidants; Bacterial Proteins; Ciprofloxacin; Escherichia coli; Glutaredoxins; Glutathione; Oxidation-Reduction; Oxidative Stress; Reactive Oxygen Species; Thioredoxins | 2016 |
[Antimicrobial susceptibility of Gram-negative bacilli of community acquired intra-abdominal infections in a hospital at Buenos Aires, Argentina].
Topics: Abdomen; Adolescent; Adult; Aged; Ampicillin; Anti-Bacterial Agents; Argentina; Ciprofloxacin; Community-Acquired Infections; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Sulbactam; Young Adult | 2016 |
Antimicrobial Potential of Thiodiketopiperazine Derivatives Produced by Phoma sp., an Endophyte of Glycyrrhiza glabra Linn.
Topics: Ampicillin; Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Drug Combinations; Endophytes; Glycyrrhiza; Microbial Sensitivity Tests; Real-Time Polymerase Chain Reaction; Saccharomycetales; Staphylococcus aureus; Streptococcus pyogenes; Streptomycin; Xanthophylls | 2016 |
Penetrating Orbital Injury From a Needlefish.
Topics: Adult; Ampicillin; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Beloniformes; Cefazolin; Ciprofloxacin; Diplopia; Diving; Fluoroquinolones; Foreign Bodies; Humans; Male; Military Personnel; Moxifloxacin; Prednisone; Prefrontal Cortex; Tomography, X-Ray Computed; Wounds, Penetrating | 2016 |
Sensitivity to Enterocins of Thermophilic Campylobacter spp. from Different Poultry Species.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Bacteriocins; Campylobacter coli; Campylobacter jejuni; Chickens; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Multiple, Bacterial; Ducks; Enterococcus faecium; Feces; Female; Male; Molecular Typing; Nalidixic Acid; Slovakia; Struthioniformes | 2016 |
Antibiotic Resistance of Bacteria Involved in Urinary Infections in Brazil: A Cross-Sectional and Retrospective Study.
Topics: Ampicillin; Anti-Bacterial Agents; Brazil; Ciprofloxacin; Cross-Sectional Studies; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Nitrofurantoin; Retrospective Studies; Sulbactam; Urinary Tract Infections | 2016 |
Synergistic activity of doped zinc oxide nanoparticles with antibiotics: ciprofloxacin, ampicillin, fluconazole and amphotericin B against pathogenic microorganisms.
Topics: Amphotericin B; Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Drug Combinations; Drug Synergism; Fluconazole; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Nanoparticles; Zinc Oxide | 2016 |
Prevalence and antimicrobial susceptibility of Acinetobacter spp. isolated from meat.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; Animals; Anti-Bacterial Agents; Cattle; Ceftazidime; Chickens; Ciprofloxacin; Cross Infection; DNA-Directed RNA Polymerases; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prevalence; Red Meat; Sulbactam; Swine; Trimethoprim, Sulfamethoxazole Drug Combination | 2017 |
Nanomechanical sensor applied to blood culture pellets: a fast approach to determine the antibiotic susceptibility against agents of bloodstream infections.
Topics: Ampicillin; Anti-Bacterial Agents; Bacteremia; Blood Culture; Ceftriaxone; Ciprofloxacin; Double-Blind Method; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Microscopy, Atomic Force; Nanotechnology | 2017 |
MazEF toxin-antitoxin proteins alter Escherichia coli cell morphology and infrastructure during persister formation and regrowth.
Topics: Ampicillin; Anti-Bacterial Agents; Cell Division; Chloramphenicol; Ciprofloxacin; DNA Replication; DNA-Binding Proteins; DNA, Bacterial; Endoribonucleases; Escherichia coli; Escherichia coli Proteins; Kanamycin; Microscopy, Electron | 2017 |
Bacteriological water quality in school's drinking fountains and detection antibiotic resistance genes.
Topics: Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Conjugation, Genetic; Drinking Water; Drug Resistance, Bacterial; Enterobacteriaceae; Humans; Microbial Sensitivity Tests; Plasmids; Schools; Tetracycline; Water Quality | 2017 |
Changes in Bacterial Resistance Patterns of Pediatric Urinary Tract Infections and Rationale for Empirical Antibiotic Therapy.
Topics: Adolescent; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Cefazolin; Cefixime; Ceftriaxone; Cefuroxime; Child; Child, Preschool; Ciprofloxacin; Community-Acquired Infections; Cross-Sectional Studies; Drug Combinations; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Humans; Infant; Male; Pediatrics; Retrospective Studies; Sulfamethizole; Trimethoprim; Turkey; Urinary Tract Infections | 2017 |
Detection of molecular changes induced by antibiotics in Escherichia coli using vibrational spectroscopy.
Topics: Ampicillin; Anti-Bacterial Agents; Cefotaxime; Ciprofloxacin; Escherichia coli; Spectrophotometry, Infrared; Spectrum Analysis, Raman; Vibration | 2017 |
Antibiotics in acute calculous cholecystitis - do Tokyo guidelines influence the surgeons' practices?
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Cefazolin; Ceftriaxone; Cholecystectomy; Cholecystectomy, Laparoscopic; Cholecystitis, Acute; Ciprofloxacin; Conversion to Open Surgery; Drug Therapy, Combination; Female; Gallstones; Humans; Length of Stay; Male; Metronidazole; Middle Aged; Pakistan; Practice Guidelines as Topic; Practice Patterns, Physicians'; Retrospective Studies; Severity of Illness Index; Surgeons; Surgical Wound Infection; Treatment Outcome | 2017 |
Within-host spatiotemporal dynamics of systemic Salmonella infection during and after antimicrobial treatment.
Topics: Ampicillin; Animal Structures; Animals; Anti-Bacterial Agents; Bacterial Load; Blood; Ciprofloxacin; Disease Models, Animal; Female; Mice, Inbred C57BL; Salmonella; Salmonella Infections; Sepsis; Spatio-Temporal Analysis | 2017 |
Automated direct screening for resistance of Gram-negative blood cultures using the BD Kiestra WorkCell.
Topics: Ampicillin; Anti-Bacterial Agents; Bacteremia; Blood Culture; Ceftriaxone; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Gentamicins; Gram-Negative Bacteria; Humans; Meropenem; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Thienamycins | 2018 |
Life-Threatening Atypical Case of Acute Generalized Exanthematous Pustulosis.
Topics: Acute Generalized Exanthematous Pustulosis; Adult; Amoxicillin; Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Enterococcus faecium; Humans; Male; Penicillin G; Periodontitis; Staphylococcal Infections; Staphylococcus aureus; Sulbactam; Systemic Inflammatory Response Syndrome | 2017 |
Assessment of the comparability of CLSI, EUCAST and Stokes antimicrobial susceptibility profiles for Escherichia coli uropathogenic isolates.
Topics: Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Bacteriuria; Cephalexin; Cephradine; Ciprofloxacin; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Nitrofurantoin; Practice Guidelines as Topic; Trimethoprim; Urinary Tract Infections; Uropathogenic Escherichia coli | 2018 |
Effect of general practice characteristics and antibiotic prescribing on Escherichia coli antibiotic non-susceptibility in the West Midlands region of England: a 4 year ecological study.
Topics: Adolescent; Adult; Aged; Ampicillin; Anti-Bacterial Agents; Antimicrobial Stewardship; Ciprofloxacin; Drug Resistance, Bacterial; Ecological and Environmental Phenomena; England; Escherichia coli; Escherichia coli Infections; Female; General Practice; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Nitrofurantoin; Practice Patterns, Physicians'; Retrospective Studies; Seasons; Urinary Tract Infections; Young Adult | 2018 |
Relative performance of antimicrobial susceptibility assays on clinical Escherichia coli isolates from animals.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Ciprofloxacin; Data Accuracy; Disk Diffusion Antimicrobial Tests; Dogs; Drug Resistance, Bacterial; Epidemiological Monitoring; Escherichia coli; Escherichia coli Infections; Horses; Humans; Microbial Sensitivity Tests; Tetracycline | 2018 |
Surveillance of antimicrobial resistance in Neisseria meningitidis strains isolated from invasive cases in Brazil from 2009 to 2016.
Topics: Adolescent; Ampicillin; Anti-Infective Agents; Brazil; Ceftriaxone; Child; Child, Preschool; Chloramphenicol; Ciprofloxacin; Drug Resistance, Bacterial; Epidemiological Monitoring; Female; Humans; Infant; Male; Meningococcal Infections; Microbial Sensitivity Tests; Neisseria meningitidis; Penicillin G; Rifampin | 2018 |
Multidrug resistance, prevalence and phylogenetic analysis of genes encoding class II and III integrons in clinically isolated Escherichia coli.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Base Sequence; Cefotaxime; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Gene Expression Regulation, Bacterial; Gentamicins; Hospitals; Humans; Imipenem; Integrons; Microbial Sensitivity Tests; Nalidixic Acid; Ofloxacin; Phylogeny; Polymerase Chain Reaction; Prevalence; Saudi Arabia; Sequence Alignment | 2018 |
Prevalence and antimicrobial susceptibility pattern of Salmonella and Shigella among food handlers in catering establishments at Debre Markos University, Northwest Ethiopia.
Topics: Adolescent; Adult; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Ciprofloxacin; Cross-Sectional Studies; Drug Resistance, Bacterial; Ethiopia; Feces; Female; Food Handling; Food Services; Humans; Male; Prevalence; Salmonella; Shigella; Universities; Young Adult | 2018 |
Multi-drug resistant Salmonella enterica serovar Typhi isolates with reduced susceptibility to ciprofloxacin in Kenya.
Topics: Ampicillin; Anti-Bacterial Agents; Ceftriaxone; Chloramphenicol; Ciprofloxacin; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; Kenya; Microbial Sensitivity Tests; Salmonella typhi; Trimethoprim, Sulfamethoxazole Drug Combination; Typhoid Fever | 2018 |
Assessing Activity of Antimicrobial Agents and Screening Antibiotic-Resistant Bacteria Through DREAM Assay.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Escherichia coli; Gentamicins; Methylene Blue; Microbial Sensitivity Tests | 2019 |
Laboratory characterisation of Salmonella enterica serotype Typhi isolates from Zimbabwe, 2009-2017.
Topics: Ampicillin; Anti-Bacterial Agents; Chloramphenicol; Ciprofloxacin; Clinical Laboratory Techniques; Disease Outbreaks; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Female; Haplotypes; Humans; Laboratories; Microbial Sensitivity Tests; Molecular Epidemiology; Salmonella enterica; Salmonella typhi; Serogroup; Typhoid Fever; Zimbabwe | 2019 |
Enteric bacteria, methicillin resistant S. aureus and antimicrobial susceptibility patterns from buses surfaces in Mekelle city, Tigray, Ethiopia.
Topics: Ampicillin; Anti-Bacterial Agents; Chloramphenicol; Ciprofloxacin; Drug Resistance, Bacterial; Enterobacteriaceae; Escherichia coli; Ethiopia; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Motor Vehicles; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination | 2019 |
Evaluation of in vitro and in vivo antibiotic efficacy against a novel bioluminescent Shigella flexneri.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Cell Line; Ciprofloxacin; Disease Models, Animal; Dysentery, Bacillary; Gastrointestinal Tract; Humans; Injections, Intraperitoneal; Luciferases; Luminescent Agents; Luminescent Measurements; Mice; Microbial Sensitivity Tests; Plasmids; Shigella flexneri | 2019 |
Historical contingency in the evolution of antibiotic resistance after decades of relaxed selection.
Topics: Ampicillin; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Directed Molecular Evolution; Drug Resistance, Bacterial; Escherichia coli; Genotype; Mutation; Public Health; Quantitative Trait, Heritable; Selection, Genetic; Tetracycline | 2019 |
Glucose sensitizes the stationary and persistent population of Vibrio cholerae to ciprofloxacin.
Topics: Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Glucose; Microbial Sensitivity Tests; Vibrio cholerae | 2020 |
Tailoring Antibiotic Prophylaxis for Ureteroscopic Procedures Based on Local Resistance Profiles May Lead to Reduced Rates of Infections and Urosepsis.
Topics: Administration, Oral; Adult; Aged; Ampicillin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Ciprofloxacin; Cross Infection; Drug Resistance, Bacterial; Female; Gentamicins; Humans; Kidney Calculi; Male; Middle Aged; Postoperative Complications; Preoperative Period; Retrospective Studies; Risk Factors; Sepsis; Ureteroscopy; Urinary Tract Infections | 2020 |
Transcriptional and Translational Inhibitors Block SOS Response and Shiga Toxin Expression in Enterohemorrhagic Escherichia coli.
Topics: Ampicillin; Anti-Bacterial Agents; Cell Wall; Ciprofloxacin; Enterohemorrhagic Escherichia coli; Escherichia coli Infections; Genes, Reporter; Protein Biosynthesis; Protein Synthesis Inhibitors; Shiga Toxin 1; SOS Response, Genetics; Transcription, Genetic | 2019 |
Effect of drug combinations on the kinetics of antibiotic resistance emergence in Escherichia coli CFT073 using an in vitro hollow-fibre infection model.
Topics: Ampicillin; Anti-Bacterial Agents; Bioreactors; Ciprofloxacin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Escherichia coli; Fosfomycin; Humans; Microbial Sensitivity Tests | 2020 |
Proteolytic Queues at ClpXP Increase Antibiotic Tolerance.
Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Drug Tolerance; Endopeptidase Clp; Escherichia coli; Escherichia coli Proteins; Green Fluorescent Proteins; Plasmids; Proteolysis; RNA-Binding Proteins; Sigma Factor | 2020 |
Proteomic Investigation of Tolerant
Topics: Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Escherichia coli; Proteomics | 2020 |
Factors associated with Salmonella infection in patients with gastrointestinal complaints seeking health care at Regional Hospital in Southern Highland of Tanzania.
Topics: Adolescent; Adult; Ampicillin; Anti-Bacterial Agents; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; Cross-Sectional Studies; Diarrhea; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Female; Gastrointestinal Diseases; Hospitals; Humans; Infant; Male; Middle Aged; Prevalence; Salmonella; Salmonella Infections; Tanzania; Trimethoprim, Sulfamethoxazole Drug Combination; Typhoid Fever; Young Adult | 2020 |
Antibiotic susceptibility of cultivable aerobic microbiota from the oral cavity of Echis carinatus from Odisha (India).
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Azithromycin; Cefpodoxime; Ceftizoxime; Ciprofloxacin; Gentamicins; Imipenem; Methicillin; Microbial Sensitivity Tests; Microbiota; Mouth; Penicillins; Phylogeny; RNA, Ribosomal, 16S; Viperidae | 2020 |
A data-based mathematical modelling study to quantify the effects of ciprofloxacin and ampicillin on the within-host dynamics of
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Ciprofloxacin; Humans; Mice; Microbial Sensitivity Tests; Models, Theoretical; Recurrence; Salmonella enterica | 2020 |
Ciprofloxacin-induced persister-cells in
Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Load; Campylobacter jejuni; Ciprofloxacin; DNA Damage; Drug Resistance, Bacterial; Drug Tolerance; Microbial Sensitivity Tests; SOS Response, Genetics | 2020 |
Pyelonephritis.
Topics: Acute Disease; Adult; Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Female; Fluid Therapy; Fluoroquinolones; Humans; Pyelonephritis; Trimethoprim, Sulfamethoxazole Drug Combination; Urinalysis | 2020 |
Characterization of Campylobacter associated gastric enteritis among patients with Human Immunodeficiency Virus (HIV) in a hospital in Accra, Ghana.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Campylobacter; Campylobacter Infections; Ciprofloxacin; Cross-Sectional Studies; Drug Resistance, Bacterial; Erythromycin; Female; Gastroenteritis; Gentamicins; Ghana; HIV Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged | 2020 |
Seven-year surveillance of the prevalence of antimicrobial-resistant Escherichia coli isolates, with a focus on ST131 clones, among healthy people in Osaka, Japan.
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactamases; Carrier State; Cefotaxime; Ciprofloxacin; Colistin; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Epidemiological Monitoring; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Feces; Humans; Japan; Microbial Sensitivity Tests; Polymerase Chain Reaction; Prevalence | 2021 |
Maternal antibiotic administration during a critical developmental window has enduring neurobehavioural effects in offspring mice.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Anxiety; Ciprofloxacin; Cognition; Female; Homing Behavior; Imipenem; Male; Metronidazole; Mice; Mice, Inbred C57BL; Penicillin V; Pregnancy; Prenatal Exposure Delayed Effects; Social Behavior; Vancomycin; Vocalization, Animal | 2021 |
Global protein responses of multidrug resistance plasmid-containing Escherichia coli to ampicillin, cefotaxime, imipenem and ciprofloxacin.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; beta-Lactams; Cefotaxime; Ciprofloxacin; Drug Resistance, Multiple; Escherichia coli; Imipenem; Plasmids; Proteome; Proteomics | 2022 |
Prevalence, antimicrobial resistance and virulence genes of Salmonella serovars isolated from humans and animals.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Cefepime; Ceftriaxone; Chloramphenicol; Ciprofloxacin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Gentamicins; Humans; Microbial Sensitivity Tests; Prevalence; Salmonella enterica; Serogroup; Tetracyclines; Virulence | 2022 |
Antimicrobial Susceptibility Survey of Invasive Neisseria meningitidis, United States 2012-2016.
Topics: Ampicillin; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Humans; Meningococcal Infections; Microbial Sensitivity Tests; Neisseria meningitidis; Penicillins; United States | 2022 |
The effect of nickel ions on the susceptibility of bacteria to ciprofloxacin and ampicillin.
Topics: Ampicillin; Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Escherichia coli; Ions; Microbial Sensitivity Tests; Nickel; Staphylococcus aureus | 2022 |
Long-term modification of gut microbiota by broad-spectrum antibiotics improves stroke outcome in rats.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Ciprofloxacin; Cytokines; Endothelin-1; Fatty Acids, Volatile; Gastrointestinal Microbiome; Infarction; Meropenem; Metronidazole; Rats; Stroke; Vancomycin | 2022 |
Community-Acquired Uropathogenic
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactamases; Cefazolin; Ciprofloxacin; Colistin; Cross-Sectional Studies; Cuba; Escherichia coli Proteins; Fosfomycin; Humans; Microbial Sensitivity Tests; Nitrofurantoin; Sulbactam; Sulfamethoxazole; Trimethoprim; Urinary Tract Infections; Uropathogenic Escherichia coli | 2022 |
Outpatient Antibiotic Resistance Patterns of Escherichia coli Urinary Isolates Differ by Specialty Type.
Topics: Ampicillin; Anti-Bacterial Agents; Child; Ciprofloxacin; Drug Resistance, Bacterial; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infections; Gentamicins; Humans; Microbial Sensitivity Tests; Outpatients; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2022 |
Population pharmacokinetics of three alternative prophylactic antibiotics during cardiac surgery with extracorporeal circulation.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cardiac Surgical Procedures; Cefazolin; Ciprofloxacin; Extracorporeal Circulation; Humans; Prospective Studies | 2023 |
Prevalence and antimicrobial susceptibility of Enterococcus spp. from urine of dogs and cats in northwestern Croatia.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Cat Diseases; Cats; Chloramphenicol; Ciprofloxacin; Croatia; Dog Diseases; Dogs; Drug Resistance, Bacterial; Enrofloxacin; Enterococcus; Enterococcus faecium; Gentamicins; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Nitrofurantoin; Penicillins; Prevalence; Rifampin; Streptomycin; Tetracycline; Vancomycin | 2022 |
Molecular Cut-off Values for Aliarcobacter butzleri Susceptibility Testing.
Topics: Ampicillin; Anti-Bacterial Agents; Arcobacter; Ciprofloxacin; Drug Resistance, Bacterial; Erythromycin; Humans; Microbial Sensitivity Tests; Tetracycline | 2022 |
The prevalence of multiple drug resistance Escherichia coli and Klebsiella pneumoniae isolated from patients with urinary tract infections.
Topics: Ampicillin; Anti-Bacterial Agents; Aztreonam; Cefepime; Ceftazidime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple; Escherichia coli; Escherichia coli Infections; Gentamicins; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Microbial Sensitivity Tests; Piperacillin; Prevalence; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2022 |
Clinical profiles and antimicrobial resistance patterns of invasive Salmonella infections in children in China.
Topics: Ampicillin; Anti-Bacterial Agents; C-Reactive Protein; Ceftriaxone; Child; Child, Preschool; China; Ciprofloxacin; Drug Resistance, Bacterial; Humans; Infant; Microbial Sensitivity Tests; Procalcitonin; Salmonella; Salmonella Infections; Trimethoprim, Sulfamethoxazole Drug Combination; Typhoid Fever | 2022 |
Ultrasound-assisted facile synthesis of Boron-Heck-coupled sclareol analogues as potential antibacterial agents against Staphylococcus aureus.
Topics: Ampicillin; Anti-Bacterial Agents; Boron; Ciprofloxacin; Drug Synergism; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcus aureus | 2022 |
Pathogenicity and transcriptome analysis of a strain of Vibrio owensii in Fenneropenaeus merguiensis.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Aztreonam; Cefazolin; Cefotaxime; Ciprofloxacin; Citrates; Gene Expression Profiling; Immunity, Innate; Lectins, C-Type; Minocycline; Oxacillin; Penaeidae; Phosphatidylinositol 3-Kinases; Piperacillin; Proto-Oncogene Proteins c-akt; Pyruvates; Streptomycin; Transcriptome; Vibrio; Virulence | 2022 |
Combinatorial screening SlipChip for rapid phenotypic antimicrobial susceptibility testing.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Ceftazidime; Ciprofloxacin; Escherichia coli; Humans; Nitrofurantoin | 2022 |
Aetiology, antimicrobial susceptibility and outcome of children with sepsis, admitted at Muhimbili National Hospital, Dar es Salaam.
Topics: Amikacin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Child, Preschool; Ciprofloxacin; Clindamycin; Coagulase; Cross-Sectional Studies; Escherichia coli; Female; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Hospitals; Humans; Infant; Male; Meropenem; Microbial Sensitivity Tests; Prospective Studies; Sepsis; Staphylococcus aureus; Tanzania | 2022 |
Prevalence and antimicrobial resistance of Campylobacter and Salmonella in layer flocks in Honshu, Japan.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Campylobacter; Campylobacter Infections; Campylobacter jejuni; Chickens; Ciprofloxacin; Drug Resistance, Bacterial; Humans; Japan; Microbial Sensitivity Tests; Prevalence; Salmonella; Tetracycline | 2022 |
European-wide antimicrobial resistance monitoring in commensal Escherichia coli isolated from healthy food animals between 2004 and 2018.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Cattle; Chickens; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Swine; Trimethoprim, Sulfamethoxazole Drug Combination | 2022 |
Characterization and Transferability of erm and tet Antibiotic Resistance Genes in Lactobacillus spp. Isolated from Traditional Fermented Milk.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Lactobacillus; Microbial Sensitivity Tests; Milk; RNA, Ribosomal, 16S; Sodium Chloride; Streptomycin; Trimethoprim; Vancomycin | 2022 |
Multi-drug resistant bacteria isolates from lymphatic filariasis patients in the Ahanta West District, Ghana.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Bacteria; beta-Lactamases; Ceftazidime; Chloramphenicol; Ciprofloxacin; Elephantiasis, Filarial; Erythromycin; Escherichia coli; Escherichia coli Infections; Gentamicins; Ghana; Humans; Infant; Meropenem; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Penicillins; Pseudomonas aeruginosa; Staphylococcal Infections; Staphylococcus aureus; Tetracyclines | 2022 |
Prevalence, antimicrobial resistance, virulence gene profile and molecular typing of Campylobacter species isolated from poultry meat samples.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Campylobacter; Chloramphenicol; Ciprofloxacin; Drug Resistance, Bacterial; Humans; Meat; Molecular Typing; Poultry; Prevalence; Virulence; Virulence Factors | 2022 |
Isolation, identification and antibiotic resistance profile of thermophilic Campylobacter species from Bovine, Knives and personnel at Jimma Town Abattoir, Ethiopia.
Topics: Abattoirs; Agar; Ampicillin; Animals; Anti-Bacterial Agents; Campylobacter; Campylobacter Infections; Cattle; Cefixime; Ceftriaxone; Cephalothin; Chloramphenicol; Ciprofloxacin; Clindamycin; Cross-Sectional Studies; Drug Resistance, Bacterial; Drug Resistance, Microbial; Ethiopia; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Tetracycline | 2022 |
Analysis of the Antimicrobial and Anti-Biofilm Activity of Natural Compounds and Their Analogues against
Topics: Aldehydes; Amikacin; Ampicillin; Anti-Bacterial Agents; Biofilms; Cephalothin; Chloramphenicol; Ciprofloxacin; Clindamycin; Eugenol; Gentamicins; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Streptomycin | 2022 |
Real world clinical feasibility of direct-from-specimen antimicrobial susceptibility testing of clinical specimens with unknown microbial load or susceptibility.
Topics: Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Feasibility Studies; Humans; Microbial Sensitivity Tests | 2022 |
Association between antimicrobial consumption and resistance rate of Escherichia coli in hospital settings.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Fluoroquinolones; Hospitals; Humans; Microbial Sensitivity Tests | 2023 |
Single Cell Killing Kinetics Differentiate Phenotypic Bacterial Responses to Different Antibacterial Classes.
Topics: Ampicillin; Anti-Bacterial Agents; Bacteria; beta-Lactams; Ciprofloxacin; Escherichia coli; Fluoroquinolones; Microbial Sensitivity Tests | 2023 |
Distribution of Virulence Genes in
Topics: Agaricus; Amoxicillin; Ampicillin; Anti-Bacterial Agents; Campylobacter; Campylobacter Infections; Campylobacter jejuni; Ciprofloxacin; Clavulanic Acid; Erythromycin; Gentamicins; Humans; Iran; Nalidixic Acid; Virulence | 2023 |
Evaluation of efflux pump inhibitory activity of some plant extracts and using them as adjuvants to potentiate the inhibitory activity of some antibiotics against
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Capsaicin; Ciprofloxacin; Erythromycin; Ethidium; Gentamicins; Humans; Multidrug Resistance-Associated Proteins; Plant Extracts; Propolis; Staphylococcal Infections; Staphylococcus aureus; Tetracycline | 2023 |
Antimicrobial resistance profiles of Campylobacter jejuni and Salmonella spp. isolated from enteritis patients in Japan.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Campylobacter Infections; Campylobacter jejuni; Cefotaxime; Ciprofloxacin; Drug Resistance, Bacterial; Enteritis; Japan; Microbial Sensitivity Tests; Salmonella; Tetracycline | 2023 |
ANTIBIOTIC RESISTANCE OF SALMONELLA TYPHI CARRIER ASSOCIATED WITH GALL BLADDER CHRONIC INFECTION IN AL-NAJAF PROVINCE.
Topics: Ampicillin; Anti-Bacterial Agents; Cefepime; Cefixime; Chloramphenicol; Ciprofloxacin; Communicable Diseases; Drug Resistance, Microbial; Gallbladder Diseases; Humans; Persistent Infection; Salmonella typhi; Tetracycline | 2023 |
Multiple antibiotic resistance index (MARI) of human-isolated Salmonella species: a practical bacterial antibiotic surveillance tool.
Topics: Ampicillin; Anti-Bacterial Agents; Child; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Humans; Infant, Newborn; Salmonella; Tetracyclines | 2023 |
Epidemiology of community origin of major multidrug-resistant ESKAPE uropathogens in a paediatric population in South-East Gabon.
Topics: Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Enterococcus; Escherichia coli; Gabon; Humans; Klebsiella pneumoniae; Male; Staphylococcus aureus; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2023 |
Epigenetic-Based Regulation of Transcriptome in Escherichia coli Adaptive Antibiotic Resistance.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Microbial; Epigenesis, Genetic; Escherichia coli; Gentamicins; Humans; Microbial Sensitivity Tests; Transcriptome | 2023 |
Sub-MIC antibiotics affect microbial ferrihydrite reduction by extracellular membrane vesicles.
Topics: Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Iron; Oxides; Proteomics | 2023 |
Study of bacterial respiratory infections and antimicrobial susceptibility profile among antibiotics naive outpatients visiting Meru teaching and referral hospital, Meru County, Kenya in 2018.
Topics: Agar; Amoxicillin; Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Humans; Kenya; Outpatients; Piperacillin; Respiratory Tract Infections; Staphylococcal Infections | 2023 |
Molecular characterization of multidrug-resistant non-typeable Haemophilus influenzae with high-level resistance to cefuroxime, levofloxacin, and trimethoprim-sulfamethoxazole.
Topics: Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Azithromycin; beta-Lactamases; Cefuroxime; Ciprofloxacin; Haemophilus Infections; Haemophilus influenzae; Humans; Levofloxacin; Microbial Sensitivity Tests; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination | 2023 |
The intestinal carrier status of Enterococcus spp. in children: clonal diversity and alterations in resistance phenotypes before and after admission to a pediatric intensive care unit.
Topics: Ampicillin; Child; Ciprofloxacin; Enterococcus; Hospitalization; Humans; Intensive Care Units, Pediatric; Phenotype; Phylogeny; Random Amplified Polymorphic DNA Technique; Vancomycin | 2023 |
Remarkable antibiofilm activity of ciprofloxacin, cefoxitin, and tobramycin, by themselves or in combination, against enteroaggregative Escherichia coli in vitro.
Topics: Ampicillin; Anti-Bacterial Agents; Biofilms; Cefoxitin; Ciprofloxacin; Diarrhea; Escherichia coli; Escherichia coli Infections; Humans; Tobramycin | 2023 |
Translation of Machine Learning-Based Prediction Algorithms to Personalised Empiric Antibiotic Selection: A Population-Based Cohort Study.
Topics: Aged; Algorithms; Ampicillin; Anti-Bacterial Agents; Cefepime; Ciprofloxacin; Cohort Studies; Female; Gentamicins; Humans; Imipenem; Machine Learning; Male; Middle Aged; Sulbactam; Sulfamethoxazole; Trimethoprim; Urinary Tract Infections | 2023 |
Medicinal plant Miconia albicans synergizes with ampicillin and ciprofloxacin against multi-drug resistant Acinetobacter baumannii and Staphylococcus aureus.
Topics: Acinetobacter baumannii; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Ciprofloxacin; Melastomataceae; Microbial Sensitivity Tests; Plants, Medicinal; Staphylococcus aureus; Tandem Mass Spectrometry | 2023 |
A metagenomic analysis for combination therapy of multiple classes of antibiotics on the prevention of the spread of antibiotic-resistant genes.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Gastrointestinal Microbiome; Genes, Bacterial; Mice; Microbiota | 2023 |
Synergistic antibacterial effects of exopolysaccharides/nickel-nanoparticles composites against multidrug-resistant bacteria.
Topics: Ampicillin; Anti-Bacterial Agents; Chloramphenicol; Ciprofloxacin; Gram-Negative Bacteria; Gram-Positive Bacteria; Kanamycin; Metal Nanoparticles; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Nickel; Pseudomonas aeruginosa | 2023 |